The importance of endogenous cannabinoids in stress-related disorders and depression by Jenniches, Imke
	
 
 
 
 
The importance of endogenous 
cannabinoids in stress-related 
disorders and depression 
 
 
 
 
Dissertation 
zur  
Erlangung des Doktorgrades (Dr. rer. nat.) 
der 
Mathematisch-Naturwissenschaftlichen Fakultät 
der 
Rheinischen Friedrich-Wilhelms-Universität Bonn 
 
vorgelegt von 
Imke Jenniches 
aus  
Neuss 
 
 
 
Bonn, April 2016 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der 
Rheinischen Friedrich-Wilhelms-Universität Bonn 
 
1. Gutachter: Prof. Dr. A. Zimmer 
2. Gutachter: Prof. Dr. M. Hoch 
 
Tag der Promotion: 19.12.2016 
Erscheinungsjahr: 2017 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Man merkt nie, was schon getan wurde, man sieht immer nur, was 
noch zu tun bleibt.” 
 
Marie Curie
Abbreviations	
Abbreviations 
 
AA Arachidonic acid 
ACTH Adrenocorticotropin hormone 
2-AG 2-arachidonoylglycerol 
AEA Arachidonoylethanolamine (Anandamide) 
ATP Adenosine triphosphate 
BCA Bicinchoninic acid assay 
BCP 1-bromo-3-chloropropane 
BDNF Brain-derived neurotrophic factor 
BLA Basolateral amygdala 
BMM Bone marrow-derived macrophages 
bp Base pair 
BSA Bovine serum albumine 
BrdU 5-Bromo-2-Deoxyuridine 
CamKII α Calcium/calmodulin dependent protein kinase II α 
CB1 Cannabinoid receptor 1 
cm Centimeter 
CMV Human cytomegalovirus (CMV) promoter 
CNS  Central nervous system 
CRH Corticotropin-releasing hormone 
CRHR1 Corticotropin-releasing hormone receptor 1 
CSDS Chronic social defeat stress 
dB Decibel 
DAG Diacylglycerol 
DAGL Diacylglycerol lipase 
DAPI 4',6-diamidino-2-phenylindole 
dH2O Deionized H2O 
DIG Digoxigenin 
DMEM Dulbecco’s Modified Eagl Medium 
DMSO Dimethylsulfoxid 
DNA Desoxyribonucleic acid 
DTT Dithiothreitol 
eCB Endocannabinoid 
ECS Endocannabinoid system 
EDTA Ethylene glycol tetraacetic acid 
ELISA Enzyme-linked immunosorbent assay 
EtOH Ethanol 
FAAH Fatty acid amid hydrolase 
FAM 6-carboxyfluorescein 
FCS Fetal calf serum 
FGF Fibroblast growth factor 
Abbreviations	
FITC Fluorescein isothiocyanate 
fl Floxed (flanked by loxP sites) 
G418 Geneticin 
GABA γ-aminobutyric acid 
g Gravitational force 
g Gram 
GPR G-protein coupled receptor 
GR Glucocorticoid receptor 
h Hour 
HBSS Hank’s buffered salt solution 
HCl Hydrochloric acid 
HEK293T Human Embryonic Kidney 293T cells  
HPA axis Hypothalamic–pituitary–adrenal axis 
HRP Horseradish peroxidase 
i.p. intraperitoneal 
JNK1 c-Jun N-terminal kinase 1 
kb Kilobase 
kDa Kilodalton 
kg Kilogram 
kHz Kilohertz 
loxP “locus of X-ing over” in Phage P1 
M Molar 
m Meter 
mM Millimolar 
mA Miliampere 
MAGL Monoacylglycerol lipase 
MALDI Matrix-assisted laser desorption/ionization 
MAPK8 Mitogen-activated protein kinase 8 
M-CSF Macrophage colony-stimulating factor 
MeOH Methanol 
MGB Minor groove binder 
min Minutes 
MR Mineralocorticoid receptor 
mRNA Messenger RNA 
ms Milliseconds 
MS Mass spectrometry 
n Number (sample size) 
NAc Nucleus accumbens 
NAPE N-acyl-phosphatidylethanolamine 
NAPE-PLD NAPE-phospholipase D 
NCAM Neural cell adhesion molecule 
NeuN Neuronal nuclear antigen 
Abbreviations	
nm Nanomolar 
ns Not significant 
ng Nanogram 
PBS  Phosphate buffered saline 
PCR Polymerase chain reaction 
PE Phosphatidylethanolamine 
PFA Paraformaldehyd 
PFC Prefrontal cortex 
Pgk-1 Phosphoglycerate kinase-1 promotor 
PI3K Phosphatidylinositide 3-kinase 
PKA Protein kinase A 
PKC Protein kinase C 
PLC Phospholipase C 
PVN Periventricular nucleus 
RNA Ribonucleic acid 
RT Room temperature 
RT-PCR Reverse transcription-PCR 
s Second 
SDS Sodium dodecyl sulfate 
SEM  Standard error of the mean 
SSC Saline sodium citrate 
TAP Tandem affinity purification 
TE Tris EDTA 
THC Δ9-tetrahydrocannabinol 
TLC Thin layer chromatography 
TOF Time of flight 
Tris Tris (hydroxymethyl) aminomethane 
TRPV1 Transient receptor potential vanilloid type-1 
U Unit 
UV Ultraviolet 
VTA Ventral tegmental area 
WHO World Health Organization 
WT Wild type 
µl Microliter 
µM Micromolar 
 
 
 
 
 
 
 
 
Summary	
Summary 
 
The endogenous cannabinoid system (ECS) is a unique neuromodulatory system, 
essentially involved in a variety of physiological processes. It consists of the two major 
endogenous cannabinoids (eCBs), anandamide and 2-AG, and a set of cannabinoid 
receptors. The signaling mechanism especially in the central nervous system (CNS) is 
well characterized. In the CNS, both endocannabinoids inhibit the release of excitatory 
and inhibitory neurotransmitters through the activation of presynaptic cannabinoid 
receptors.  
The ECS is predominantly expressed in brain regions crucially involved in the 
regulation of memory and emotion, such as the prefrontal cortex, hippocampus and 
amygdala. Disruption of the ECS through pharmacological or genetic invalidation of 
cannabinoid CB1 receptors has been linked to depression in humans and depression-like 
behaviors in mice. Thus, there is an increasing evidence to support a role for the ECS in 
the neurobiology of psychiatric disorders. However, the similar mode of action of both 
eCBs exacerbates the discrimination of distinct functions to either anandamide or 2-AG. 
To elucidate the impact of 2-AG on the development and manifestation of anxiety- and 
depression-related disorders, constitutive as well as cell-type specific knockout mice of 
the main 2-AG biosynthetic enzyme diacylglycerol lipase α (DAGLα) were analyzed in 
detail. The deletion of Dagla caused severe behavioral alterations leading to increased 
anxiety, altered fear responses and depressive-like phenotypes. In the past decade, the 
endocannabinoid system has also emerged as an important regulator of the stress 
response and as a candidate mediator of stress adaptation. In line with this, the 
constitutive and neuronal deletion of Dagla markedly increased the sensitivity to chronic 
stress. Despite the vastly gained knowledge concerning the ECS, the prime cellular 
source of 2-AG in the brain is yet unknown. Neurons, microglia as well as astrocytes hold 
a functional ECS and produce 2-AG in vitro. First promising insights regarding cellular 
source of 2-AG under baseline conditions and in response to chronic stress are given 
through this study. 
The present findings evidently support the assumption that a dysregulated ECS, in 
particular the altered 2-AG signaling, negatively affects the emotional state of rodents.  
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 Introduction 
1.1 The endocannabinoid system 
Since time immemorial plants are used as therapeutics against a variety of diseases. The 
medicinal use of Cannabis sativa goes back to 2000 BC and even the psychotropic 
properties are known since then (Murray et al. 2007). Thus, Cannabis sativa and its 
extracts are one of the oldest herbal drugs. However, only in 1964 the psychoactive 
ingredient Δ9-tetrahydrocannabinol (THC) was isolated and identified (Gaoni & 
Mechoulam 1964). It took another 30 years until the molecular target of THC, the 
endogenous cannabinoid receptors, were identified. In the late 1980s, the first 
cannabinoid receptor (CB1) was identified and characterized (Devane et al. 1988; 
Matsuda et al. 1990) followed by the cannabinoid receptor 2 (CB2) (Munro et al. 1993) 
and the two main endogenous cannabinoids N-arachidonoylethanolamine (anandamide, 
AEA) and 2-arachidonoylglycerol (2-AG) in mid 1990s (Devane et al. 1992; Mechoulam et 
al. 1995) (Fig. 1).  
 
Figure 1: Structural formal of the main psychoactive compound of Cannabis sativa, Δ9-
tetrahydrocannabinol (THC), and the endogenous cannabinoids anandamide and 2-AG  
 
In the past decades the research interest in the cannabinoid field has grown 
tremendously and today the search term “cannabinoid” gives more than 19000 hits in 
“Pubmed” (http://www.ncbi.nlm.nih.gov/pubmed/), the worldwide most frequently used free 
search engine for publications on life sciences, with upward tendency. Growing research 
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interest elucidated the role of the endocannabinoid system (ECS) in many physiological 
processes and showed that the ECS plays an important role in health and disease. Its 
signaling mechanism especially in the central nervous system (CNS) is well characterized.  
In the CNS, the endogenous cannabinoids (eCBs) act as retrograde messenger 
molecules on inhibitory and excitatory synapses (Katona et al. 1999; Katona et al. 2006). 
2-AG and anandamide are produced in the postsynapse, released into the synaptic cleft 
and activate presynaptic cannabinoid receptors, thereby initiating ECS signaling. In 
contrast to other neurotransmitters, eCBs are mainly synthesized on demand rather than 
stored in vesicles. The two major cannabinoid receptors CB1 and CB2 belong to the 
superfamily of G protein-coupled receptors and exhibit distinct expression profiles. CB1 is 
highly expressed in the brain and constitutes the main neuronal cannabinoid receptor 
(Matsuda et al. 1990), whereas CB2 is mainly expressed on immune cells and in the 
periphery (Munro et al. 1993; Pacher & Mechoulam 2011). Recent publications showing 
the presence of CB2 on brainstem neurons and in other brain areas (Van Sickle et al. 
2005; Ashton et al. 2006; Li & Kim 2015) led to an “identity crisis” of the receptor (Atwood 
& Mackie 2006), and until today the functional presence of CB2 on neurons remains 
controversial. Besides the two well-characterized cannabinoid receptors CB1 and CB2 
rising evidence supports the occurrence of other eCB targets, like the transient receptor 
potential vanilloid type-1 (TRPV-1) receptor, the orphan G-protein coupled receptors 
GPR55 (Di Marzo et al. 2010; Ross 2009) and GPR18 (McHugh et al. 2012), and the 
peroxisome proliferator activated receptors (PPAR) α and γ (Pistis & Melis 2010).  
Additionally, the ECS comprises several catabolic and metabolic enzymes. The two 
main endogenous cannabinoids anandamide and 2-AG are produced on demand from 
lipid precursors via distinct pathways. The canonical view is that anandamide is mainly 
synthesized by the N-acyltransferase (NAT) and N-acyl-phosphatidylethanolamines-
specific phospholipase D (NAPE-PLD) and hydrolyzed by the fatty acid amino hydrolase 
(FAAH) (for review see Rahman et al. 2014). Instead, two sn2-specific diacylglycerol 
lipases (DAGLα and DAGLß) are responsible for the synthesis of 2-AG, a 
monoacylglycerol, which is mainly metabolized by monoacylglycerol lipase (MAGL) to 
arachidonic acid and glycerol. In addition, both eCBs can be oxidized by cyclooxygenase-
2 (COX-2), distinct lipooxygenases (LOXs), or cytochromes P450 (CYPs) (Urquahrt et al. 
2015) leading to the production of new biological active metabolites (Rouzer & Marnett 
2011; Alhouayek M & Muccioli 2014).  
Overall the complex composition and intrinsic signaling pathways reveal the 
important contribution of the ECS in a variety of biological processes. The following 
sections will give a short synopsis of neuronal ECS signaling, the biosynthesis of the main 
eCB 2-AG and the contribution of the ECS in emotional processes. 
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1.2 ECS signaling 
At neuronal synapses the cannabinoid neurotransmitter system acts in a retrograde 
fashion. Hereby, the endogenous cannabinoids reduce synaptic inputs onto the stimulated 
neuron in a highly selective and restricted manner. Upon depolarization of the 
postsynaptic neuron leading to an increase of cytoplasmatic Ca2+ levels, the endogenous 
cannabinoids are synthesized and released into the synaptic cleft. Subsequently, the 
eCBs bind to presynaptic cannabinoid receptors and thereby activate Gi signaling. This 
signaling cascade leads, among others, to a decrease of intracellular Ca2+ levels by 
inhibiting Ca2+ channels, thus inhibiting neurotransmitter release (Fig. 2). The described 
mechanism is responsible for the depolarization-induced suppression of inhibition (DSI) or 
depolarization-induced suppression of excitation (DSE), in GABAergic neurons (Ohno-
Shosaku et a. 2001) or glutamatergic neurons, respectively (Kreitzer et al. 2001).  
 
 
Figure 2: Retrograde signaling of the endocannabinoid system, exemplarily illustrated for the action of 
2-AG: A) Strong postsynaptic depolarization causes influx of Ca2+ through voltage-gated Ca2+ channels. The 
increase in intracellular Ca2+ concentration induces the production of diacylglycerol (DAG) through unknown 
pathways. B) Strong glutamate signaling activates NMDA receptors, resulting in a large Ca2+ elevation and 
induction of 2-AG production and release through the same pathways. C) Massive release of glutamate 
activates mGluR5/1 receptors and triggers production of DAG via the activation of PLCß. Subsequent DAGL 
activity converts DAG into 2-AG. Abbreviations: 2-AG: 2-arachindonoyl glycerol, AMPA: a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor (ionotropic glutamate receptor), CB1: cannabinoid receptor 1, DAG: 
diacylglycerol, DAGL: diacylglycerol lipase, GABA: γ-aminobutyric acid (inhibitory neurotransmitter), NMDA 
receptor: N-methyl-D-aspartate receptor (ionotropic glutamate receptor), PIP2: phosphatidylinositol-2-
phosphat, PLCß: phospholipase-Cß. 
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In addition, a further well-described mechanism triggers the release of 2-AG at 
glutamatergic synapses. A massive release of glutamate can lead to an activation of 
postsynaptic metabotropic glutamate receptors (mGluR1/mGluR5) and triggers the 
production of diacylglycerol (DAG) by phospholipase-Cß (PLCß). Subsequent DAGL 
activity leads to the conversion of DAG into 2-AG (for review see: Katona & Freund 2008). 
Furthermore, strong activation of highly Ca2+-permeable N-methyl-D-aspartate (NMDA) 
receptors can directly lead to a Ca2+ influx and thereby induce endocannabinoid release 
via yet unknown pathways (Kano et al. 2009) (Fig. 2). For the termination of cannabinoid 
receptor activation the eCBs are rapidly removed from the synaptic cleft and degraded 
presynpatically by different hydrolytic pathways. 
Besides its prevalence in the CNS, the ECS exerts key peripheral functions related 
to immunity, bone metabolism, gastrointestinal-, cardiovascular- and reproductive 
functioning (Chiurchiú et al. 2015; Idris & Ralston 2012; Izzo & Sharkey 2010; Montecucco 
& Di Marzo 2012; Meccariello et al. 2014). However, functions and signaling mechanisms 
are best described in the CNS.   
1.3 Metabolism of 2-AG: the diacylglycerol lipases 
2-AG and anandamide are the two best-studied endogenous cannabinoids. Nevertheless, 
2-AG is the most abundant eCB in the CNS, with concentrations up to 800 fold higher 
than anandamide (Sugiura et al. 1995), and acts as a full agonist on both cannabinoid 
receptors (Gonsiorek et al. 2000; Savinainen et al. 2001). Even though anandamide binds 
with higher affinity to CB1, it is just a partial agonist on cannabinoid receptors (Mackie et 
al.1993). Furthermore, the retrograde eCB signaling seems to be primary 2-AG 
dependent, since DSI is completely lost in the hippocampus of mice lacking DAGLα (Gao 
et al. 2010; Tanimura et al. 2010). Based on these differences, 2-AG might be the main 
natural cannabinoid agonist and the key endocannabinoid involved in retrograde signaling 
in the brain (Sugiura et al. 2006; Tanimura et al. 2010). 2-AG is mainly produced by the 
hydrolysis of a DAG molecule containing arachidonic acid in sn2 position. DAGs are 
important second messenger molecules, which can directly activate effector molecules or, 
as in this particular case, serve as a substrate to generate further signaling lipids (Ueda et 
al. 2014). The DAG precursor is provided by phospholipase C (PLC)-mediated hydrolysis 
of the membrane phospholipid phosphatidylinositol (PI). In a next step the DAG lipases 
hydrolyze DAG into 2-AG and a free fatty acid (Prescotts & Majerus 1983; Sugiura et al. 
1995).  
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However, other pathways to generate 2-AG involving phospholipase-A1 and lyso-
PLC have also been described (Bisogno et al. 1999). 
The degradation of 2-AG is mainly mediated by MAGL. This enzyme catalyzes the 
hydrolysis of 2-AG into arachidonic acid and glycerol (Dinh et al. 2002). However, more 
recently, the Aß-hydrolases ABHD6 and ABHD12 have been reported to also hydrolyze 
endocannabinoids (Blankman et al. 2007; Fiskerstrand et al. 2010). Furthermore, 2-AG 
can be oxidized by LOX-12 and COX-2 (for review see Urquahrt et al. 2015) resulting in 
the production of bioactive prostanoid glyceryl ester that play an important role in pain and 
immunomodulation (Hu et al. 2008) (Fig. 3). 
 
 
Figure 3: Alternative biosynthetic and degradative pathways of 2-AG (Fezza et al. 2014):  
AA: arachidonic acid, 2-AG: 2-arachidonoylglycerol, ABHD6/12: serine hydrolases, α/β-hydrolase domain 
6/12, COX-2: cyclooxygenase 2, DAGL: diacylglycerol lipase, 12-LOX: 12-lipooxygenase, MAGL: 
monoacylglycerol lipase, PA: phosphatidic acid, PGE2-G: prostaglandin E2 glycerol ester, PI: 
phopshatidylinositol, PLA1: phospholipase A1, PLC: phospholipase C. 
 
DAG lipases were first described and studied in the context of arachidonic acid 
release (Prescott & Majerus 1983; Allen et al. 1992). However, since the identification of 
2-AG as an endocannabinoid (Sugiura et al. 1995) the function and regulation of DAG 
lipases appeared in a new light. Two isoforms of the 2-AG producing DAG lipases, 
DAGLα and DAGLß, have been cloned and described in detail (Bisogno et al. 2003). Both 
enzymes show a high similarity in men and mice (DAGLα: 97 %, DAGLß: 79 %), are 
closely related and exhibit an sn1-specifity in terms of their DAG substrates (Bisogno et al. 
2003). Nevertheless, both enzymes show different distinct expression profiles in the 
developing brain and adult organism. While DAGLα is constantly expressed during 
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neuronal development and in the adult brain, DAGLß is less abundant in the adult CNS, 
but has a broader expression pattern in peripheral tissues (Bisogno et al. 2003). 
Throughout the brain development, DAGLα is located in axon growth cones shifting to 
postsynaptic dendritic spines in the adult CNS (Bisogno et al. 2003). Both enzymes are 
absent from axonal tracts in the adult mouse brain (Bisogno et al. 2003).  
Knockout studies revealed an 80-90 % reduction of brain 2-AG in Dagla-/- mice and 
only a 50 % reduction in Daglb-/- mice (Gao et al. 2010; Tanimura et al. 2010). However, 
DAGLß seems to be the main synthesizing enzyme of 2-AG in the liver (Gao et al. 2010). 
Thus, the two isoforms individually contribute to the 2-AG production in a tissue-
dependent manner (Gao et al. 2010). Even though recent studies showed a regulatory 
phosphorylation of DAGLα (Shonesy et al. 2013) and proteomic studies indicate that both 
isoforms can be palmitoylated (Kang et al. 2008; Martin & Cravatt 2009), still very little is 
known about the regulation of DAGL activity. 
In the CNS, neurons are thought to be the main producer of 2-AG. However, 
microglia cells, as the primary immune effector cells in the central nervous system, 
produce large amounts of endocannabinoids, especially 2-AG. In vitro studies revealed 
that the production of eCBs in microglia is approximately 20-fold higher than in neurons 
(Walter et al. 2003a). In addition, astrocytes also possess a functional ECS and produce 
endocannabinoids (Walter et al. 2002, 2003b). 
Even though the main source of 2-AG in the CNS is not yet clear, it has already 
been shown that altered endocannabinoid signaling greatly influences the emotional state 
of humans and rodents and contributes to the pathophysiology of anxiety and depression 
(Hill et al. 2008a; Patel & Hillard 2006; Steiner et al. 2008). Thus, the following sections 
will introduce stress-related and depressive disorders and the contribution of the ECS in 
the development of these psychiatric diseases. 
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1.4 Stress-related and depressive disorders 
1.4.1 Stress and anxiety disorders 
Prolonged stress is mostly associated with negative emotions, such as anxiety and fear. 
Anxiety is defined as a future-oriented mood state in anticipation of a possible, 
forthcoming danger, while fear is an alarm response to a present or imminent threat 
(Barlow 2002). In general, fear and anxiety are necessary warning adaptation in humans 
and animals, facilitating adaptations for survival. However, in case of anxiety disorders 
these emotional states become excessive and unreasonable. All anxiety disorders share 
the core features of excessive fear, anxiety, and avoidance, but differ in the specific object 
or situation of concern (American Psychiatric Association 2013). The estimated lifetime 
prevalence of an anxiety disorder exceeds 15 % (Kessler et al. 2009). Patients suffering 
from such diseases are often severely restricted in their every day life, including the 
inability to work and impairments in social interactions (Kessler et al. 2009). Generalized 
anxiety disorder (GAD) is one of the most common anxiety disorders, with a lifetime risk of 
about 4 %, and is among others marked by chronic worrying, nervousness, and tension 
(Ruscio et al. 2007). Diagnostic criteria for GAD according to “The Diagnostic and 
Statistical Manual of Mental Disorders - Fifth Edition“ (DSM-V) (American Psychiatric 
Association 2013) are exemplarily listed in table 1.  
Table 1: Diagnostic criteria for generalized anxiety disorder (GAD) according to the DSM-V 
DSM-V diagnostic criteria for generalized anxiety disorder 
A. Excessive anxiety and worry, occurring more days than not for at least 6 month 
B. The individual finds it difficult to control the worry. 
C. The anxiety and worry are associated with 3 (or more) of the following      
     symptoms: 
    1. Restlessness or feeling keyed up or on edge 
    2. Being easily fatigued 
    3. Difficulty concentrating or mind going blank 
    4. Irritability 
    5. Muscle tension 
    6. Sleep disturbances 
D. The anxiety, worry, or physical symptoms cause distress or impairment in social, 
     occupational, or other important areas of function. 
E. The disturbances is not attributable to the physiological effects of a substance 
     or another medical condition. 
F. The disturbance is not better explained by another mental disorder. 
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Another highly prevalent stress- and fear-related disease is the post-traumatic stress 
disorder (PTSD). Since the fifth DSM edition, PTSDs are no longer classified as classical 
anxiety disorders, but are rather categorized as trauma- and stress-related diseases. 
PTSD is developed after an exposure to traumatic events and is accompanied by a 
constellation of heterogeneous symptoms including hyperarousal, sleep disturbances, 
difficulty concentrating and most notably re-experiencing of the traumatic event (American 
Psychiatric Association 2013). Therefore, this disorder shares symptoms with “distress” 
disorders, such as major depression, and anxiety disorders, for instance GAD or panic 
disorders. Lifetime PTSD prevalence ranges between 6-9 % in the general population, but 
among victims of severe traumatic events, such as war, genocides or rapes, the 
prevalence of PTSD is 20 % up to 40 % (reviewed in Sareen 2014). Consequently, PTSD 
represents a common mental health problem, arising from the formation of pathological 
fear memory (for review see Desmedt et al. 2015). The ability to learn fear allows 
organisms to anticipate harm and to develop appropriate defense behavior, hence fear 
memory facilitates adaptation and is essential for survival. However, if the memory is 
reactivated via a non-specific stress response, leading to a generalization of fear, it entails 
a pathological state. Therefore, PTSD embodies a learning paradigm in which long-term 
memories related to distinct events persist over time and context (Zoellner et al. 2014).  
Particularly the limbic system, including the amygdala, the hippocampus and the 
prefrontal cortex, are responsible for emotional processing and the formation of fear 
memory. Anxiety disorders are often associated with a malfunction of this system (for 
review see Dunsmoor & Paz 2015; Baldi et al. 2015). Several signaling pathways crucial 
for the development of anxiety and stress-related disorders have been described. It 
became apparent that amygdalar and hippocampal synaptic plasticity, epigenetic changes 
and increased stress-hormone levels are connected with stress- and anxiety disorders (for 
review see Peña et al. 2014; Deppermann et al. 2014). However, the underlying 
mechanisms are not fully understood. Moreover, the ECS was shown to play a crucial role 
in the processing of mood and emotions. The connection between the ECS and emotion 
is specified in chapter 1.4.3.  
Today’s first line pharmacotherapy for several anxiety disorders consists of 
anxiolytic drugs, such as benzodiazepines, or antidepressants, such as selective 
serotonin reuptake inhibitors (Coplan et al. 2015). However, not all patients respond to the 
currently available treatment options and high degree of co-occurrence of depressive and 
anxiety disorders impede the diagnosis and subsequent pharmacological and 
psychological treatment (Coplan et al. 2015). Thus, the comprehensive understanding of 
biological mechanism involved in these mental disorders and the development of new 
treatment strategies is of high importance. 
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1.4.2 The stress-depression connection  
Depression is a highly prevalent psychiatric disorder with a lifetime risk up to 20 % and is 
associated with high levels of mortality and morbidity (Kessler et al. 2005; Holma et al. 
2010). According to the World Health Organization (WHO), depression is the leading 
cause of disability worldwide and is one of the most diagnosed mental disorders among 
adults (Fact sheet N°369,  WHO, October 2015). Even though the understanding of the 
pathophysiology of depression including its diverse causes has evolved in the last 
decades, vast gaps remain in the treatment and individual therapy of depressive 
disorders. This is also reflected in the fact that at least 30 % of the patients do not remit 
after a year of multiple antidepressant therapies and treatment-resistance with up to 20 % 
is rather high (Warden et al. 2007; Mrazek et al. 2014). The common treatment of major 
depressive disorders (MDD) consists of a combined pharmacological and psychological 
therapy. The classical therapeutics such as monoaminooxidase inhibitors, selective 
reuptake inhibitors and tricyclic antidepressant are given to increase neurotransmitter 
levels. These treatment strategies are a consequence of the widely accepted monoamine-
hypothesis, which states that the deficit of certain neurotransmitters, such as serotonin, 
dopamine and noradrenalin, are the main causes of depression (Schildkraut 1965; 
Coppen 1967).  However, several other antidepressants exist, such as ketamine or 
lithium, which do not directly target neurotransmitter levels, but are nevertheless effective 
even though the exact mode of action is unknown (Scheuing et al. 2015; Can et al. 2014). 
Today MDD is diagnosed based on “The Diagnostic and Statistical Manual of Mental 
Disorders - Fifth Edition“ (DSM-V) (American Psychiatric Association 2013). According to 
the DSM-V, primarily symptoms of either depressed mood or anhedonia (loss of interest, 
loss of pleasure) must be manifested and overall at least five criteria as seen in the DSM-
V list must be present for at least two weeks (Tab. 2).  
 
Table 2: Diagnostic criteria for MDD according to the DSM-V 
DSM-V diagnostic criteria for Major Depressive Disorder 
1. Depressed mood most of the day. 
2. Diminished interest or pleasure in all or most activities. 
3. Significant unintentional weight loss or gain. 
4. Insomnia or hypersomnia.	
5. Agitation or psychomotor retardation noticed by others. 
6. Fatigue or loss of energy. 
7. Feelings of worthlessness or excessive or inappropriate guilt. 
8. Diminished ability to think or concentrate, or indecisiveness. 
9. Thoughts of death or suicide. 
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MDD represents a major public health concern, because of the short- and long-term 
detrimental effects to the patients and for the various long-lasting co-morbidities, such as 
cardiovascular disease and metabolic syndrome (Gan et al. 2013; Rotella & Manucci 
2013). However, anxiety disorders are the most common comorbidities of depression 
(Wittchen & Jacobi 2005).  
Genetic factors play an important role in the development of MDD, as indicated by 
family studies showing a 2- to 3-fold increased lifetime risk of developing MDD among 
first- degree relatives. Twin studies even showed a heritability of 40-50 % (for review see 
Levison 2006). Several candidate genes have been implicated in depressive disorders 
such as serotonin-transporter (Lesch et al. 1996; Uher & Guffin 2010) or brain-derived 
neurotrophic factor (BNDF) (Eisch et al. 2003; Chen et al. 2006). However, these genes 
rather represent a genetic predisposition than being solely responsible for the 
development of MDD. Psychiatric disorders, like MDD, usually result from a complex 
interplay of genetic and environmental factors that act cumulatively throughout lifetime 
(Uher 2014). These environmental factors are mostly adverse events during childhood or 
ongoing and recent stress (Kendler et al. 2002; Kendler et al. 2006). Hereby, chronic 
stress is a main environmental risk factor for development of depressive disorders (de 
Kloet et al. 2005; Lupien et al. 2009). The well-described effect of chronic stress on the 
development of depression is also supported by the finding of a disrupted hypothalamic-
pituitary-adrenal (HPA) axis in MDD patients (for review see Anacker et al. 2011).  
The HPA axis, including its end-effectors the glucocorticoid hormones, is part of the 
body´s stress response system. In order to adapt to a stressful event, which can be any 
internal or external stimulus perceived as a threat to the homeostasis, the organism 
triggers several physiological and behavioral alterations (Chrousos 2009). This stress 
response system is located both in the CNS and in peripheral organs. The central effector 
system includes parts of the HPA axis and the locus ceruleous/norepinephrine-autonomic 
systems with their end-products cortisol and norepinephrine and epinephrine, respectively 
(Chrousos 2009). Brain regions belonging to the limbic system differentially regulate the 
HPA axis and the release of glucocorticoids. Accordingly, the amygdala is believed to 
activate the HPA axis, whereas the hippocampus is crucial for the termination of the HPA 
axis response to stress (for review see Smith & Vale 2006).  
However, this system can be maladaptive if the stress stimulus has a stronger 
intensity and/or duration than the individual ability to an adequate response. This 
dysregulation results in the development of a series of adverse effects, such as mood 
alteration, induction of anxiety or cognitive dysfunction (Marques et al. 2009). Under 
healthy conditions, the HPA axis is controlled by a negative feedback loop by which 
cortisol inhibits the release of upstream effector molecules, particularly the corticotropin-
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releasing hormone (CRH) and the adrenocorticotropic hormone (ACTH). However, 
persistent stress can disturb this glucocorticoid feedback mechanism (Fig. 4). 
 
 
Figure 4: Normal and impaired regulation of the HPA axis (modified from Ising & Holsboer 2006): AVP: 
arginine vasopressin, ACTH: Adrenocorticotropic hormone, CRH: corticotropin-releasing hormone, POMC: 
Pro-opiomelanocortin. 
 
The HPA axis is further regulated on the level of the hypothalamus and by a diverse 
group of afferent projections not only from limbic, but also from mid-brain, and brain stem 
nuclei (Herman et al. 2003). Furthermore, the ECS influences the release of 
glucocorticoids and is an important modulator of the physiological stress responses. Thus, 
the next section addresses the role of the ECS in stress and emotion. 
1.4.3 ECS in emotional processes 
For millennia cannabis has been consumed throughout different cultures for its mood 
elevating and euphoric effects (Williamson & Evans 2000). Since the discovery of the 
psychoactive plant compound THC and its mode of action by activating the cannabinoid 
receptors, the ECS became of great research interest as a modulator of mood and 
emotion. However, adverse effects of cannabis such as panic attacks or paranoia have 
also been described. Furthermore, excessive cannabis use during adolescence has been 
associated with an increased risk of schizophrenia (Rubino & Parolaro 2008) and CB1 
receptor availability is reduced in the hippocampus of schizophrenia patients 
(Ranganathan et al. 2015).  
Dysregulation of the ECS has been implicated in several psychiatric disorders. 
Previous studies showed reduced serum anandamide levels and an increased CB1 
receptor availability throughout the brain of patients suffering from PTSD (Neumeister et 
stress 
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al. 2014). Furthermore, increased CB1 receptor density was reported in the prefrontal 
cortex of depressed suicide victims (Hungund et al. 2004). In line with this, the CB1 
receptor and the eCB synthesizing enzymes are abundantly expressed in brain areas 
implicated in emotional and mood regulation, such as the amygdala, hypothalamus and 
the hippocampus (Mackie et al. 2005; Patel et al. 2009). Furthermore, CB1 receptors and 
endocannabinoids participate in the control of the HPA axis, indicating an important role in 
stress response (Hill et al. 2010a). For instance repeated homotypic stress produces a 
robust elevation of amygdalar 2-AG content and thereby induces HPA axis habituation 
(Patel et al. 2009; Hill et al. 2010b). In addition, mice with disrupted endocannabinoid 
signaling are more sensitive to chronic stress (Dubreucq et al. 2012). 
For a brief period from 2006 until 2008, the CB1 antagonist rimonabant was 
clinically used in Europe under the trade name Accomplia® to treat obesity. However, the 
compound caused serious adverse psychiatric side effects including anxiety and 
depression (Christensen et al. 2007), which led to a withdrawal of Accomplia® from the 
market. These clinical findings validated previous results from rodent studies showing that 
the genetic or pharmacological blockade of CB1 increases depression- and anxiety-like 
behavior (Valverde et al. 2005; Valverde & Torrens 2012). Furthermore, serum 
endocannabinoid levels are decreased in depressed patients (Hill et al. 2008) and the 
chronic treatment with antidepressants led to a significant increase in 2-AG levels in 
various brain areas, indicating that 2-AG could be important for the antidepressant effect 
of these drugs (Smaga et al. 2014). Depression is frequently associated with a reduced 
adult neurogenesis (Sheline et al. 2003; Lee et al. 2013), also seen in mice with reduced 
cannabinoid levels (Gao et al. 2010). In line with these discoveries, endocannabinoids 
promote adult neurogenesis (Zhang et al. 2014) and the cannabinoid receptors are highly 
expressed in neuronal stem cells (Galve-Roperh et al. 2013). 
In conclusion, the ECS is an important modulator of emotional processes and disrupted 
endocannabinoid signaling contributes to the development of affective disorders. 
Therefore, modulation of the ECS is a promising target to treat depressive and anxiety 
disorders. 
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1.4.4 Modeling depression in mice 
Animal modeling of human diseases is an essential cornerstone in the analysis of disease 
mechanisms and the preclinical testing of potential new therapeutic drugs. Especially 
rodents are routinely used to model and investigate various human diseases including 
diseases of the CNS for instance epilepsy, Parkinson's disease, Huntington's disease, 
Alzheimer's disease, traumatic brain injury and stroke (Grone & Baraban 2015; Lee et al. 
2012; Lee et al. 2013; Kitazawa et al. 2012; Marklund & Hillered 2011; Fluri et al. 2015). 
The emphasis is apparently on diseases associated with neurodegeneration. However, in 
the last decades several animal models and paradigms to mimic psychiatric disorders 
have been established and routinely used, such as schizophrenia, depression and anxiety 
disorders (Samsom & Wong 2015).  
Neuropsychiatric diseases are associated with a variety of heterogeneous 
physiological and psychological symptoms. Whereas most of the physiological alterations, 
such as weight gain or loss, insomnia or hypersomnia and neuroanatomical changes are 
easily measurable in rodents, most of the psychological aspects like depressed mood, 
guilt and low self-esteem cannot be convincingly ascertained (Nestler & Hyman 2010; 
Dedic et al. 2011).  
Up to now, three criteria, including construct validity, face validity and predictive 
validity, are widely accepted to assess the reliability of an animal model (McKinney and 
Bunney 1969; Nestler & Hyman 2010). Construct validity implies that the symptoms 
manifested in an animal are based on the same neurobiological mechanism as in 
humans. Face validity is defined as a similarity of specific behavioral or physiological 
symptoms of the disease between the animal and affected humans. Lastly, the same 
treatment strategies have to be effective in the model as in the clinic (predictive validity) 
(McKinney and Bunney 1969). The more criteria a proposed model fulfills, the more 
convincing and widely accepted it will be (Dedic et al. 2011).  
Neuropsychiatric disorders, like depression, are multifactorial diseases and therefore 
inherently difficult to mirror in rodents. Nevertheless, various symptoms of depression can 
be tested in rodents (Tab. 3). 
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Table 3: Depression-associated endphenotypes that can be modeled in mice (adopted from Dedic et 
al. 2011) 
DSM-V symptoms Endophenotypes in mice Appropriate test/analysis 
Depressed mood Cannot be modeled - 
Decreased interest or loss of 
pleasure 
Anhedonia Sucrose preference 
Weight gain or loss Can easily be measures Weight gain/ loss after 
stress 
Insomnia or Hypersomnia Abnormal sleep architecture EEC recordings 
Agitation or psychomotor 
retardation 
Alterations in locomotion Open-field, alterations in 
home-cage activity 
Fatigue or loss of energy Alterations in locomotion Reduced home-cage 
activity, 
Nest building 
Feelings of worthlessness or 
inappropriate guilt 
Cannot be modeled - 
Diminished ability to think or 
concentrate 
Deficits in working and spatial 
memory 
Morris water maze, Y-maze 
Thoughts of death or suicide Cannot be modeled - 
 Additional endophenotypes  
 Anxiety-related behavior Open-field, Light-dark box, 
O-maze 
 Changes in social behavior Social interaction/ 
avoidance 
 Behavioral despair Tail suspension test, Forced 
swim test 
 Neuroendocrine disturbance Corticosterone secretion, 
Dexamethasone 
suppression 
 Neuroanatomical changes Hippocampal volume 
 
 
Nowadays most (non-genetic) animal models of depression mainly rely on stress-
induced behavioral changes (Kato et la. 2015), since chronic stress is a main risk factor 
for the development of depression (de Kloet et al. 2005; Lupien et al. 2009). Accepted 
models are the chronic unpredictable mild stress (for review see Willner 2005), social 
defeat stress (Berton et al. 2006), maternal separation (for review see Nishi et al. 2014) 
and prenatal stress (Mueller & Bale 2008). Although none of these models perfectly 
reproduce the symptoms of depression observed in humans, translational rodent models 
combined with the analysis of postmortem tissue from depressed patients led to important 
discoveries in the last decades (Menard et al. 2015). To develop an appropriate rodent 
model of depression, advance in genetics and pharmacology must be combined with 
environmental challenges like chronic stress (Dedic et al. 2011). 
In conclusion, modeling depression in mice is a useful and necessary tool to 
understand the pathophysiology of this disease and to find new therapeutic targets for a 
pharmacological treatment of depressive disorders. 
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1.5 Aim of the thesis 
One aim of this study was to investigate the impact of 2-AG and its main synthesizing 
enzyme DAGLα on the development of depressive- and anxiety-like behaviors. Therefore, 
constitutive as well as different conditional Dagla-/- mice were analyzed. Disruption of the 
ECS has been linked to depression in humans and depression-like behaviors in mice. 
Since eCBs are produced on demand, the pathways and enzymes involved in 
endocannabinoid biosynthesis play a major role in regulating the activity of this system. 
However, up to now the main cellular source of 2-AG in the CNS is still unknown. To 
determine the impact of DAGLα activity in neurons and microglia cells, which are the main 
2-AG producing cells in vitro, different cell type-specific Dagla-/- mice were analyzed. The 
behavioral and molecular analysis of these knockout mouse lines will give an insight into 
the impact of DAGLα activity in anxiety and depressive disorders. 
 
A second aim of this thesis was to analyze the reactivity of the constitutive as well as 
neuronal-specific Dagla-/- mice to chronic stress, using a model of chronic social defeat 
stress. Chronic stress is a main risk factor of major depressive disorder and genetic or 
pharmacologic blockade of the CB1 receptor leads to an increased sensitivity towards 
chronic stress. Thus, this study aims to determine the impact of 2-AG on this altered 
stress reactivity.  
 
A further aim was to establish a suitable method to discover potential interaction partners 
of DAGLα. Even though several in vitro studies revealed certain potential regulatory 
mechanisms, until now very little is known about the regulation of DAGLα. Therefore, 
protein-protein interactions between DAGLα and potential candidate proteins were 
analyzed using tandem affinity purification. 
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 Material and Methods 
2.1 Equipment 
Technical instrument Identifier, Company 
Analgesia Meter Hot Plate TSE Systems 
Analytical balance BP 121 S, Sartorius 
Animal tracking software EthoVision® XT, Noldus 
Cell culture incubator Binder GmbH 
Centrifuges Biofuge fresco, Heraeus Instruments 
Biofuge pico, Heraeus Instruments 
Biofuge stratos, Heraeus Instruments 
Megafuge 1.0R, Heraeus Instruments 
Cryostat CM3050S, Leica GmbH 
Digital gel documentation ChemiDoc MP imaging systems, Bio-Rad 
Laboratories 
Electroporation system MicroPulser™ Electroporator, Bio-Rad 
Laboratories 
Electrophoresis chamber (agarose 
gels) 
Sub-Cell GT System, Bio-Rad Laboratories 
Electrophoresis chamber 
(polyacrylamide gels) 
XCell SureLock® Mini-Cell, Life Technologies 
EMCCD camera equipped with a 
494/20 and 572/28 bandpass emission 
filter wheel 
Rolera MGI plus EMCCD camera, Decon 
Science Tec 
Home cage activity measurement Mouse-E-Motion, Infra-e-motion, Henstedt– 
Ulzburg, 
Imaging of TLC plates: 
        LED lamp equipped with a  
        HEBO V01 excitation filter. 
10 x 1 W 420 nm LEDs, Roithner Lasertechnik 
HEBO V01, Hebo Spezialglas 
Laminar flow hood Herasafe, Kendro 
Liquid handling platform Janus®, Perkin Elmer 
Magnetic stirrer MR 3001 K, Heidolph, Fisher  
Microplate analyzer MRX TC II, Dynex Technologies 
Microscope Eclipse TS 1000, Nikon 
Axiovert 200 M fluorescent microscope, Zeiss 
Open-field test device Open-field ActiMot, TSE Systems 
PCR cycler iCycler, Bio-Rad Laboratories 
pH meter inoLab, WTW  
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Technical instrument Identifier, Company 
Real-time PCR cycler LightCycler® 480 Instrument II, Roche 
Spectrophotometer NanoDrop 1000, Thermo scientific 
SpeedVac SPD111V Thermo Fisher 
Startle response box TSE startle response test system, TSE Systems 
Sterilizing oven Varioklav 25T, H+P Labortechnik 
Tissue homogenizer Precellys 24, Bertin Technologies 
Ultrasonic bath Ultrasonic cleaning bath USC-THD, VWR 
Vortexer Vortex-Genie 2, Scientific Industries  
Western Blot System iBlot® Gel Transfer Device, Life Technologies 
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2.2 Chemicals and reagents 
2.2.1 Chemicals 
Chemicals Company 
Amitriptiline hydrochloride Sigma-Aldrich 
Albumin bovine Fraction V, pH 7.0 standard grade, 
lyophil. (BSA) 
Serva 
ANTI-FLAG® M2 Affinity Gel Sigma-Aldrich 
Azidocoumarin (3-azido-7-hydroxycoumarin) Carl Roth 
Brilliant Blue R-250 Sigma-Aldrich 
1-Bromo-3-chlorpropane (BCP) Sigma-Aldrich 
BrdU (B5002-250mg) Sigma-Aldrich 
Cremophor® EL/ Kolliphor®EL Sigma-Aldrich 
Cu(I)TFB( Tetrakis(acetonitrile)copper(I) 
tetrafluoroborate) 
Sigma-Aldrich 
DAPI Fluoromount-G® SouthernBiotech 
N,N-diisopropylethylamine Sigma-Aldrich 
ECL Western Blotting substrate Thermo Fisher (PierceTM) 
Ethidium bromide solution (10 mg/ml)  Sigma-Aldrich 
Fluoromount-G® SouthernBiotech 
JZL184, MAGL Inhibitor Sigma-Aldrich 
Lipofectamin®2000 Transfection Reagent Thermo Fisher 
2-Methylbutan/ Isopentan Sigma-Aldrich 
Paraformaldehyd Sigma-Aldrich 
Strep-tag® Protein Purification Buffer Set IBA Lifescience 
Sucrose, for microbiology Sigma-Aldrich 
Strep-Tactin® Superflow® high capacity 50% 
suspension 
IBA Lifescience 
THC (dronabinol) THC Pharm GmbH 
TRIzol® Reagent Thermo Fisher 
Tween20 Sigma-Aldrich 
URB594, FAAH Inhibitor Sigma-Aldrich 
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2.2.2 Kits  
Kits Company 
PeqGOLD Plasmid Miniprep Kit I Peqlab 
PeqGOLD Gel Extraction Kit C-Line Peqlab 
GeneEluteTM HP Plasmid MidiPrep Kit Sigma-Aldrich 
GoTaq® Green Master Mix (PCR) Promega 
BCA Protein Assay Kit Thermo Fisher (PierceTM) 
Two-TAP Cloning Kit, mammalian (5-1623-001) IBA Lifescience 
 
 
2.2.3 Buffers and solutions 
If not stated otherwise all buffers and solutions were prepared with dH2O and all 
chemicals were purchased from Applichem, Life Technologies, Merck, Carl Roth or 
Sigma-Aldrich. 
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Buffer and solution Composition Application 
Borate buffer 0.1 M Boric acid 
adjusted to pH 8.5 
Immunohistochemistry 
Citrate buffer 10 mM Citric acid 
0.05 % (v/v) Tween 20  
adjusted to pH 6.0 
Immunohistochemistry 
Clickmix/ Coumarin 
labeling solution  
850 µl Ethanol 
2  50 µl 10 mM Cu(I)TFB in acetonitrile 
10 µl 2 mg/ml Azidocoumarin in  
EtOH 
Click chemistry 
Hünigs base 4 % N,N-diisopropylethylamine in 
hexane 
Click chemistry 
Mouse tail lysis buffer 100 mM Tris/HCl pH 8.0 Mouse tail lysis 
 5 mM EDTA  
 200 mM NaCl  
 0.2 % (w/v) SDS  
2x SSC 0.3 M NaCl 
30 mM Na-citrate dihydrate 
adjusted to pH 7.0 
Immunohistochemistry 
TAE buffer 40 mM Tris-acetate 
1 mM EDTA pH 8.0 
Agarose gel 
elctrophoresis 
TBS (Tris-buffered 
saline) 
50 mM Tris-HCl 
150 mM NaCl 
adjusted to pH 7.5 
Immunohistochemistry 
TE buffer 10 mM Tris  
1 mM EDTA, pH 8.0 
DNA isolation 
 adjusted to pH 7.4  
4 % PFA 4 % (w/v) Paraformaldehyd Fixation of brain tissue 
RIPA 5 mM EDTA 
10 mM Tris pH 8.0 
0.1 % SDS 
150 mM NaCl 
0.5 % Dexycholic acid 
1 % Nonidet-P40 
add 1 tablet cOmplete™ Mini per 10 
ml RIPA buffer and store at 4°C 
Protein isolation  
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2.2.4 Enzymes and antibodies 
Enzyme/ antibody/ serum Company 
Proteinase K NEB 
Superscript II Reverse Transcriptase Invitrogen 
Taq Polymerase NEB 
Phusion High Fidelity DNA Polymerase NEB 
Restriction enzyme: XbaI, HindIII NEB 
Restriction buffer 2.1 NEB 
Anti-DAGLα (DGLa-Rb-Af380, rabbit, polyclonal) Frontier Institute Co.Ltd 
Anti-DAGLα (ab81914, goat, polyclonal, 
AB_1658310) 
Abcam 
Anti-BrdU (ab6326, rat, monoclonal, AB_305426) Abcam 
Anti-Iba1 (019-19741, rabbit, polyclonal) Abcam 
Anti-NeuN AlexaFluor® 488 (MAB377X, mouse, 
monoclonal, AB_2149209) 
Merck Milipore 
Anti-FLAG® (F7425, rabbit, polyclonal, AB_439687) Sigma-Aldrich 
Donkey anti-goat AlexaFluor®488 (A-11055, 
AB_10564074) 
Life Technologies 
Donkey anti-rabbit HRP conjugated (711-035152, 
AB_10015282) 
Dianova 
Donkey anti-rabbit AlexaFluor®488 (A-21206, 
AB_10049650) 
Life Technologies 
Goat anti-rabbit AlexaFluor®594 (A-11037, 
AB_10561549) 
Life Technologies 
Goat anti-rat AlexaFluor®594 (A-11007, 
AB_10561522) 
Life Technologies 
Normal goat serum (ab7481) Abcam 
Normal donkey serum (ab7475) Abcam 
 
2.2.5 Antibiotics  
Substance Working concentration Company 
Ampicillin 100 µg/ml Applichem 
Kanamycin 50 µg/ml Applichem 
G418 Sulfate, Geneticin® 400 µg/ml Thermo Fisher 
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2.2.6 Plasmids 
Plasmid Description 
pCR-BluntII-TOPO (BC148308) MGC premier mouse cDNA clone: 
Dagla (BioCat GmbH) 
pENTRY-IBA51 StarGate Entry Vector is required 
to generate Donor Vectors (IBA) 
pESG-IBA168 Allows the expression of C-
terminal Twin-Strep®-FLAG-tag-
fusion-proteins, contains the CMV 
promotor  
 
2.3 Animals 
In this study constitutive as well as different tissue-specific Dagla deficient mice (2-4 
months old) were used for molecular and behavioral analysis. To generate Dagla 
knockout mice two loxP sites flanking exon 1, which contains the promoter region, were 
inserted (Ternes 2013). This loxP sites allow Cre-mediated excision of the flanked exon. 
The Cre recombinase is derived from the P1 Bacteriophage and catalyses site-specific 
recombination between two recognition sites (loxP sites) leading to the excision of DNA 
fragments (Hoess et al. 1984). This Cre/loxP system is widely used to produce 
constitutive as well as conditional loss of gene function in specific-cell types.  
Accordingly, to obtain constitutive Dagla deficient mice (Dagla-/-) homozygous Dagla 
floxed (Daglafl/fl) mice on a C57BL/6J genetic background were bred with Pgk1-Cre mice 
(Lallemand et al. 1998), a transgenic mouse line which express Cre ubiquitously (Ternes 
2013; Jenniches et al. 2015). In addition, to generate cell-specific Dagla knockout mice 
Daglafl/fl mice were either bred with Synapsin 1-Cre transgenic mice (Zhu et al. 2001) to 
obtain neuron-specific Dagla deficient mice (Syn-Dagla-/-) or LysM-Cre transgenic mice 
(Clausen et al. 1999) to generate myeloid cell-specific Dagla knockout mice  
(LysM-Dagla-/-). Synapsin 1-Cre mice express the Cre recombinase under the neuron-
specific promoter Synapsin 1, which leads to Cre/loxP recombination exclusively in 
neurons. Whereas in LysM-Cre mice Cre expression is driven by the Lysozyme M 
promoter, which leads to Cre-mediated DNA excision in myeloid cells, like microglia and 
macrophages. 
For all experiments Daglafl/fl littermates or wild type controls (WT) on a C57BL/6J 
genetic background were used as control animals. WT mice were originally obtained from 
a commercial breeder (Janvier, France) and bred at our animal facility. Unless otherwise 
stated, all mice were group-housed (4-5 animals per cage) in standard laboratory cages 
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under a normal light-dark cycle (light phase for 12 hours, light on at 09:00 am) with ad 
libitum access to food and water under SFP conditions. Male CD1 mice (6 months old 
retired breeders), used as aggressor mice in the chronic social defeat stress (CSDS) 
paradigm, were obtained from a commercial breeder (Janvier, France) and single-caged 
in standard laboratory cages under a reversed light-dark cycle (light phase for 12 hours, 
light on at 09:00 pm) with ad libitum access to food and water. All experiments followed 
the guidelines of the German Animal Protection Law and the Local Committee for Animal 
Health, LANUV NRW, approved the experiments. 
 
2.4 Behavioral experiments 
2.4.1 Sucrose preference test 
Anhedonic-like behavior of mice was analyzed by a sucrose preference test. Mice were 
housed individually and the animals could freely choose between 1 % sucrose solution 
and water. In general most rodents prefer sweet solutions to mere water with a preference 
up to 95 % for C57BL/6 mice (Pothion et al. 2004). This preference is typically decreased 
in various affective disorders, including depression and therefore a plausible measure of 
depressive-like behavior in mice (Katz et al. 1981). The consumption was measured for 
48 h and the position of the bottles was changed after 24 h. The sucrose preference (%) 
was calculated as sucrose solution consumed divided by the total amount of solution 
consumed. 
2.4.2 Forced swim test 
Animals were tested for behavioral despair in the forced swim test. This test is based on 
the assumption that mice try to escape an aversive (stressful) stimulus such as water. For 
this test mice were placed individually into a glass cylinder (height 28 cm, diameter 20 cm) 
containing water (height 14 cm, 24-25°C). Immobility time was recorded during the last 4 
min of the 6 min testing period and is considered a measure of helpless behavior (Porsolt 
et al. 1977).  
For pharmacological studies mice were treated either with the antidepressant amitriptyline 
or with MAGL (JZL184) or FAAH (URB597) inhibitors. Therefor, mice received either 10 
mg/kg amitriptyline i.p. 30 min prior to the test, or 20 mg/kg JZL184 or 0.5 mg/kg URB597 
2 h before the forced swim test. JZL184, URB597 and amitriptyline hydrochloride were 
dissolved in Tween20 and afterwards diluted in 0.9% saline (final concentration of 
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Tween20 < 0.1%). Vehicle control animals were treated with Tween20 (final 
concentration < 0.1%) diluted in 0.9% saline. 
2.4.3 Social preference test 
Social interaction behavior of mice was assessed by the social preference test. Social 
interaction is a fundamental component of rodent behavior and disrupted in a variety of 
neuropsychiatric disorders (Nestler & Hyman 2010). To analyze social interaction mice 
were individually habituated to the transparent open-field box (44 cm x 44 cm) for 5 min 
on three consecutive days before the testing day. The floor was covered with bedding 
material. On the testing day the arenas (open-field boxes) contained two metal grid cages 
in opposing corners and an unfamiliar mouse of the same gender and age was placed in 
one of the metal grid cages. The test animals were introduced and their location 
recorded for 10 min using the EthoVision XT software (Noldus Information Technology 
Inc.). Calculated was the time spent investigating the partner mouse compared to the 
empty cage. A sign of social preference is a significantly higher time spent investigating 
(the nose of the mouse is not more than 1 cm from the wall of the grid cage) the partner 
mouse compared to the empty cage.  
2.4.4 Social avoidance test 
Social avoidance behavior was analyzed in a variant form of the social interaction test. 
Mice were habituated as described in 2.4.3. On the testing day one metal grid cage 
containing a foreign CD1 mouse (male retired breeder) was placed close to one wall of 
the open-field box. The movement of each test animal was recorded for 5 min using the 
EthoVision XT software (Noldus Information Technology Inc.). Calculated was the time 
spent investigating the foreign CD1 mouse. The less time the test mouse spent 
interacting with the CD1 the higher the social avoidance behavior. In this test CD1 
mice were used for the interaction analysis, because animals of the same mouse 
strain were used as aggressors in the chronic social defeat paradigm (described in 
chapter 2.4.14). Thus, stressed (defeated) mice tend to spend less time interacting 
with a foreign CD1 mouse, indicative of social avoidance behavior.  
2.4.5 Home cage activity measurement 
Home cage activity was recorded using an infrared system (Mouse-E-Motion, Infra-e-
motion GmbH), whereby an infrared sensor is attached to the mouse cage lid and records 
movements in the home cage every 30 s. For this test mice were housed in single-cages 
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and habituated to the reversed light/dark cycle (light phase for 12 hours, light on at 9:00 
pm) for at least seven days. Movements were sampled and averaged over 1 h. 
2.4.6 Open-field test 
Anxiety behavior and locomotor activity were analyzed using the open-field test. Animals 
were tested in a sound-isolated, dimly illuminated room (20 lux) in an open-field box (44 
cm x 44 cm). The mice were allowed to explore the box freely and their behavior was 
recorded for 10 or 30 min. Analysis was conducted using ActiMot (TSE Systems) or the 
“EthoVision XT” software (Noldus Information Technology Inc). The time spent in the 
center of the open-field box (25 % of the whole area) is considered a measure of anxiety. 
Rodents usually avoid open lit-up areas and increased anxiety is associated with 
decreased time spent in the center of the open-field box. In addition, spontaneous 
locomotor activity and exploratory behavior were determined by the total distance 
travelled in the arena and the number of rearings. 
2.4.7 Light-dark box test 
Anxiety behavior was analyzed in the light/dark box test. Animals were tested in a sound-
isolated room in an open-field box (44 cm x 44 cm) divided into a light (2/3 of area) and a 
dark (1/3 of the area) compartment. The light compartment was brightly illuminated (800 
lux). Each animal was placed in the dark compartment and allowed to explore the arena 
freely for 10 min, while their behavior was recorded. This test is based on the fact that 
rodents avoid open highly illuminated areas (Crawley et al. 1984; Bourin & Hascöet 2003) 
and that increased anxiety behavior further decreases the time spent in the open 
compartment.  
2.4.8 Zero-maze test 
Anxiety-related behavior was also tested in the zero-maze (height 40 cm, internal 
diameter 46 cm, width 5.6 cm) in a sound-isolated room. The maze was divided into four 
equal quadrants, with non-transparent walls enclosing the two opposite quadrants. 
Animals were placed in the open area of the zero-maze and their movements were 
recorded for 5 min with 600-700 lux illumination. Time spent in the different areas and 
distance travelled was analyzed using “EthoVision XT” software (Noldus Information 
Technology Inc.).  
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2.4.9 Fear conditioning paradigm 
The Fear conditioning paradigm is based on the analysis of fear extinction, a process, 
which leads to a decline of conditioned fear response. This behavioral test is based on the 
process of respondent conditioning, in which a conditioned (neutral) stimulus is associated 
with an unconditioned stimulus. Here the neutral stimulus is a sound-cue, which is paired 
with an aversive stimulus (electric foot-shock) to evoke a fear response. On the extinction 
days following the conditioning the animals were presented only to the sound-cue and the 
freezing behavior was determined. Freezing is a measure of anxiety in rodents and 
characterized by persistent immobility of the animal. 
 
 
Figure 5: Startle response test system (modified from TSE Systems) 
 
For this test a sound-protected box equipped with a foot shock device, loud speakers and 
a vibration-sensitive platform to detect movements was utilized (Fig. 5; TSE-Systems 
GmbH). For conditioning, mice were placed in a small grid chamber and after 3 minutes a 
tone (80 dB, 9 kHz) was presented for 20 s, which co-terminated with a 2 s electric foot 
shock of 0.7 mA. To evaluate the conditioned freezing response mice were placed into a 
glass cylinder (diameter 8 cm) in the same box and after 3 min habituation, the same tone 
was presented. Vibrations caused by the movements of the animal were recorded during 
conditioning and on days 1, 2, 3 and 6 after conditioning (extinction trial 1, 2, 3, 6). 
Periods of activity were indicated by peaks exceeding twice the baseline level. Behavior 
was considered as freezing, if the amplitude of the peaks remained below this threshold 
for more than 3 s. The percentage of time that the animal spent freezing during a test 
session was calculated for each trial and served as an indicator for the decline from one 
session to the next. 
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2.4.10 Hot plate test 
The hot plate test is used to assess acute pain sensitivity of rodents to a thermal stimulus. 
Animals were placed in a plastic cylinder on a 52°C hot surface (Analgesia Meter Hot 
Plate, TSE Systems). The latency (in seconds) to the first reaction of pain was measured. 
This first reaction of pain is defined as shaking the hind paw, licking the paw or jumping. 
The test was terminated when the animal showed the first reaction of pain or after 30 s.   
2.4.11 Pup retrieval test 
Maternal care was assessed by the pup retrieval test. In this test, the entire litter was 
removed and after 5 minutes 3 pups (day 2-7 after birth) were returned to the home cage 
away from the nest at an opposite end of the cage. The entire test was recorded on video. 
The latency (in seconds) to sniff a pup and retrieve it to the nest was measured. If a 
female had not retrieved all pups within 5 min the test was terminated, resulting in a 
latency of 300 s. In addition, the pups were checked for the presence of a milk spot as an 
indicator for nursing behavior. 
2.4.12 Maternal behavior 
To analyze maternal care the behavior of nursing female mice were recorded using a 
time-sampling procedure (20 sec observation every third minute for 1 h between 9 AM 
and 10 AM on postnatal days 2–7). This results in 21 observations of each dam per day. 
During the days of observation females and their litter were single-housed and the home 
cages were not changed, because cage cleaning can stress the nursing females and 
therefore may affect the maternal behavior. Frequencies of nursing and overall time spent 
interacting with the pups were calculated by taking the average of observations per dam 
of 3-4 observation days.   
2.4.13 Tetrad test 
The tetrad test is widely used to analyze cannabinoid receptor-mediated behavioral 
effects in rodents. This test consists of a series of behavioral paradigms including 
spontaneous activity, hypothermia, catalepsy and analgesia. Animals were treated with 8 
mg/kg THC (dronabinol) or 0.9 % saline (i.p.) 30 min before the test. Rectal body 
temperature was measured directly before the injection and 30 min after injection. 
Subsequently, spontaneous activity was analyzed in a 10 min open-field test, followed by 
a hot plate test. THC injection solution was prepared by diluting THC stock solution (100 
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mg/ml in 100 % EtOH) in cremophor and saline. Vehicle solution contained equal 
concentrations of EtOH and cremophor diluted in saline. 
 
2.4.14 Chronic social defeat paradigm 
Chronic stress is a main cause of depression in humans (de Kloet et al. 2005; Lupien et 
al. 2009). Several chronic stress models have been established to investigate stress-
induced depressive-like behavior and molecular adaptations in rodents, such as chronic 
social defeat stress (CSDS). In humans, chronic social defeat, like bullying in schools or 
workplaces, can lead to sociophobia, the loss of self-esteem, anxiety and depression 
(Björkqvist 2001). The animal model CSDS is based on a resident-intruder paradigm, in 
which a young male mouse (intruder) is placed into the home cage of another older, more 
aggressive male (resident). The defeated animal is considered to experience social 
stress.  
2.4.14.1 Screening for aggressive CD1 mice 
Reproducible and successful application of chronic social defeat stress is strongly 
dependent on the consistent levels of aggressive behaviors of the CD1 mice. In general 
single-caged retired breeders exhibit the strongest territoriality and aggressiveness 
against foreign males and are therefore the most recommended aggressors. 
Nevertheless, aggression levels vary greatly between individuals and a screening 
procedure is essential. In this study a screening procedure described by Golden et al. 
2011 was applied. 
The 3 days screening was performed in the home cage of the CD1 mouse. Each day a 
novel 7-9 weeks old C57BL6/J mouse was placed in the home cage of the aggressor for 
up to 5 min and the latency to the first aggression is recorded. Only CD1 mice that 
attacked in at least two of the three screening days with a latency to attack less than 60 s 
were selected for the social defeat paradigm. 
2.4.14.2 Social defeat protocol 
Chronic social defeat stress is a widely used chronic stress model for rodents to elicit 
depressive-like behavior. This paradigm is based on repeated social defeat sessions 
between a young C57BL6/J mouse and a larger and aggressive male CD1 mouse, which 
were screened for aggressive behavior (Point 2.4.12.1).  In this paradigm a 7-9 weeks old 
male C57BL6/J mice was subjected to bouts of chronic social defeat by a CD1 mouse for 
5-10 min daily for 10 consecutive days (Golden et al. 2011). After each social defeat the 
animals were separated by a perforated plastic glass wall which allows sensory but no 
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physical contact for the following 24 h (Fig. 6). In order to prevent any habituation the 
intruder C57BL6/J mice was exposed to a novel resident´s home cage on each day. 
Subsequent to the last social defeat the animals were single-caged and tested in a battery 
of different anxiety- and depression-related behavioral tests. 
 
 
Figure 6: Cage divided by a perforated plexiglass wall (Golden et al. 2011) 
2.5 Measurement of endocannabinoids 
Brains were collected and immediately frozen in liquid nitrogen. For pharmacological 
studies, mice were intraperitoneally injected with either 20 mg/kg JZL184 or 0.9 % saline 2 
hours before tissue collection. Striatum, cortex, hippocampi, and amygdala samples were 
punched from the frozen brain slices (1.0 mm) with the use of a metal matrix for mouse 
brains (Zivic Instruments) and cylindrical brain punchers (Fine Science Tools; internal 
diameter, 1.0 mm). Extraction and quantification of endogenous cannabinoids (eCB) was 
carried out as previously described (Lomazzo et al. 2014) by Dr. Laura Bindila (Prof. Beat 
Lutz, Institute of Physiological Chemistry, University Medical Center, Mainz). Endogenous 
2-AG levels were measured employing a 5500 QTrap® triple-quadrupole linear ion trap 
mass spectrometer (AB SCIEX). For quantification, triplicate calibration curves were run. 
Quantification of 2-AG was performed using Analyst 1.6.1 software. The obtained eCB 
values were normalized to the amount of protein. 
2.6 Measurement of corticosterone  
Fecal corticosterone levels were measured using the DetectX® Corticosterone Enzyme 
Immunoassay Kit (Arbor Assays). To extract steroids from collected feces (stored at -
80°C) samples were firstly dried for 2 h at 37°C. Subsequently, 200 – 300 mg of dried 
feces were transferred into a 5 ml microcentrifuge tube and 1 ml 100 % EtOH per 100 mg 
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of solid was added. For extraction samples were incubated for 30 min at RT in a shaking 
incubator. Subsequently, samples were centrifuged at 4500 rpm for 15 min. Six hundred 
µl of the supernatant was transferred into a 1.5 ml microcentrifuge tube and the samples 
were evaporated to dryness in a SpeedVac for 1 h at 35°C. Extracted samples were kept 
at -20°C overnight.  
On the next day samples were dissolved in 100 µl EtOH, followed by 400 µl Assay buffer, 
and vortexed and incubated for 5 min at RT. The vortexing and incubation steps were 
repeated for three times. Afterwards the samples were diluted 1:2 with assay buffer, since 
the ethanol concentration must be less than 5 % for the following immunoassay. The 
immunoassay was performed according to the manufacturer´s protocol. After incubation of 
all kit reagents for 30 min at RT, the corticosterone standards were prepared according to 
the manufacturer´s protocol (concentration range: 78.128 pg/ml to 10000 pg/ml). 
Subsequently, 50 µl of diluted samples or standards (in duplicates) were pipetted into the 
wells of a clear microtiter plate coated with an antibody to capture sheep antibodies 
followed by 25 µl DetectX® Corticosterone (Peroxidase-) Conjugate and 25 µl DetectX® 
Corticosterone Antibody. After 1h shaking at RT, wells were aspirated and washed 4 
times with 300 µl wash buffer following 100 µl TMB substrate per well. Towards 30 min 
incubation at RT 50 µl stop solution were added to each well. The samples were analyzed 
at 450 nm in a microplate reader.   
 
2.7 Immunohistochemistry 
2.7.1 DAGLα staining 
The loss of DAGLα protein was confirmed by immunohistochemistry staining of cryofixed 
brain slices. Brains were perfused with 4 % paraformaldehyde (PFA) in phosphate-buffer 
saline (PBS), overnight cryoprotected with 20 % sucrose in PBS at 4°C, frozen in dry ice 
cooled isopentane and stored at -80°C. Brains slices (thickness: 18 µM) were 
permeabilized with TBS (Tris-buffered saline) containing 0.3 % Tween-20 for 10 min at RT 
and subsequently washed 3 times for 5 min in TBS. Antigen retrieval was conducted by 
20 min incubation with citrate buffer at 65°C, followed by 3 washing steps (5 min, RT) in 
TBS. Afterwards, slices were blocked with TBS plus (TBS containing 0.3 % Triton X-100, 
10 % donkey serum and 2 % BSA) for 1 h at RT followed by the staining with anti-DAGLα 
antibody (DGLα-Rb-Af380) overnight at 4°C (final concentration 0.5 µg/ml in TBS plus). 
On the next day, slices were washed with TBS (3 times 5 min at RT) and again blocked 
with TBS plus for 1 h at RT. Subsequently, the AF488 labeled rabbit-specific secondary 
antibody was added for 1 h at RT (dilution 1:500 in TBS plus, Donkey anti-rabbit 
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AlexaFluor®488). After a washing step in TBS (3 times 5 min at RT) stained brain slices 
were embedded in DAPI Fluoromount-G® media (Southern Biotechnology Associates, 
Inc.). Fluorescence images were obtained with a Zeiss Axiovert 200 M fluorescent 
microscope with 20x and 10x objective lenses. 
2.7.2 DAGLα/Iba1 co-staining 
To verify the Dagla LysM-Cre mouse line, brain slices of LysM-Dagla-/- and Daglafl/fl mice 
were co-stained with anti-DAGLα (ab81914, goat, Abcam) and Iba1 (019-19741, rabbit, 
Abcam) antibodies. Stainings were performed and kindly provided by PD Dr. Andras 
Bilkei-Gorzo (Institute of Molecular Psychiatry, University of Bonn). Iba1 (ionized calcium 
binding adaptor molecule 1) is a microglia/macrophage-specific protein, which is widely 
used as a marker for microglia cells. Brains were perfused with 4 % paraformaldehyde 
(PFA) in phosphate-buffer saline (PBS) and subsequent embedded in paraffin (paraffin 
embedding was performed in cooperation with the Institute of Pathology, University 
Hospital Bonn, Bonn). Brains slices (thickness: 4 µM) were permeabilized and blocked 
with 3 % BSA in PBS (phosphate-buffered saline) containing 0.5 % Triton X-100 for 60 
min at RT and subsequently washed twice for 5 min in PBS. Subsequently, slices were 
co-stained with anti-DAGLα (1:300) and anti-Iba1 (1:200) antibodies diluted in 3 % BSA in 
PBS for 48 h at 4°C, followed by 20 min incubation at RT. Afterwards, slices were washed 
with PBS (3 times 10 min at RT) and incubated with the secondary antibodies donkey 
anti-goat AlexaFluor®488 (1:1000; Life Technologies) and goat anti-rabbit 
AlexaFluor®594 (1:1000; Life Technologies) diluted in 3 % BSA in PBS. After a washing 
step in PBS (3 times 10 min at RT), stained brain slices were embedded in Fluoromount-
G® media (Southern Biotechnology Associates, Inc.). Fluorescence images were obtained 
with a Zeiss Axiovert 200 M fluorescent microscope with 20x objective lenses.  
2.7.3 Adult neurogenesis 
To label dividing cells, 5-bromo-2´-deoxyuridine (BrdU, 50 mg/kg dissolved in sterile PBS; 
Sigma Aldrich) was i.p. injected once daily on 3 consecutive days. The thymidine analog 
BrdU is incorporated into replicating DNA in dividing cells and can be subsequently 
detected by anti-BrdU antibodies. Mice were sacrificed with isopentane either 24 h or 21 
days after the last BrdU injection and transcardially perfused with 4 % PFA in PBS. Brains 
were cryoprotected with 20 % sucrose for 24 h and frozen in dry ice-cooled isopentane. 
Subsequently, brains were embedded in Tissue Tek and serial coronal free-floating 
cryosections (40 µM) were cut through the rostrocaudal axis of the hippocampus from 
bregma -0.94 to -3.34 mm. All steps of the staining protocol were conducted on free-
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floating section in 24-well plates and if not stated otherwise all steps were performed at 
RT. First slices were washed 3 times with TBS and permeabilized for 10 min in TBS 
containing 0.3 % Tween-20. Subsequently, after 3 washing steps in TBS (5 min) slices 
were incubated in 2xSSC for 20 min at 65°C. Afterwards, slices were shortly washed in 
dH2O and incubated in 2 M HCl for 30 min at 37°C followed by 10 min incubation in 
Borate buffer. Then, slices were 3 times washed with TBS for 5 min and blocked in TBS 
plus II (TBS containing 0.3 % Triton X-100, 5 % goat serum, 2 % BSA) for 1h. In a next 
step, slices were stained with anti-BrdU antibody (dilution 1:500 in TBS plus II) and 
AF488-conjugated anti-NeuN antibody (dilution 1:250 in TBS plus II) overnight at 4°C. On 
the next day slices were washed 3 times for 5 min with TBS and again blocked with TBS 
plus II for 1 h. Subsequently, the AF594-labeled rat-specific secondary antibody was 
added for 2 h at RT (dilution 1:500 in TBS plus II). After a washing step in TBS (3 times 5 
min at RT) stained brain slices were transferred to glas coverslips and embedded in DAPI 
Fluoromount-G® media (Southern Biotechnology Associates, Inc.). Fluorescence images 
were obtained with a Zeiss Axiovert 200 M fluorescent microscope with 20x objective lens. 
BrdU-positive cells were counted in the subgranular zone of the hippocampus. The total 
number of cells was calculated as follows: 
 
N = total cells counted x (1/ssf) x (1/asf) x (1/tsf)  
 
The selected sampling fraction (ssf) is 0.125 (6/48) for the 24 h time point after BrdU 
injection and 0.167 (8/48) for 21 days after BrdU injection, because 6 or 8 slides out of 48 
were used for analysis. Since the whole dentate gyrus was used as the counting frame, 
the value for the area sampling fraction (asf) equals 1.  Furthermore the thickness 
sampling fraction (tsf = the height of the dissector/ the mean thickness of the section) is 
0.25 (10/40). The calculated number of BrdU positive cells was multiplied by the factor of 
2, because only one hemisphere was used for the analysis. 
2.8 Cell culture  
2.8.1 Isolation and cultivation of bone marrow-derived 
Macrophages 
Bone marrow-derived macrophages (BMM) were isolated from femur and tibia of adult (2-
4 months) wild type and Dagla-/- mice, respectively. BMM are primary macrophages 
derived from bone marrow cells in vitro in the presence of the macrophage colony-
stimulating factor (M-CSF). The growth factor M-CSF is responsible for the proliferation 
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and differentiation of myeloid progenitor cells into cells of the macrophage/monocyte 
lineage. In this study the culture medium of L929 cells, a cell line that secretes M-CSF, 
was used a source of this growth factor. Therefore L929 cells were cultured and the 
medium of confluent cells was collected and stored at -20°C until further usage. For the 
differentiation of bone marrow cells into a homogenous population of mature BMMs L929-
conditioned medium was added to the growth medium (15 % (v/v)). In the following the 
isolation of BMM is described in detail: 
After baring the hind legs from skin and muscle tissue without bruising the bone, bones 
were stored in ice-cold PBS and all following steps were performed under sterile 
conditions. Bones were cut with a scissor at both ends to expose the medullary canal and 
the bone marrow was rinsed with a 27-gauge needle and 10 ml ice-cold PBS into a 10 cm 
cell culture dish. By pipetting the bone marrow cells up and down a single-cells 
suspension was revealed and transferred through a 0.2 µm cell strainer into a 50 ml falcon 
tube. Subsequently, 20 ml of PBS were added and the isolated cells were centrifuged for 
10 min (1200 g, 4°C). Meanwhile cells were counted using a hemacytometer. The cell 
pellet was resuspended in an adequate amount of growth medium (described below) to 
obtain a density of 1.5x106 cells/ ml. Subsequently, 1 ml cell suspension diluted in 10 ml 
growth medium was plated on a 10 cm petri dish and cultivated at 5 % CO2 and 37°C. On 
the third day 5 ml of fresh growth medium were added to each petri dish and cells were 
further cultivated as described previously. Fully differentiated macrophages were 
harvested with a cell scraper at day 7 and plated for further experiments in standard cell 
culture dishes.  
 
Macrophage growth medium    
RPMI 1640     
+ Heat-inactivated FCS 10  % (v/v) 
+ Penicillin/Streptomycin mix 1 % (v/v) 
+ ß-Mercaptoethanol 0.1  % (v/v) 
+ L292-conditioned medium/ M-CSF 15 % (v/v) 
Sterile-filtered with an 0.2 µm filter  
 
All chemicals were purchased from Life Technologies and Gibco. 
 
2.8.2 Cultivation and transfection of Neuro-2a cells 
In this study Neuro-2a (N2a) cells, a mouse neuroblastoma cell line, were used for the 
expression of c-terminal tagged DAGLα. N2a cells were cultivated in DMEM (4.5 g/l 
glucose) containing 10 % (v/v) heat-inactivated FCS (fetal calf serum), 1 % (v/v) 
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Penicillin/streptomycin mix and 1 % (v/v) Sodium-pyruvate. All chemicals were purchased 
from Life Technologies and Gibco. For maintenance sub-confluent cultures (70-80%) were 
split twice weekly 1:5 or 1:10 and cultivated at 5 % CO2 and 37°C. Therefore adherent 
cells were washed with PBS and incubated with trypsin (1 ml 0.25 % trypsin-EDTA per 
T75 flask) for 5 min at 37°C. Subsequently, cells were detached by gently tapping against 
the cell culture flask and 9 ml growth medium (per ml trypsin) was added to inactivate 
trypsin. Afterwards detached cells were transferred into a 15 ml falcon and centrifuged 
(800 g, 5 min, 4°C). The cell pellet was resuspended in 10 ml growth medium and 
distributed on fresh culture flasks.  
For transfection 3x105 cells per well were seeded in a 6-well plate (10 cm2 surface area/ 
well) and cultivated for 24 h until all cells adhered to the surface. On the next day 1.5 ml 
fresh growth medium was added to each well and the cells were transfected with the help 
of Lipofectamin®2000 transfection reagent (Life Technologies). Lipofectamin is a cationic 
liposome based transfection reagent that interacts with negatively charged nucleic acids, 
allowing them to easily pass the cell membrane. It provides high transfection efficiency, 
high transgene expression in numerous mammalian cell types and at the same time low 
cytotoxicity.   
The following transfection mixture was applied: 
Transfection mixture per well:  Incubation 
2.5 µg Vector DNA in 150 µl DMEM  5 min, RT 
12 µl Lipofectamine®2000 in 150 µl DMEM 5 min, RT 
Mix both solutions  10 min, RT 
 
The described transfection mixture was added to each well and after 24 h at 5 % CO2 and 
37°C the medium was replaced by fresh growth medium. Selection of transfected cells by 
adding the appropriate antibiotic (400 µg/ml G418) to the medium started 48 h after 
transfection. The vector contained cDNA of DAGLα and a neomycin (G418) resistance 
cassette.  
For long-term storage N2a cells were frozen at -80°C in growth medium containing 10 % 
DMSO. Therefore a cell pellet from a 70-80 % confluent T75 culture flasks was 
resuspended in 1 ml freezing medium, slowly frozen (1°C/ min) using Mr.Frosty™ 
Freezing Container (Nalgene) at -80°C and stored at -80°C. 
2.9 	Cultivation	and	electroporation	of	E.	coli	
The E.coli TOP10 strain was used for molecular cloning experiments. For plasmid 
isolation bacterial cells were cultured in LB medium (5 ml or 100 ml) containing the 
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appropriate antibiotic (kanamycin or ampicillin) at 37°C and 180 rpm overnight. In general 
bacterial cultures were either inoculated with a single-clone picked from an LB agar plate 
or 1:100 with a pre-culture. 
 
LB medium    
H2O     
Tryptone 1  % (w/v) 
Yeast extract 0.5 % (w/v) 
NaCl 1  % (w/v) 
Autoclaved at 121°C, 20 min   
for LB agar add agarose 1.5  % (w/v) 
 
For electroporation electrocompetent E.coli TOP10 cells (50 µl) were either incubated with 
10 µl ligation reaction, or 1 µl plasmid DNA 5 min on ice and transferred into a pre-cooled 
electroporation cuvette (GenePulser®Cuvette 0.2 cm, Bio-Rad). Subsequently, the cells 
were electroporated using an electropulser (MicroPulser™; program EC2: 2.5 kV, 1 
Pulse). Immediately 800 µl antibiotic-free LB medium was added and the cells were 
transferred into a 2 ml microcentrifuge tube and incubated for 1 h at 37°C. Afterwards 100 
µl of the electroporated cells were plated on a LB agar plate containing 100 µg/ml 
ampicillin or 50 µg/ml kanamycin and incubated overnight at 37°C. On the next day single 
colonies were picked for further investigations. For long-term storage 500 µl of an 
overnight culture were added to 500 µl sterile glycerol, gently mixed and stored at -80°C. 
 
2.10 Molecular biology methods 
2.10.1 DNA purification and measurement 
Plasmid DNA was amplified in E. coli TOP10. In order to isolate plasmid DNA, 
commercially available Mini and Midi kits for plasmid purification were used. For Mini 
preparation the plasmid DNA isolation protocol provided in the PeqGOLD Plasmid 
Miniprep Kit I (Peqlab) was used. For Midi preparation, the GeneEluteTM HP Plasmid 
MidiPrep Kit (Sigma) was utilized according to the manufacturer’s instructions.  
 
For mouse genotyping DNA from mice tail biopsies were isolated. Tissue samples were 
incubated overnight in mouse tail lysis buffer and proteinase K (1 mg/ml) at 45°C on an 
agitating shaker (550 rpm). Subsequently, the samples were centrifuged (12000 g, 10 
min) and the supernatant was transferred into a fresh tube. Adding an equal volume of 
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isopropanol precipitated the DNA. Afterwards the DNA pellet was twice washed with 70 % 
ethanol, dried for approximately 10 min at 50°C and dissolved in 100 µl TE buffer. 
 
The concentration of DNA was determined using a spectrophotometer. DNA absorbs 
ultraviolet light at a wavelength of 260 nm (A260). The absorbance of 1 unit at A260 is 
equivalent to a DNA concentration of 50 µg/ml. The purity of a DNA preparation is 
assessed by the ratio of absorbance at 260 and 280 nm. A pure DNA preparation exhibits 
an A260/A280 ratio of approximately ≈ 1.8. 
2.10.2 Agarose gel electrophoresis 
For separation of DNA fragments from PCR reactions or plasmid restriction digests 
agarose gel electrophoresis was performed. Therefore 1 % or 1.5 % agarose gels in TAE 
buffer were poured and run in a TAE buffer containing electrophoresis chamber at 120 V 
for 50 min. 1 Kb Plus DNA Ladder (Life Technologies) was used for estimating the size of 
the DNA fragments. For all reactions not performed with the GoTaq®Green Master Mix, 
the following 6x loading dye was used: 30 % (v/v) glycerol, 0.4 % (w/v) Orange G (Sigma-
Aldrich). 
DNA fragments in agarose gels were stained with ethidium bromide. Therefore gels were 
incubated in a 1.5 µg/ml ethidium bromide bath for 10-20 min and stained DNA fragments 
were detected with a ChemiDoc MP imaging systems at 300 nm. 
 
2.10.3 DNA amplification by PCR/ genotyping 
For sequence specific amplification of DNA fragments for molecular cloning and mouse 
genotyping, polymerase-chain reaction (PCR) was applied. Each PCR reaction was 
specifically adapted to the temperature requirements of the oligonucleotides and the 
length of the desired PCR product. GoTaq® Green Master Mix (Promega) was used for all 
genotyping PCR reactions. The Master Mix contains Taq Polymerase, dNTPs, MgCl2 and 
reaction buffer. Established PCR conditions and a list of oligonucleotides are listed below: 
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1) The amplified mouse Dagla cDNA led to a 3135 bp PCR fragment (Tab. 4): 
 
Table 4: PCR reaction and corresponding program for Dagla cDNA amplification 
PCR reaction for the amplification of Dagla cDNA  
Sterile water 34.5 µl 
pESG-forward Primer:  
5´-AGCGGCTCTTCAATGCCCGGGATCGTGGTG -3´ 
0.5 µl 
pESG-reverse Primer:  
5´-AGCGGCTCTTCTCCCGCGTGCCGAGATGACC -3´ 
0.5 µl 
Phusion High Fidelity DNA Polymerase 1 µl 
Buffer HF (NEB) 10 µl 
Deoxynucleotide Mix (10 mM, Sigma Aldrich)  1 µl 
DMSO  1.5 µl 
pCR-BluntII-TOPO (Dagla cDNA clone) (100-150 ng/µl) 1 µl 
Program  
  1 x Initial denaturation 98°C 2 min 
30 x Denaturation      98°C 30 s 
        Annealing 68°C 45 s 
        Elongation 72°C       2 min 
  1 x Final elongation 72°C       5 min 
  Cooling 4°C   ∞ 
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2) For the genotyping of the constitutive Dagla-/- mice the following PCR strategy was 
used (Tab. 5): 
 
Table 5: PCR reaction and corresponding program for the genotyping of Dagla-/- mice  
PCR reaction (20 µl) for Dagla-/- mice genotyping 
Sterile water 7.5 µl 
P1: KO_PCRa_fwd: 5´-TAGCTTAGCCCCCATGTGAC-3´ 0.5 µl 
P2: KO_PCRa_ rev: 5´-CCCAGTAGCCACAGAACCAT-3´ 0.5 µl 
P3: KO_PCRa_WT_Allel: 5´-GAGATGGGTCCACCTCCTT-3´ 0.5 µl 
GoTaq®Green Master Mix 10 µl 
Mouse tail DNA (100-150 ng/µl) 1 µl 
Program  
  1 x Initial denaturation 95°C 30 s 
30 x Denaturation      95°C      30 s 
        Annealing 56°C 60 s 
        Elongation 68°C      60 s 
  1 x Final elongation 68°C    5 min 
  Cooling 4°C      ∞ 
 
The wild type allele led to a PCR product of 404 bp, whereas the knockout allele yielded a 
204 bp fragment (Fig. 7). 
 
 
Figure 7: PCR strategy for genotyping of constitutive Dagla-/- mice 
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3) For genotyping of the Syn- and LysM-Dagla-/- mouse lines two PCR reactions were 
conducted, in which both the loxP sites (Tab. 6) and the presence of the Cre recombinase 
(Tab. 7) were verified. PCR setups and programs are listed below: 
 
Table 6: PCR reaction and corresponding program for the genotyping of Daglafl/fl mice  
PCR reaction (20 µl) for Daglafl/fl (Syn- and LysM-Dagla-/-) mice genotyping: loxP 
Sterile water 8 µl 
P4: LoxPa_fwd: 5´-CCTCCAGGCCTACAGAA-3´ 0.5 µl 
P5: LoxPa_ rev: 5´-CACCGGAGAACTGGTTTG-3´ 0.5 µl 
GoTaq®Green Master Mix 10 µl 
Mouse tail DNA (100-150 ng/µl) 1 µl 
Program  
  1 x Initial denaturation 95°C 30 s 
30 x Denaturation    95°C      30 s 
        Annealing 60°C 60 s 
        Elongation 68°C        60 s 
  1 x Final elongation 68°C        5 min  
  Cooling 4°C      ∞ 
 
Expected fragment size for the wild type allele was 630 bp. Integration of the loxP sites 
resulted in a 680 bp DNA-fragment (Fig. 8).  
 
 
Figure 8: PCR strategy for the genotyping of Daglafl/fl mice 
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Table 7: PCR reaction and corresponding program for the genotyping of Syn- and LysM-Dagla-/- mice 
PCR reaction (20 µl) for Syn- and LysM-Dagla-/- genotyping: Cre recombinase 
Sterile water 8 µl 
Cre_fwd: 5´-CATTTGGGCCAGCTAAACAT -3´ 0.5 µl 
Cre_ rev: 5´-CCCGGCAAAACAGGTAGTTA-3´ 0.5 µl 
GoTaq®Green Master Mix 10 µl 
Mouse tail DNA (100-150 ng/µl) 1 µl 
Program  
  1 x Initial denaturation 94°C 3 min 
30 x Denaturation      94°C 30 s 
        Annealing 62°C 60 s 
        Elongation 72°C       60 s 
  1 x Final elongation 72°C       7 min 
  Cooling 4°C   ∞ 
 
The presence of Cre led to a 454 bp fragment. The PCR strategy for the verification of the 
Cre recombinase was similar for both Cre-lines (LysM-Cre and Synapsin1-Cre). 
 
2.10.4 Cloning of the DAGLα expression vector 
The Two-TAP Cloning Kit (Iba Lifescience) was used to generate a DAGLα expression 
vector. This two-step cloning approach allows easy and fast subcloning of the gene of 
interest into different expression vectors, which provide different promoters and tags.  
All cloning steps were performed according to the manufacturer´s protocol. Initially Dagla 
cDNA was amplified from mouse cDNA clone (pCR-BluntII-TOPO) using primers 
containing the LguI StarCombinase1™ recognition site (GCTCTTC) (Chapter 2.10.3) for 
efficient insertion of the DNA fragment into the pENTRY-IBA51 donor vector. After 
verifying the integration by a restriction digest with XbaI and HindIII and sequence 
analysis (GATC Biotech AG), the Dagla cDNA was subcloned into the final expression 
vector pESG-IBA-168 containing a c-terminal tandem Strep-tag II and Flag-tag. 
Subcloning was conducted in a simultaneous restriction and ligation reaction using Esp3I 
endonuclease and T4-DNA ligase (step 2). All cloning steps were performed in E.coli TOP 
cells. The sequence-specific cleavage of DNA was performed with restriction 
endonucleases in their recommended buffer systems. DNA digestion for analytical 
purposes was performed with 1 µg DNA for 3 h at 37°C. Detailed cloning steps are listed 
below: 
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Step 1: Cloning of Dagla cDNA into pENTRY-IBA51 
pENTRY-IBA51 (ca. 5 ng, 1860 bp) 10 µl 
PCR product (0.7 ng/µl pro 0.5 kb) 12 µl 
StarSolution M1 (LguI restriction enzyme (5 U/µl)) 1 µl 
StarSolution M2 (T4-DNA-Ligase (1 U/µl)) 1 µl 
StarSolution M3 (buffer) 1 µl 
Incubate for 1 h at 30°C  
 
 
Step 2: Subcloning of Dagla cDNA into pESG-IBA168 
pESG-IBA168 (ca. 5 ng, 5497 bp) 10 µl 
pENTRY-IBA51-Dagla (2 ng/µl) 12 µl 
StarSolution A1 (Esp3I restriction enzyme (10 U/µl)) 1 µl 
StarSolution A2 (T4-DNA-Ligase (1 U/µl)) 1 µl 
StarSolution A3 (buffer + 250 mM DTT + 12.5 mM ATP) 1 µl 
Incubate for 1h at 30°C  
 
2.10.5 RNA purification and measurement 
Total RNA from frozen brain tissue was extracted using Trizol® Reagent (Life 
Technologies). Brain tissue was transferred into 2 ml tubes containing 1.4 mm zirconium 
oxide beads and homogenized in TRIzol® (100 mg tissue/1 ml TRIzol®) by vigorous 
shaking in a tissue homogenizer. After centrifugation (12000 g, 10 min 4°C) the 
homogenate was transferred into a fresh tube and 1-bromo-3-chloropropane (BCP) (1:5) 
was added. After sustained vortexing for 30 s and 3 min incubation at RT, samples were 
centrifuged (12000 g, 10 min, 4°C) and the RNA containing upper phase was transferred 
into a fresh tube. Subsequently, the RNA was precipitated with isopropanol (1:1) and 
washed two times with 75 % EtOH. Finally the RNA was dried for 10 min at 50°C and then 
dissolved in 20 µl RNase-free water and stored at -80°C. Purity and RNA concentration 
were evaluated by optical density measurements at 260 and 280 nm. The absorbance of 
1 unit at 260 nm is equivalent to a RNA concentration of 40 µg/ml. 
 
2.10.6 Reverse transcription polymerase chain reaction 
Isolated RNA was transcribed into cDNA by reverse transcription using SuperScript® II 
Reverse Transcriptase and Oligo(dT)12-18 primers (Life Technologies). As a first step the 
absolute amount of RNA per sample (1000 ng) was adjusted to a volume of 10 µl. 
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Subsequently, 1 µl (0.5 µg/µl) of the Oligo(dt)12-18 primer were added to each reaction. The 
cDNA synthesis was performed with the following master mix and the described cycling 
program: 
 
Master Mix per reaction  
Sterile water 1 µl 
5 x first strand buffer (Life Technologies) 4 µl 
DTT (0.1 M, Life Technologies) 2 µl 
Deoxynucleotide Mix (10mM, Sigma-Aldrich) 1 µl 
 
Cycling parameters  
10 µl RNA (200-1000 ng, dissolved in RNAse-free water) + 1 µl Oligo(dt) 12-18 primer 
70°C     10 min 
  4°C  3 min 
Add 8 µl master mix per sample 
42°C 2 min 
4°C 3 min 
Add 1 µl SuperScript® II Reverse Transcriptase per sample 
42°C  60 min 
70°C 15 min 
4°C 10 min 
 
 
The obtained cDNA was adjusted to a concentration of 15 ng/µl and stored at -20°C. 
 
2.10.7 Real-time reverse transcription PCR (qRT-PCR) 
Differences in mRNA expression were determined in triplicate by custom TaqMan® Gene 
Expression Assays (Applied Biosystems). The TaqMan gene expression analysis is one 
option for real-time RT-PCR using the FRET (fluorescence resonance energy transfer) 
technology. FRET is based on an energy transfer between two chromophores. For RT-
PCR a short gene-specific oligonucleotide probe, fluorescently labeled at the 5’ end (FAM 
= 6-carboxyfluorescein) and quenched by a non-fluorescent tag (MGB = minor groove 
binder) at the 3’ end, is added to the cDNA sample together with an unlabeled pair of 
primers. Due to the complementarity the probe hybridizes with the target sequence and is 
cleaved during the PCR reaction through the 5’à3’ exonuclease activity of the 
polymerase. Thereby the fluorescent signal is no longer quenched and increases with 
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each PCR cycle proportionally to the amount of available cDNA template. For relative 
quantification, the expression level of the gene of interest is compared to the expression 
level of a constitutively expressed housekeeping gene. In this study GAPDH was used as 
a housekeeping control. Each 10 µl reaction consisted of 1x TaqMan® universal PCR 
Master Mix (Applied Biosystems, Darmstadt, Germany), 4 µl cDNA and 1x Custom 
TaqMan® Gene Expression Assay (Tab. 8). Samples were processed in a LightCycler® 
480 (Roche, Germany) with the following cycling parameters: 95°C for 10 min, 40 cycles 
at 95°C for 15 s and 60°C for 1 min. Analysis was performed using the LightCycler® 
480SW Software version 1.5.1 (Roche, Germany) and analyzed with the 2−ΔΔCT method 
(Livak & Schmittgen 2001). 
 
Table 8: TaqMan® Gene Expression Assay ID´s and corresponding genes used for gene expression 
analysis 
Target mRNA Assay ID 
BDNF Mm01334042_m1 
CB1 receptor (Cnr1) Mm00432621_s1 
CRH Mm01293920_s1 
CRHR1 Mm00432670_m1 
Dagla Mm00813830_m1 
Daglb  Mm00523381_m1 
FAAH Mm00515684_m1 
c-FOS (FOS) Mm00487425_m1 
GAPDH Mm99999915_g1 
GR (Nr3c1) Mm00433832_m1 
MAGL (Mgll) Mm00432621_s1 
NAPE-PLD Mm00724596_m1 
 
2.11 Protein biochemistry 
2.11.1 Polyacrylamide gel electrophoresis 
Isolated and purified proteins were separated and analyzed via SDS-Polyacrylamide gel 
electrophoresis (SDS-PAGE). Therefore, 13 µl of each protein purification step were 
added to 5 µl 4x NuPAGE® LDS sample buffer and 2 µl 10x NuPAGE® Sample Reducing 
(500 mM DTT) agent and heated for 10 min at 70°C. Samples were separated on precast 
NuPAGE™ Novex™ 4-12 % Bis-Tris Protein Gels using a protein electrophoresis 
chamber (200 V, 45 min). NuPAGE™ MES SDS Running buffer (1x: 50 mM MES, 50 mM 
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Tris Base, 0.1 % SDS, 1 mM EDTA, pH 7.3) complemented with 0.1 % 
NuPAGE™Antioxidants was used as running buffer. All chemicals were purchased from 
Life Technologies.  
In a next step protein gels were either stained with Coomassie Brilliant Blue to visualize all 
proteins or used for western blotting. Coomassie Brilliant Blue is a commonly used dye to 
stain proteins. For this staining protein gels were first incubated in the Coomassie staining 
solution (0.5 g Brilliant Blue R-250, 45 % methanol, 45 % dH2O, 10 % acetic acid) for 30 
min at RT and afterwards destained by changing the destain solution (20 % methanol, 70 
% dH2O, 10 % acetic acid) several times, until the background disappeared and only the 
protein bands were visible. 
 
2.11.2 Western Blot 
Western blotting was used to identify specific proteins. Therefore, proteins were first 
separated via polyacrylamide gel electrophoresis (Chapter 2.11.1) and were transferred to 
a PVDF (polyvinylidene difluoride) membrane (iBlot® 2 Transfer Stacks, PVDF; Life 
Technologies) using the iBlot® Gel Transfer Device. Subsequently, the membrane was 
blocked with 5 % BSA or skim milk powder in TBS-T (TBS containing 0.1 % Tween-20) for 
1 h at RT and overnight incubated at 4°C with anti-DAGLα (1:500, DGLα-Rb-Af380) or 
anti-FLAG (1:500, F7425) antibody diluted in 5 % BSA in TBS. On the next day, the 
membrane was washed three times in TBS-T and incubated with a horseradish 
peroxidase-conjugated secondary antibody diluted in 5 % BSA in TBS-T (1:10000, donkey 
anti-rabbit-HRP, Dianova) for 2 h at RT. After washing the membrane 3 times with TBS-T 
for 5 min at RT, 1 ml ECL substrate (Pierce) was added to the blot and proteins were 
directly detected with the ChemiDoc MP imaging systems. Enhanced chemiluminescence 
(ECL) is a method that provides highly precise detection of proteins. In this 
chemiluminescent reaction the horseradish peroxidase catalyzes the oxidation of luminol 
into a light-emitting reagent. 
 
2.11.3 Tandem affinity purification 
 
Tandem affinity purification (TAP) is a purification strategy for the efficient isolation of 
native protein complexes. In this study a Strep-Flag-TAP (SF-TAP) was conducted. 
Therefore, the DAGLα protein was C-terminal tagged with a tandem Strep-tag II followed 
by a single Flag-tag using the pESG-IBA168 expression vector. Both protein-tags have a 
medium affinity and avidity to their immobilized binding partners, allowing an elution of the 
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SF-tagged protein under native conditions. The Strep-tag consists of 8 amino acids (Trp-
Ser-His-Pro-Gln-Phe-Glu-Lys) and is capable of binding into the biotin-pocket of 
streptavidin. Bound proteins were eluted with desthiobiotin having a strikingly greater 
affinity to streptavidin than the Strep-tag. Biotin and streptavidin form one of the strongest 
non-covalent interactions in nature. In addition, previous studies showed that a tandem 
Strep-tag unlike a single Strep-tag increases the purification yield (Junttila et al. 2005). 
The Flag-tag consists of 8 amino acids (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) and binds to 
the anti-FLAG antibody, which is covalently attached to agarose. The FLAG octapeptide 
was used to elute bound proteins (Fig. 9). The detailed purification protocol is described 
below. 
 
Figure 9: Principal of tandem affinity purification using Strep-tag II and Flag-tag (adopted from IBA 
Lifescience) 
 
Tagged DAGLα protein was overexpressed in Neuro-2a cells. To purify DAGLα and 
bound proteins a cell pellet from two T175 cell culture flasks of 80-90 % confluent N2a 
cells (approximately 5x107 cells) was dissolved in 500 µl RIPA buffer containing one 
cOmplete™ Mini protease inhibitor cocktail tablet (Roche) per 10 ml RIPA buffer and 
incubated for 30 min on ice. Subsequently, disrupted cells were centrifuged (10000 g, 10 
min, 4°C) and the supernatant was used for TAP. The order of the two purification steps 
was essential for the amount of purified protein and the highest yields were obtained if the 
FLAG purification step was followed by the Strep purification. First 90 µl Anti-FLAG®M2 
affinity gel (Sigma-Aldrich) together with 100 µl TBS were added to a Spin Column with a 
polyethylene filter (~30 µm pore size, Pierce) and equilibrated 2 x 250 µl with RIPA buffer 
and shortly centrifuged (100 g, 5 s). Subsequently, the cell lysate was added to the 
column and incubated in an overhead-tumbler for 1h at 4°C to guarantee optimal binding 
of the tagged protein to the matrix. All following steps were conducted at RT and via 
gravity-flow instead of centrifugation. In a next step, the affinity gel was washed once with 
500 µl TBS containing 0.2 % Nonidet-P40 and twice with 500 µl TBS. To elute the bound 
proteins 2 x 200 µl elution buffer (TBS + 200 µg/ml FLAG®Peptide, Sigma-Aldrich) was 
added to the column and each time incubated for 10 min at RT. During incubation the 
column was properly closed and inverted several times. The eluates (E1, E2) were 
collected, combined and further used for the Strep-tag purification system.  
x"
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Therefore, 100 µl Strep-Tactin®Superflow® suspension was added to a Spin Column 
(described above) and 3 times washed with 500 µl TBS (100 g, 5 s). Subsequently, the 
eluate from the Flag purification was added to the column and incubated in an overhead-
tumbler for 1 h at 4°C. Afterwards the column was washed 3 times with buffer W (100 mM 
Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA; Iba Lifescience). All following steps were 
again conducted at RT and via gravity-flow instead of centrifugation. To elute all bound 
proteins 2 x 200 µl elution buffer E (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 
2.5 mM desthiobiotin; Iba Lifescience) was added to the column and each time incubated 
for 10 min at RT. During the incubation time the column was frequently inverted. The 
eluates were collected, combined and 4x concentrated with 3K centrifugal filters (Amicon 
Ultra-0.5 ml; Merck Millipore) to a volume of 100 µl. Concentrated purified proteins were 
stored in 50 % glycerol at -20°C. Samples (10-20 µl) were taken from all purification steps 
and used for polyacrylamide gel electrophoresis and western blot analysis. 
2.11.4 MALDI-TOF/TOF	mass	spectrometry	
Matrix Associated Laser Desorption Ionization (MALDI) coupled to time of flight (TOF) 
analyzers have been successfully applied to determine the mass of proteins, peptides and 
polymers. In addition, TOF/TOF is a tandem mass spectrometry method where two time-
of-flight mass spectrometers are used consecutively. MALDI-TOF/TOF mass 
spectrometry gives a specific peptide map when proteins are digested with specific 
enzymes like trypsin. This peptide maps can be used to identify proteins via existing 
databases. In this study MALDI-TOF/TOF was used to identify potential interaction 
partners of DAGLα. Therefore, TAP- and Flag-purified proteins (see 1.11.3) were first 
electrophoretic separated on precast NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gels. 
Precast gels were run for approximately 2.5 cm and stained with Coomassie Brilliant Blue 
to label all proteins. Subsequently, gels were destained until the background was 
completely gone and the protein bands were only stained faintly. All following steps, 
MALDI analysis and protein identification, were conducted in cooperation with Dr. Marc 
Sylvester at the Institute of Biochemistry and Molecular Biology (AG Prof. Dr. Volkmar 
Gieselmann, University of Bonn). Polyacrylamide gels were cut in 6 pieces per lane 
followed by a complex procedure in which proteins were reduced, alkylated and digested. 
These samples are mixed with a suitable matrix solution and spotted onto a metal plate. 
During MALDI analysis a pulsed laser irradiates the sample, leading to ionization of the 
sample molecules. These ions are analyzed in a TOF/TOF tandem mass spectrometer. 
The time of ion flight through the electromagnetic fields differs according to the mass-to-
charge ratio (m/z) value of the ion. Finally, mass spectra from major peptide ions are 
obtained and compared to databases to identify all proteins in the sample.  
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2.12 Click chemistry  
2.12.1 In vitro assays 
Analysis of DAGLα activity was assessed by in vitro assays using a labeled substrate 
(synthesized and kindly provided by Prof. C. Thiele, LIMES Life and Medical Sciences 
Institute, University of Bonn). The two applied substrates are diacylglycerols (DAGs) with 
a labeled palmitic acid in the sn-1 position (1-palmitoyl-2-linoyl-sn-glycerol and 1-
palmitoyl-2-arachidonoyl-sn-glycerol; Fig. 10). The labeling consists of a terminal c-c triple 
bound, which is not present in any natural occurring fatty acid. After the extraction of lipids 
the terminal alkyne could be easily labeled via the so-called click-reaction with a 
fluorogenic dye and separated via thin layer chromoatographie (TLC). Subsequently, 
clicked fatty acids were detected by fluorescence imaging (described in detail in Chapter 
2.12.2 and 2.12.3).  
 
Figure 10: The labeled DAGLα substrates: A) 1-palmitoyl-2-linoyl-sn-glycerol and B) 1-palmitoyl-2-
arachidonoyl-sn-glycerol 
 
In vitro assays were performed with cell cultures or lysates of WT and Dagla-/- 
macrophages (BMM) and SF-TAP purified DAGLα. For the experiments in cell culture 25 
µM or 50 µM of the substrate (1-palmitoyl-2-linoyl-sn-glycerol, stock: 4.9 mM in trifluoro 
acetic acid) were added to the growth medium of WT and Dagla-/- BMM (5x105 cells/ well 
in a 6-well plate) and after 24 h lipids were extracted. Therefore cells were washed twice 
with 1 ml PBS followed by lipid extraction with 500 µl MeOH/CHCl3 (5/1) per well by 
vigorously shaking for 30 s. Subsequently, the MeOH/CHCl3 mix was transferred into a 
microcentrifuge tube and 100 µl CHCl3 were added. The lipid fraction was used directly for 
TLC analysis (Chapter 2.12.2) or stored at -20°C. 
The in vitro assays with cell lysates were performed as follows: First macrophages 
were seeded 24 h before the experiment in a density of 5x105 cells/ well in a 6-well plate. 
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On the following day, cells were harvested by trypsination and subsequent centrifugation 
(1200 g, 10 min, 4°C). Cells were washed in sterile PBS and centrifuged again. 
Afterwards, cell pellets (each 5x105 cells) were resuspended in 100 µl assay buffer (50mM 
Tris/HCl pH 7.0, 0.1 % Triton X-100) and disrupted by repeated (10x) pipetting through a 
27-gauge needle. Cell Lysates were centrifuged (800 g, 5 min, 4°C) again and the 
supernatant was transferred into a new microcentrifuge tube. For the in vitro assay cell 
lysates were incubated with 50 µM substrate for 0 min, 10 min, 30 min, 120 min or 180 
min at 37°C. Subsequently, lipids were extracted by adding 2 x 2 volumes (200 µl each) of 
MeOH/CHCl3 (1/1). The lower MeOH/CHCl3 phase containing the lipid fraction was stored 
at -20°C until further analysis. 
For in vitro assays with tagged DAGLα 10 µl concentrated TAP or Flag purified 
DAGLα (in 50 % glycerol) was added to 90 µl assay buffer (50mM Tris/HCl pH 7.0, 0.1 % 
Triton X-100) and incubated with 50 µM substrate for 0 min, 10 min, 30 min or 120 min at 
37°C. Lipid extraction and storage was performed as described above. 
 
2.12.2 Lipid isolation and click reaction 
Lipids from in vitro assays or cell cultures were isolated with MeOH/CHCl3 (5/1 or 1/1) and 
stored at -20°C. Before TLC analysis was performed, the fatty acids were further extracted 
and clicked. Therefore the lipid fraction (400 µl for in vitro assays and 600 µl for cell 
culture experiments) was first centrifuged (12000 g, 30 s) and the supernatant was 
transferred into a fresh 2 ml microcentrifuge tube. To acetify the solution 400 µl H2O 
containing 1 % acetic acid was added, vigorously shaked and centrifuged as above. The 
lower phase from the two phase mixture containing the fatty acids was collected and 
evaporated in a speed vac for 10 min at 45°C. Subsequently, 7 µl CHCl3 were added per 
sample and samples were 3 times vortexed for 2 min and in between centrifuged as 
above. Afterwards 30 µl coumarin labeling solution (clickmix: 850 µl Ethanol, 50 µl 10 mM 
Cu(I)TFB in acetonitrile 10 µl 2 mg/ml Azidocoumarin in  EtOH) was added and samples 
were incubated for 3 h at 43°C. In parallel 7 µl of each standard (50 µM CHCl3) were also 
mixed with 30 µl clickmix, incubated as above and hereafter treated as the other samples. 
Following the click-reaction, 30 µl CHCl3 was added and samples/standards were 
vortexed for 2 min, sonicated for 5 min in an ultrasonic bath and again 3 times vortexed 
for 2 min and centrifuged as above. Ten µl of each sample and standard were applied 
onto silica gel TLC plates (Chapter 2.12.3). 
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2.12.3 Thin layer chromatographie (TLC) 
Thin layer chromatographie (TLC) is a method used to separate the components of a 
mixture using a thin stationary phase. In this study, silica gel 60 plates (Merck) with silica 
gel, a granular, porous form of silicon oxide, as the stationary phase were used. First, 10 
µl of each sample or standard were carefully applied onto the TLC-plates with a small 
glass capillary. After the samples were completely dried the TLC plates were run in a 
saturated chamber containing CHCl3/MeOH/H2O/acetic acid (65/25/4/1) for 10 cm (above 
the start zone). Subsequently, the plates were dried and run in isohexane/ethyl acetate 
(1/1) to the upper edge of the plate and again dried. To ensure that all coumarin dye 
molecules are in the strongly fluorescent deprotonated form, the plates were shortly 
soaked in N,N-diisopropylethylamine (Hünigs base). Immediately the coumarin signal was 
detected using a high sensitivity Electron-Multiplying CCD (EMCCD) camera, equipped 
with a 494/20 and 572/28 bandpass emission filter wheel, which is part of the imaging 
system. Labeled fatty acids were detected using a series of exposures (420 nm, LED 
lamp) with detection at 494 and 572 nm. In the described makro (provided by Prof. 
C.Thiele, LIMES Life and Medical Sciences Institute, University of Bonn; Thiele et al., 
2012) 8 pictures with each of the two filters with exposure times between 20 ms and 5 s 
were taken resulting in a total of 16 images. Intensities of individual bands of labeled fatty 
acid were quantified using ImageJ densitometry software, and expressed relative to the 
substrate signal, as a measure of fatty acid relative abundance in the different samples. 
2.13 Statistical analysis 
Data are presented as means ± SEM and the numbers of samples are indicated in the 
individual figures. Statistical significance was assessed by Students t-Test, Mann-Whitney 
U test or two-way ANOVA with Bonferroni´s post-hoc test. Significance level was set at p 
< 0.05. GraphPad Prism software (Version 5.0d, GraphPad Software Inc.) was used for 
the analysis of behavioral data. 
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 Results 
3.1 Behavioral and molecular analysis of Dagla-/- mice 
The following section outlines the behavioral and molecular analysis of constitutive Dagla 
deficient mice. Dagla-/- mice were tested in different anxiety- and depression-related 
behavioral tests to reveal the impact of DAGLα in the regulation of mood and emotion. All 
anxiety- and depression-related behavioral experiments (Chapter 3.1.3, 3.1.4) were 
performed at least twice with different cohorts of animals. All animals were tested in a battery 
of behavioral tests always starting with the least stressful one. In all cases, first a sucrose 
preference test, followed by an open-field, social preference, light-dark test and forced swim 
test were performed, or alternatively open-field, zero-maze and forced swim test. The tests 
were performed in weekly intervals. Another cohort of animals was housed in a room with an 
inverse light-dark cycle and tested for home cage activity. If not stated otherwise, all 
behavioral experiments were performed with mixed-gender groups.  
3.1.1 Endocannabinoid measurements and gene expression 
analysis 
Constitutive Dagla-/- mice were generated by crossing homozygous Dagla floxed (Daglafl/fl) 
mice on a C57BL/6J genetic background with Pgk1-Cre mice (Ternes 2013; Jenniches et al. 
2015), a transgenic mouse line expressing Cre ubiquitously (Lallemand et al. 1998). 
Therefore, either wild type C57BL/6J (WT) or Daglafl/fl mice are adequate control animals. In 
the following part of the results WT mice were used as controls. However, to exclude that 
loxP sites might influence gene expression, mRNA levels of ECS related genes of Dagla-/-, 
WT and Daglafl/fl mice were compared.  
Gene expression analysis showed similar expression levels of Dagla and other ECS 
related genes in Daglafl/fl mice and WT controls (Fig. 11A). In addition, relative quantification 
of whole mRNA revealed a complete loss of Dagla transcript in brain tissue of Dagla-/- mice (t 
= 11.75, p < 0.0001; Fig. 11A) using a probe which spans the exon junction between exon 8 
and 9, as already shown in previous studies (Ternes 2013). The deletion of DAGLα protein 
was validated by immunohistochemistry staining of cryofixed brain slices. Staining was 
completely lost in Dagla-/- tissue (Fig. 11B).  
Since DAGLα is the main synthesizing enzyme of 2-AG in the adult brain, the 
measurements of endocannabinoids (eCB) is an important indicator for the knockout of 
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Dagla and the analysis of possible compensatory mechanisms. Measurements were 
performed by Dr. Laura Bindila (Work group of Prof. Dr. Beat Lutz, Institute of Physiological 
Chemistry, Johannes Gutenberg University Medical Center, Mainz). Results showed a 80-90 
% reduction of 2-AG levels in cortex, hippocampus, striatum (genotype: F(1,23) = 124.4, p < 
0.0001) and amygdala (t = 17.69, p < 0.0001) of Dagla-/- mice (Fig. 11C). 2-AG content was 
unchanged in Daglafl/fl compared to WT controls (t = 1.558, p = ns; Fig. 11D), showing that 
the insertion of the loxP sites did not influence the activity of DAGLα. Furthermore, a 
significantly reduced level of anandamide in cortex, hippocampus (genotype: F(1,23) = 23.63, p 
< 0.0001) and amygdala (t = 3.308, p < 0.01) of Dagla-/- mice (Fig. 11E) was discovered. This 
reduction seemed to be brain region-dependent, because anandamide levels in the striatum 
did not differ between genotypes (t = 0.6376, p = ns). In contrast, arachidonic acid (AA) 
content, the main metabolite of 2-AG, was unaffected in most of the analyzed brain areas. 
Only amygdalar AA was significantly reduced in Dagla-/- mice (t = 11.20, p < 0.0001; Fig. 
11F).  
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Figure 11: Validation of Dagla-/- mice and endocannabinoid (eCB) measurement. (A) Shown are mRNA 
levels normalized to GAPDH. Real-time RT-PCR results show a complete loss of Dagla mRNA transcript in 
Dagla-/- mice (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 5 animals/group, 
****p < 0.0001). (B) Representative DAGLα immunostainings of (I) wild type and (II) Dagla-/- mice hippocampi. 
Staining is completely absent in Dagla-/- (scale: 100 µm) (C) 2-AG levels are significantly decreased (by 80-90%) 
in cortex, hippocampus, striatum and amygdala of Dagla-/- mice. (D) Similar 2-AG levels were observed in Daglafl/fl 
mice and WT controls. (E) Anandamide (AEA) levels were decreased in cortex by 60%, hippocampus by 30% and 
amygdala by 25%, but not in the striatum of Dagla-/- mice. (F) Arachidonic acid (AA) content was significantly 
reduced in the amygdala, but not changed in cortex, hippocampus and striatum of Dagla-/- mice. Please note that 
the amount of 2-AG, AEA and AA in the amygdala was measured in a separate experiment. Statistical analysis 
for eCB measurement in cortex, hippocampus and striatum: two-way ANOVA, Bonferroni’s post-hoc test, values 
represent mean ± SEM: n = 5 animals/group, *p < 0.05, **p < 0.01, ****p < 0.0001. Statistical analysis for eCB 
measurement in amygdala samples: Student´s t-test, values represent mean ± SEM: n = 10 animals/group, **p < 
0.01, ****p < 0.0001 (modified from Jenniches et al. 2015). 
 
 
Subsequent to the molecular analysis of Dagla-/- mice, the animals were subjected to a 
variety of different behavioral tests. Initially, the animals were analyzed in a tetrad test to 
assess CB1 receptor-mediated effects. 
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3.1.2 Tetrad test 
The tetrad test is widely used to analyze cannabinoid receptor (CB1)-mediated behavioral 
effects in rodents. Treatment with THC leads to decreased locomotor activity, decreased 
body temperature and analgesia in WT animals (Little et al. 1988). The tetrad test was 
conducted once with 4-5 animals per group to analyze CB1 mediated-effects and reveal 
potential changes of CB1 signaling in Dagla-/- mice.  
THC treatment (8 mg/kg) led to a similar reduction of body temperature in WT and 
Dagla-/- mice (treatment effect: F(1,15) = 22.77, p < 0.001; genotype effect: F(1,15) = 0.4895, p = 
ns; Fig. 12A). Furthermore, Dagla-/- mice and WT showed a delayed pain response in the hot 
plate test after THC treatment (F(1,16) = 15.62; p < 0.01; Fig. 12B). This analgesic effect of 
THC did not differ between genotypes (F(1,16) = 2.917; p = ns; Fig. 12B). In addition, THC 
treatment led to a reduced locomotor activity in the open-field test, as seen in a significantly 
reduced distance travelled (F(1,16) = 46.83, p < 0.0001; Fig. 12C), and reduced rearings in 
both genotypes (F(1,15) = 171.5, p < 0.0001; Fig. 12D). However, vehicle treated Dagla-/- mice 
had a overall reduced locomotor activity including reductions in distance travelled (F(1,16) = 
4.850, p < 0.05; Fig. 12C) and rearings (F(1,15) = 11.34, p < 0.01; Fig. 12D).  
 
 
Figure 12: Tetrad test of Dagla-/- mice. (A) THC treatment (8 mg/kg) significantly reduced body temperature of 
Dagla-/- mice and WT controls. (B) Furthermore, THC had a similar analgesic effect in both genotypes, leading to 
a delayed pain response in the hot plate test. (C) THC treatment led to a significantly reduced distance travelled 
in Dagla-/- mice and WT controls. However, Dagla-/- mice had a generally reduced locomotor activity (genotype 
effect: *p < 0.05). (D) Treatment with THC also reduced rearings in both genotypes. In addition, significantly 
decreased number of rearings was found in vehicle treated Dagla-/- mice (##p < 0.01). Statistical analysis: two-way 
ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 4-5 animals/group, *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001, ##p < 0.01. 
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In conclusion, THC treatment resulted in similar behavioral changes in Dagla-/- and WT 
mice. Thus, lack of Dagla did not influence CB1 receptor-mediated effects of THC. 
3.1.3 Maternal behavior and body weight 
Mice lacking Dagla are viable and fertile, but if nests were disturbed, for instance after cage 
changes, Dagla-/- mice often neglected their offspring. It is considered to be highly 
characteristic for rodents to retrieve pups, if they are absent from the nest. Therefore, 
maternal behavior was analyzed in the pup retrieval test. Indeed, Dagla-/- mice needed 
significantly more time to recollect the pups from the opposite corner of the home cage into 
the nest compared to WT controls, indicating a decreased maternal care behavior (U = 8.00, 
p < 0.05; Fig. 13A). In addition, one of the tested Dagla-/- dams did not retrieve their pups at 
all and two dams only retrieved one or two out of three pups during the test period of 300 s. 
On the other hand, the percentage of pups from each litter of tested dams with visible milk 
spots did not differ between genotypes (t = 0.8044, p = ns; Fig. 13B).  
In line with these results, nursing behavior (t = 1.21, p = ns; Fig. 13C) and interaction 
time with the offspring (t = 1.259, p = ns; Fig. 13D) were not affected in Dagla-/- mice. For the 
analysis of maternal care, the behavior of nursing female mice was recorded using a time-
sampling procedure (20 sec observation every third minute for 1 h between 9 AM and 10 AM 
on postnatal days 2–7), resulting in 21 observations of each dam per day. Pup retrieval and 
maternal care behavior was assessed in different cohorts. Compatible with the described 
results, no significant differences in the body weight of Dagla-/- pups compared to age 
matched control mice were observed (F(1,12) = 0.9201, p = ns; Fig. 13E), which strongly 
supports that nursing behavior was unchanged. However, after weaning (at the age of 3 
weeks) the body weight of Dagla-/- mice was significantly reduced compared to WT controls 
(male mice: F(1,26) = 20.9, p < 0.001; female mice: F(1,22) = 128.6, p < 0.0001; Fig. 13F,G).  
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Figure 13: Dagla-/- mice showed a deficit in maternal care and reduced body weight. (A) Dagla-/- mice 
showed decreased maternal care compared to WT controls in the pup retrieval test. The latency in seconds was 
recorded to sniff the pups and retrieve them to the nest (Mann-Whitney U test, values represent mean ± SEM: n = 
7 mice/group, *p < 0.05). (B) However, percentage of pups with milk spots per litter did not differ between 
genotypes (Student´s t-test, values represent mean ± SEM: n = 5-7 litter, p = ns). (C) Nursing behavior as a 
measure of maternal care did not differ between Dagla-/- and WT control mice. Shown is the mean number of 
observations of nursing behavior during observation period (Student´s t-test, values represent mean ± SEM: n = 
4-7 dams, p = ns). (D) Interaction of moms with pubs was similar for both genotypes. Shown is the mean number 
of observations of interaction with pups during observation period (Student´s t-test, values represent mean ± 
SEM: n = 4-7 dams, p = ns). (E) Body weights of Dagla-/- and WT controls before weaning did not differ between 
the genotypes (two-way ANOVA with repeated measurements, Bonferroni’s post-hoc test, values represent mean 
± SEM: n = 7 animals/group). (F, G) However, body weights of adolescent and adult male (F: n = 12 
animals/group) and female (G: n = 14 animals/group) Dagla-/- mice were significantly reduced. Please note that 
the SEM was very small for some data points, thus resulting in very small error bars (two-way ANOVA with 
repeated measurements, Bonferroni’s post-hoc test, values represent mean ± SEM: **p < 0.01, ***p  < 0.001, 
****p < 0.0001) (modified from Jenniches et al. 2015). 
 
To determine if the deficit in maternal care reflects a general disturbance of social 
behavior, a social preference test was performed (Fig. 14A,B). WT and Dagla-/- mice 
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displayed a similar ratio of the time spent with the partner mouse was compared to the empty 
cage (t = 0.4321, p = ns; Fig. 14A). The time spent with the gender-matched partner mouse 
was significantly higher compared to the empty cage in both genotypes (F(1,36) = 51.27, p < 
0.0001; Fig. 14B), indicative of a normal sociability in both genotypes. 
 
 
Figure 14: Dagla-/- mice displayed normal sociability. (A) Dagla-/- mice showed the same social preference like 
WT controls. The ratio between the time spent with a partner to time spent with an empty cage did not differ 
between genotypes (Student´s t-test, values represent mean ± SEM: n = 10 animals/group, p = ns). (B) 
Preference for the partner mouse was significantly higher in both genotypes (two-way ANOVA, Bonferroni’s post-
hoc test, values represent mean ± SEM: n = 10 animals/group, ****p < 0.0001) (modified from Jenniches et al. 
2015). 
3.1.4 Analysis of anxiety-related behavior 
To reveal potential effects of Dagla knockout on anxiety-related behavior, several tests were 
performed. First, anxiety-like behavior and locomotion was analyzed in the open-field test, 
where the time spent in the center of the open-field box is inversely correlated to the state of 
anxiety (Gould et al. 2009). Data are presented as distance travelled (Fig. 15A) and time 
spent in the center (Fig. 15B) over time in 10-min bouts. The total distance travelled was 
similar in Dagla-/- and WT mice (F(1,23) =  1.986, p = ns; Fig 15A). In addition, the distance 
travelled decreased during the test session (between the 10-min bouts) in both genotypes 
due to habituation to the novel environment, revealing a significant main effect for time 
(F(2,46)= 35.93, p < 0.0001; Fig. 15A). However, Dagla-/- mice spent less time exploring the 
center of the open-field compared to WT controls (genotype effect: F(1,20) = 5.751, p < 0.05; 
Fig. 15B). These results indicate that exploratory behavior and locomotor activity was not 
affected by the deletion of Dagla, whereas anxiety levels were slightly elevated in Dagla-/- 
mice.  
Anxiety-like behavior was further analyzed in the light/dark box test (Fig. 15C-G). In this 
test the time spent in the dark area is correlated to the state of anxiety. Furthermore, delayed 
first entries into the light area and less transitions between the two areas are measures of 
anxiety. The time spent in the dark area (F(1,36) = 0.0000005, p = ns; Fig. 15C), distance 
travelled in both compartments (F(1,36) = 2.830, p = ns; Fig. 15D) and the first entry into the 
light area did not differ between genotypes (t = 0.4582, p = ns; Fig. 15E). However, the 
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number of transitions between the two areas was significantly decreased for Dagla-/- mice (t = 
2.708, p < 0.05; Fig. 15F), indicating a slightly increased anxiety-like behavior in Dagla-/- 
mice. Furthermore, Dagla-/- mice showed a decreased number of rearings in both areas 
(genotype: F(1,36) = 21.18, p < 0.0001; Fig. 15G). Reduced frequencies of rearing are 
correlated with reduced exploratory behavior and increased anxiety. 
 
  
Figure 15: Dagla-/- mice showed slightly increased anxiety-like behavior. (A,B) Exploratory and anxiety-
related behavior was analyzed in the open-field test. (A) No significant genotype differences in total distance 
travelled were observed (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 11 
animals/group, p = ns). (B) Dagla-/- spent less time exploring the center and therefore displayed an anxiety-like 
phenotype (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 11 animals/group, *p 
< 0.05,  **p < 0.01). (C-G) Anxiety-behavior was further analyzed in the light/dark box test. (C) Time spent in the 
dark area did not differ between genotypes (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean 
± SEM: n = 9-11 animals/group, p = ns). (D) Dagla-/- and WT mice showed a similar distance travelled in both 
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areas (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 9-11 animals/group, p = 
ns). (E) The latency to first enter the light area was similar in both genotypes (Student´s t-test, values represent 
mean ± SEM: n = 9-11 animals/group, p = ns). (F) However, number of transitions between both areas was 
significantly decreased for Dagla-/- mice compared to WT controls (Student´s t-test, values represent mean ± 
SEM: n = 9-11 animals/group, *p < 0.05). (G) The number of rearings in both areas was significantly decreased in 
Dagla-/- mice compared to WT controls (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± 
SEM: n = 9-11 animals/group, *p < 0.05, **p < 0.01) (modified from Jenniches et al. 2015). 
 
Anxiety-like behavior was further analyzed in the zero-maze test, where time spent in 
the open areas is negatively correlated with the state of anxiety (Shepherd et al. 1994). A 
similar time spent in the open area was observed for Dagla-/- and WT mice (F(1,40) = -12.80, p 
= ns; Fig. 16A), indicative of a unaltered anxiety-state of mice lacking Dagla. Two-way 
ANOVA of the distance travelled revealed a significant genotype effect (F(1,40) = 4.739, p < 
0.05; Fig. 16B). Distance travelled in the open area was significantly increased in Dagla-/- 
mice (t = 2.939, p < 0.01; Fig. 16B). 
 
 
Figure 16: Dagla-/- mice showed an altered behavior in the zero-maze test. (A,B) Anxiety-like behavior was 
analyzed in the zero-maze test. (A) Time spent in the open or dark area was not significantly changed in Dagla-/- 
mice (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 20-22 animals/group, p = 
ns). (B) However, distance travelled in the open arms was significantly increased in Dagla-/- mice (two-way 
ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 20-22 animals/group, **p < 0.01) 
(modified from Jenniches et al. 2015). 
 
 
Overall the results of the conducted tests revealed a slightly increased anxiety-like 
behavior of mice lacking Dagla.  
3.1.5 Analysis of depression-related behavior 
 
Disturbed cannabinoid signaling has been correlated with depressive-like behavior in rodents 
(Martin et al. 2002; Valverde & Torrens 2012). To analyze the impact of DAGLα and 2-AG on 
this depression-related phenotype, Dagla-/- mice were subjected to several behavioral tests. 
First, home cage activity was analyzed. Changes in the general activity and 
disturbances in the light/dark cycle are related to depression. Similar time-dependent 
alterations in the home cage activity were observed in Dagla-/- and WT mice. Both mouse 
lines displayed an increased activity during the dark phase and a normal circadian rhythm 
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(F(95, 1235) = 0.9226, p = ns; Fig. 17A). Additionally, locomotor activity during the light and the 
dark phase did not differ between genotypes (F(1,13) = 0.05578, p = ns; Fig. 17A). 
Next, despair behavior, which is often considered as a symptom of depression, was 
evaluated in the forced swim test. In this test the immobility time of the animals is a measure 
of depressive-like behavior (Porsolt et al. 1977) and antidepressant drugs decrease the 
immobility time. The deletion of Dagla led to an increased immobility time in both male and 
female mice.  The forced swim test revealed a significant genotype effect (F(1,37) = 31.07, p < 
0.0001; Fig. 17B), but no gender effect (F(1,37) = 1.085, p = ns; Fig. 17B). 
Another symptom of depression, anhedonia (reduced responsiveness to pleasurable 
stimuli), was investigated in the sucrose preference test. Dagla-/- mice had a reduced 
preference for sucrose revealing a genotype effect (F(1,33) = 7.397, p < 0.05; Fig. 17C), which 
was significant in males (t = 3.296, p < 0.01; Fig. 17C), but not in females (t = 0.5783, p = ns; 
Fig. 17C). 
 
 
Figure 17: Dagla-/- mice displayed a depressive-like phenotype. (A) Locomotor activity and circadian rhythm 
was analyzed by home cage activity measurement. Dagla-/- mice did not show any changes in circadian rhythm 
and overall activity (two-way ANOVA repeated measurements, Bonferroni’s post-hoc test, values represent mean 
± SEM: n = 14 animals/group, p = ns). (B) Male and female Dagla-/- mice displayed depression-like behavior in the 
forced swim test. The immobility time of Dagla-/- animals was significantly increased compared to WT controls 
(two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 8-12 animals/group, **p < 0.01, 
***p < 0.001). (C) Anhedonia was assessed by sucrose preference. Sucrose preference of male but not female 
Dagla-/- mice was significantly decreased compared to WT controls (two-way ANOVA, Bonferroni’s post-hoc test, 
values represent mean ± SEM: n = 8-11 animals/group, **p < 0.01) (modified from Jenniches & Zimmer 2015). 
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Treatment with the antidepressant amitriptyline (10 mg/kg) significantly decreased the 
immobility time of Dagla-/- (vehicle vs. amitriptyline: t = 5.386, p < 0.0001; Fig. 18A) and 
control mice in the forced swim test (vehicle vs. amitriptyline: t = 2.963, p < 0.05) and could 
therefore reverse the depressive-like phenotype of Dagla-/- mice. In addition, after treatment 
with amitriptyline there was no longer a significant difference detectable between the 
genotypes (t = 0.2239, p = ns). Furthermore, to analyze the impact of 2-AG and anandamide 
on the depressive-like phenotype, Dagla-/- mice were treated either with the MAGL inhibitor 
JZL184 or the FAAH inhibitor URB597 2 h before the forced swim test. Neither JZL184 nor 
URB597 significantly changed the immobility time of Dagla-/- (JZL184: t = 1.122, p = ns; 
URB597: t = 0.3351, p = ns; Fig. 18A) or WT mice (JZL184: t = 1.468, p = ns; URB597: t = 
1.560, p = ns; Fig. 18A) compared to vehicle controls. However, subsequent to both 
treatments no significant difference between the genotypes was observed (JZL184: t = 
2.022, p = ns; URB597: t = 0.6697, p = ns). In contrast, the comparison of the vehicle treated 
animals revealed a significant genotype effect (t = 3.205, p < 0.01; Fig. 18A). Measurements 
of 2-AG and anandamide levels in the amygdala after JZL184 treatment showed an increase 
of 2-AG in WT  (t = 5.812, P < 0.0001; Fig. 18C) and Dagla-/- mice (t = 9.398, p < 0.0001; Fig 
18B,C). However, even after the treatment with JZL184, Dagla-/- mice still showed a much 
lower 2-AG level than vehicle treated WT mice (t = 12.14, p < 0.0001; Fig. 18C). Thus, 
MAGL inhibition could not restore the 2-AG level in the amygdala of Dagla-/- mice. 
Furthermore, after treatment with JZL184 no differences in anandamide levels between the 
genotypes were detected (t = 0.5918, p = ns; Fig. 18D), which was observed in the vehicle 
control group (t = 3.414, p < 0.01; Fig. 18D). Therefore, MAGL inhibition seemingly 
normalized anandamide levels in the amygdala of Dagla-/- mice. 
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Figure 18: Effects of MAGL and FAAH inhibition and antidepresssant treatment in the forced swim test. 
(A) Antidepressant treatment with 10 mg/kg amitriptyline significantly decreased immobility time of WT and Dagla-
/- mice. In contrast, neither treatment with 20 mg/kg JZL184 nor with 0.5 mg/kg URB597 significantly changed the 
immobility of WT or Dagla-/- mice. However, after treatment with MAGL and FAAH inhibitor we could no longer 
observe a difference between the genotypes (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean 
± SEM: n = 10-19 animals/group, #p < 0.0001, **p < 0.0001, ####p < 0.0001). (B,C) Treatment with 20 mg/kg 
JZL184 significantly increased 2-AG levels in the amygdala of WT (C: two-way ANOVA, Bonferroni’s post-hoc 
test, values represent mean ± SEM: n = 5-10 animals/group, ####p < 0.0001) and Dagla-/- mice (B: Students t-test, 
values represent mean ± SEM: n = 5-10 animals/group, ****p < 0.0001). However, MAGL inhibition could not 
restore the 2-AG level in Dagla-/- mice (C: two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± 
SEM: n = 5-10 animals/group, ****p < 0.0001). (D) Treatment with JZL184 did not significantly change AEA levels 
in the amygdala in WT or Dagla-/- mice. However, after MAGL inhibition no difference between the genotypes was 
observed (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 5-10 animals/group, p 
= ns) (modified from Jenniches et al. 2015). 
 
The results show that mice lacking Dagla display several symptoms related to 
depression. In conclusion, the deletion of Dagla, thus the lack of 2-AG, caused a severe 
disturbance in the emotional state of rodents. 
3.2 Behavioral and molecular analysis of neuron-specific 
Dagla-/- mice 
As described in chapter 3.1, constitutive lack of Dagla led to increased anxiety and a 
depressive-like phenotype in mice. However, which cell type might be responsible for this 
phenotype is still unknown. Therefore, this part of the results summarizes the molecular and 
behavioral analysis of neuron-specific Dagla-/- mice (Syn-Dagla-/-). All anxiety- and 
depression-related behavioral experiments were performed once with male or mixed-gender 
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cohorts. The animals were tested in several behavioral tests, always starting with the least 
stressful one. 
3.2.1 Endocannabinoid measurements and gene expression 
analysis  
To obtain Syn-Dagla-/- mice, homozygous Daglafl/fl mice were bred with Synapsin1-Cre mice 
(Zhu et al. 2001). In all following experiments Daglafl/fl littermates were used as control 
animals. Knockout of Dagla was verified by TaqMan gene expression analysis, which 
revealed a 60-70 % reduction of Dagla mRNA in cortex (t = 6.01, p < 0.0001; Fig. 19A) and 
hippocampus (t = 3.352, p < 0.05; Fig. 19B) of Syn-Dagla-/-. Reductions of Dagla mRNA in 
the amygdala failed to reach the level of significance (t = 2.525, p = ns; Fig. 19B). In addition, 
mRNA levels of other genes related to the ECS were not affected (Fig. 19A). Syn-Dagla-/- 
mice were further verified by staining of cryofixed brain slices. Immunostainings showed an 
almost complete loss of DAGLα protein (Fig. 19C). 
 
 
Figure 19: Validation of Syn-Dagla-/- mice and endocannabinoid (eCB) measurement. (A) Shown are mRNA 
levels normalized to GAPDH. Real-time RT-PCR results show a 60 % reduction of Dagla mRNA transcript in Syn-
Dagla-/- mice compared to Daglafl/fl controls. However, other genes related to the endocannabinoid system did not 
differ between genotypes (n = 4-6 animals/group). (B) In addition, Dagla mRNA levels were significantly reduced 
(60-70 %) in amygdala and hippocampus of Syn-Dagla-/- mice compared to Daglafl/fl controls (two-way ANOVA, 
Bonferroni’s post-hoc test, values represent mean ± SEM: n = 3-4 animals/group, *p < 0.05, **p < 0.01, ****p < 
0.0001). (C) Representative DAGLα immunostainings of (I) Daglafl/fl, (II) Dagla-/- and (III) Syn-Dagla-/- mice brain 
slices. Staining is completely absent in Dagla-/- brain and almost lost in Syn-Dagla-/- brain (scale: 500 µm; blue: 
Dapi; green: DAGLα staining). 
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The main cellular source of 2-AG in the brain is still unknown. Neurons, microglia and 
astrocytes have been shown to produce 2-AG in vitro (Walter et al. 2003a). Therefore, 
endocannabinoid levels were measured in different brain parts of Syn-Dagla-/- mice. This 
analysis was performed by Dr. Laura Bindila (University of Mainz). 2-AG levels were 
unchaged in hippocampus (t = 0.02273, p = ns; Fig. 20A) and prefrontal cortex (PFC) (t = 
0.6304, p = ns; Fig. 20A) of Syn-Dagla-/- mice compared to Daglafl/fl control mice. 
Furthermore, anandamide (hippocampus: t = 1.357, p = ns; PFC: t = 0.7648, p = ns; Fig. 
20B) and AA (hippocampus: t = 1.207, p = ns; PFC: t = 2.247, p = ns; Fig 20C) levels were 
not affected in Syn-Dagla-/- mice compared to controls. However, this eCB measurement 
showed a significant reduction of AA in the hippocampus and PFC of constitutive Dagla-/- 
mice (Fig. 20C), which was not present in previous experiments (Fig. 11F). 
 
 
Figure 20: 2-AG and anandamide levels were not affected by the neuron-specific knockout of Dagla. (A-C) 
Shown are the amounts of 2-AG and anandamide (AEA) relative to the amount of total protein per sample. (A) 2-
AG levels were not decreased in cortex or hippocampus of Syn-Dagla-/- mice compared to Daglafl/fl control mice. 
(B) Furthermore, anandamide (AEA) levels were not changed in Syn-Dagla-/- mice compared to controls. (C) 
Arachidonic acid (AA) content was also not altered in Syn-Dagla-/- mice. For direct comparison values of 
constitutive Dagla-/- mice are also represented. Statistical analysis for eCB measurement: two-way ANOVA, 
Bonferroni’s post-hoc test, values represent mean ± SEM: n = 5-6 animals/group, ***p < 0.001, ****p < 0.0001. 
 
In addition, male adult 2-3 month old Syn-Dagla-/- mice have an approximately 10 % 
reduced body weight compared to controls (t = 2.523, p < 0.05; Fig. 21). The reduction was 
less pronounced compared to constitutive Dagla-/- mice. 
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Figure 21: Syn-Dagla-/- mice had a reduced body weight. Adult (2-3 month old) male Syn-Dagla-/- mice have a 
significantly reduced body weight compared to age-matched Daglafl/fl control mice (Students t-test, values 
represent mean ± SEM: n = 10 animals/group, *p < 0.05). 
 
Following the molecular analysis and body weight measurements, Syn-Dagla-/- mice 
were analyzed in different anxiety- and depression-related behavioral tests.  
3.2.2 Analysis of anxiety-related behavior  
Locomotor activity and anxiety-related behavior of male Syn-Dagla-/- mice was assessed in 
the open-field test. Data are presented as distance travelled (Fig. 22A) and time spent in the 
center (Fig. 22B) over time in 10-min bouts. Distance travelled (F(1,18) = 0.9124, p = ns; Fig. 
22A) and the time spent in the center (F(1,18) = 1.128, p = ns; Fig. 22B) did not differ 
significantly between Syn-Dagla-/- and Daglafl/fl control mice. Distance travelled (between the 
10-min bouts) decreased over time in both genotypes, leading to a significant time effect 
(F(2,36) = 73.61, p < 0.0001; Fig. 22A).  
 
Figure 22: Syn-Dagla-/- mice displayed no anxiety-like behavior. (A,B) Exploratory and anxiety-related 
behavior of male Syn-Dagla-/- was analyzed in the open-field test. (A) No significant genotype differences in total 
distance travelled were observed (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n 
= 11 animals/group, p = ns). (B) In addition, time spent exploring the center did not differ between genotypes. 
(two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 10 animals/group, *p < 0.05,  **p 
< 0.01). 
 
Thus, in contrast to constitutive Dagla-/- mice, Syn-Dagla-/- mice exhibited no anxiety-
like phenotype in the open-field test. 
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3.2.3 Fear conditioning paradigm  
Previous studies showed that the constitutive lack of CB1 or Dagla leads to a deficit in fear 
extinction (Marsicano et al. 2002; Ternes 2013; Jenniches et al. 2015). To analyze the 
impact of neuronal DAGLα to this phenotype, a mixed-gender group of Syn-Dagla-/- mice was 
subjected to the same paradigm.  
Extinction of fear is characterized by a decreasing freezing response over time. Two 
types of fear extinction can be distinguished: between-session extinction considers the 
decline in freezing behavior between extinction trials. Within-session extinction describes the 
decline in freezing that occurs within a single extinction trial. Behavioral data were analyzed 
for between- and within-session extinction 
A decline of fear responses between the extinction trials E1 to E3 was observed for 
Daglafl/fl control mice, whereas freezing times of Syn-Dagla-/- animals increased over time 
(Fig. 23A). The knockout line sustained an elevated freezing level, whereas Daglafl/fl controls 
returned progressively to base-line levels. Two-way ANOVA revealed a significant main 
effect for genotype (F(1,62) = 25.81, p < 0.0001; Fig.  23A) and time x genotype interaction 
(F(3,62) = 3.858, p < 0.05; Fig. 23A). Syn-Dagla-/- animals reacted with increased fear 
responses on extinction days E2 (p < 0.05), E3 (p < 0.01) and E6 (p < 0.001) compared to 
Daglafl/fl controls. In addition, a significantly increased freezing time on extinction trial E6 
compared to E1 was observed in Syn-Dagla-/- mice (t = 3.755, p < 0.01; Fig. 23A). Thus, 
Syn-Dagla-/- mice displayed disrupted between-session fear extinction. 
Next, within-session extinction was determined. For the first extinction session E1, no 
decline in the freezing response was detected in any of the genotypes. Freezing behaviors of 
Syn-Dagla-/- mice were comparable to Daglafl/fl animals (genotype effect: F(1,48) = 0.1068, p = 
ns; Fig. 23B). In contrast, significant main effects for genotype were observed for the 
following extinction trials E2 (F(1,48) = 6.988, p < 0.05; Fig. 23C), E3 (F(1,48) = 19.01, p < 
0.0001; Fig. 23D) and E6 (F(1,48) = 26.44, p < 0.0001; Fig. 23E). Syn-Dagla-/- animals showed 
continuously increased fear responses on extinction trials E2, E3 and E6 (Fig. 23C-E). At 
extinction trial E2, a decline of the freezing response was detected for Daglafl/fl mice, whereas 
the freezing time of Syn-Dagla-/- mice remained constant during the whole test session (Fig. 
23C). In addition, a sustained freezing behavior was detected upon persisting tone 
presentation on extinction trial E3 (p < 0.05 after 60 s until the end of the session; Fig. 23D) 
and E6 (p < 0.01 after 60 s until 120s, p < 0.001 after 120 s until 180 s; Fig. 23E). However, 
no significant interactions between genotype and freezing behavior were observed (E2: F(2,48) 
= 0.9859, p = ns; E3: F(2,48) = 0.1449, p = ns; E6: F(2,48) = 2.008, p = ns; Fig. 23C-E). The 
analysis of within-session extinction revealed that Syn-Dagla-/- mice showed a tendency 
towards an impaired fear extinction during prolonged tone presentation.  
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Figure 23: Syn-Dagla-/- mice displayed an increased fear response and impaired fear extinction. (A-E) Syn-
Dagla-/- and Daglafl/fl controls were conditioned with a tone-foot shock pairing in the conditioning chamber. All 
animals were exposed to a 180 s tone in a neutral environment 1, 2, 3 and 6 days after the conditioning 
procedure. (A) Syn-Dagla-/- mice showed an increased freezing behavior (two-way ANOVA, Bonferroni’s post-hoc 
test, values represent mean ± SEM: n = 9 animals/group, *p < 0.05, **p < 0.01, ***p < 0.001) and an impaired 
between-session extinction of conditioned fear (two-way ANOVA, Bonferroni’s post-hoc test, values represent 
mean ± SEM: n = 9 animals/group, genotype effect ****p < 0.0001, interaction *p < 0.05).  (B) On extinction day 
E1, Syn-Dagla-/- and Daglafl/fl mice showed similar freezing behavior. (C-E) However, Syn-Dagla-/- mice showed 
increased freezing behavior on extinction day 2, 3 and 6 (two-way ANOVA, Bonferroni’s post-hoc test, values 
represent mean ± SEM: n = 8-9 animals/group, *p < 0.05, **p < 0.01, ***p < 0.001). 
 
In conclusion, lack of Dagla in neurons led to an increased fear response and a deficit 
in between-session extinction in a cued fear conditioning paradigm. A comparable phenotype 
was detected in constitutive Dagla-/- mice (Ternes 2013; Jenniches et al. 2015). 
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3.2.4 Analysis of depression-related behavior  
A constitutive lack of Dagla led to the development of a depressive-like phenotype in mice. 
Therefore, Syn-Dagla-/- mice (mixed-gender group) were subjected to different behavioral 
tests related to depression. First, activity in the home cage was analyzed. Home cage activity 
measurements revealed time-dependent alterations in both Syn-Dagla-/- and Daglafl/fl 
animals, resulting in similar circadian rhythm in both genotypes (F(46,828) = 1.131, p = ns; Fig. 
24A). However, a reduced locomotor activity in Syn-Dagla-/- mice was observed (genotype 
effect: F(1,18) = 5.936, p < 0.05; Fig. 24A).  Overall activity was significantly reduced in the 
dark, active phase of the animals (t = 2.968, p < 0.05; Fig. 24B), but not in the light phase (t = 
1.223, p = ns; Fig. 24B).  
Furthermore, despair behavior was analyzed in the forced swim test. Immobility time 
was significantly increased in Syn-Dagla-/- mice (t = 2.257, p < 0.05; Fig. 24C), indicative of a 
depressive-like phenotype. Another symptom of depression, anhedonia, was evaluated in the 
sucrose preference test. Syn-Dagla-/- had a significantly reduced preference for sucrose (t = 
4.377, p < 0.001; Fig. 24D). 
 
 
Figure 24: Syn-Dagla-/- mice displayed a depressive-like phenotype. (A) Locomotor activity and circadian 
rhythm was analyzed by home cage activity measurements. Syn-Dagla-/- mice displayed a similar circadian 
rhythm as Daglafl/fl controls, but reduced locomotor activity (two-way ANOVA repeated measurements, 
Bonferroni’s post-hoc test, values represent mean ± SEM: n = 10 animals/group, interaction: p = ns, genotype: p 
< 0.05). (B) Overall activity was significantly reduced in the the dark, but not in the light phase (two-way ANOVA, 
Bonferroni’s post-hoc test, values represent mean ± SEM: n = 10 animals/group, *p < 0.05). (C) Syn-Dagla-/- mice 
displayed a depression-like behavior in the forced swim test. The immobility time of Syn-Dagla-/- animals was 
light phase dark phase
0
100
200
300
400
ac
tiv
ity
 d
et
ec
tio
ns
Mean activity Syn-Dagla-/-
*
Daglafl/fl Syn-Dagla-/-
0
20
40
60
80
100
su
cr
os
e 
pr
ef
er
en
ce
 (%
)
Sucrose preference Syn-Dagla-/-
***
Forced swim test Syn-Dagla-/-
Daglafl/fl Syn-Dagla-/-
0
25
50
75
100
125
150
175
200
im
m
ob
ili
ty
 ti
m
e 
(s
)
*
Daglafl/fl
Syn-Dagla-/-
10 12 14 16 18 20 22 0 2 4 6 8 10 12 14 16 18 20 22 0 2 4 6 8
0
200
400
600
800
time of day 
ac
tiv
ity
 d
et
et
ct
io
ns
Home cage activity Syn-Dagla-/- 
Daglafl/fl
Syn-Dagla-/-
* genotype
  effect
A) 
B) 
C) D) 
Results	 	68	
significantly increased compared to Daglafl/fl controls (Students t-test, values represent mean ± SEM: n = 10 
animals/group, *p < 0.05). (C) Anhedonia was assessed by sucrose preference. Sucrose preference of  
Syn-Dagla-/- mice were significantly reduced compared to Daglafl/fl controls (Students t-test, values represent 
mean ± SEM: n = 10 animals/group, ***p < 0.001). 
 
In summary, Syn-Dagla-/- mice displayed a depressive-like phenotype in the forced 
swim and sucrose preference test, similar to that seen in mice ubiquitously lacking Dagla. 
3.2.5 Adult neurogenesis 
Previous studies showed a reduced adult neurogenesis in mice lacking Dagla, leading to a 
reduced number of BrdU (5-bromo-2´-deoxyuridine) positive cells in the dentate gyrus of the 
hippocampus (Jenniches et al. 2015). Reduced adult neurogenesis and a reduction of 
hippocampal volume are related to depression. To elucidate the participation of neuronal 
DAGLα to the observed phenotype, adult neurogenesis of Syn-Dagla-/- mice was analyzed. 
Neuronal proliferation and survival were analyzed in the dentate gyrus of the hippocampus, 
one of the two neurogenic niches in the adult brain.   
The number of BrdU labeled cells was similar in Syn-Dagla-/- and Daglafl/fl mice on day 
1 (t = 1.651, p = ns; Fig. 25) and day 21 (t = 1.371, p = ns; Fig. 25) after BrdU injection. Thus, 
neuronal proliferation (day 1) and survival (day 21) were not altered in the hippocampus of  
Syn-Dagla-/- mice. 
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Figure 25: Adult neurogenesis was similar in both Syn-Dagla-/- and Daglafl/fl mice. (A) Proliferation and 
neuronal survival in the subgranular zone of the hippocampus was similar in Syn-Dagla-/- mice and Daglafl/fl 
controls (Students t-test, values represent mean ± SEM: n = 3-4 animals/group, p = ns). (B) Representative 
microphotograph of BrdU labeled (red fluorescent), NeuN (green fluorescent) and Dapi (blue fluorescent) stained 
cells in the dentate gyrus of the hippocampus of Syn-Dagla-/- mice (BII, IV) and Daglafl/fl controls (BI, III) 24 h and 
21 days after BrdU injection. 
 
3.3 Behavioral and molecular analysis of microglia-
specific Dagla-/- mice 
Microglia produce high amounts of 2-AG in vitro and exhibit a functional endocannabinoid 
system. Thus, the deletion of Dagla in these cells might contribute to the observed anxiety 
and depression-like phenotype of constitutive Dagla-/- mice. To elucidate the role of DAGLα 
in microglia, LysM-Dagla-/- mice were analyzed in the same behavioral paradigms as Dagla-/- 
mice. All anxiety- and depression-related behavioral experiments were performed at least 
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twice with independent cohorts of animals (male or mixed-gender groups). Animals were 
tested in several behavioral tests always starting with the least stressful one. 
3.3.1 Endocannabinoid measurements and gene expression 
analysis 
To obtain LysM-Dagla-/- mice, homozygous Daglafl/fl mice were bred with LysM-Cre mice 
(Clausen et al. 1999). In all following experiments Daglafl/fl littermates were used as control 
animals. Gene expression analysis revealed similar Dagla (t = 1.022, p = ns; Fig. 26A) and 
Daglb mRNA levels (t = 0.6480, p = ns; Fig. 26B) in whole brain tissue samples of LysM-
Dagla-/- mice and Daglafl/fl controls. 
LysM-Cre leads to a specific deletion of Dagla in cells of the monocyte-lineage, 
representing a minor part of the CNS cell populations. Thus, a specific deletion in microglia 
and macrophages is difficult to detect in whole brain samples. Therefore, LysM-Dagla-/- mice 
were further verified by immunohistochemistry stainings of cryofixed brain slices. Brain Slices 
of LysM-Dagla-/- and Daglafl/fl control mice were co-stained with anti-Dagla and anti-Iba1 
antibodies. Immunostainings showed a significantly reduced number of Dagla/Iba1 double-
positive cells in LysM-Dagla-/- animals compared to controls (t = 3.915, p < 0.001; Fig. 
26B,C), resulting in a 30 % knockout of Dagla in microglia of LysM-Dagla-/- mice. In addition, 
previous studies showed an 80 % reduction of Dagla mRNA in primary macrophages of this 
very LysM-Dagla-/- mouse line (Jehle et al. 2016). 
Next, endocannabinoid levels were determined. For direct comparison, eCB levels 
were also measured in constitutive Dagla-/- mice. Similar 2-AG contents in the cortex (t = 
1.063, p = ns), striatum (t = 0.3642, p = ns) and hippocampus (t = 1.083, p = ns; Fig. 26D) 
were detected in LysM-Dagla-/- and Daglafl/fl mice. As expected, 2-AG levels were 
dramatically reduced in different brain areas of Dagla-/- mice (Fig. 26D). In addition, 
anandamide levels (referred as AEA) were significantly reduced in the cortex of  
LysM-Dagla-/- mice compared to Daglafl/fl controls (t = 4.146, p < 0.001; Fig. 26E). A similar 
tendency was seen in the hippocampus (Fig. 26E). Interestingly, anandamide levels were 
equally reduced in brain samples of LysM-Dagla-/- and Dagla-/- mice (cortex: t = 0.6877, p = 
ns; hippocampus: t = 0.5878, p = ns; Fig. 26E). However, no differences in arachidonic acid 
(AA) contents between LysM-Dagla-/- mice, Dagla-/- mice and Daglafl/fl controls were detected 
(F(2,32) = 2.065, p = ns; Fig. 26F). 
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Figure 26: Verification of LysM-Dagla-/- mice and eCB measurements. (A) Shown are mRNA levels 
normalized to GAPDH. Real-time RT-PCR showed similar expression levels of Dagla and Daglb in LysM-Dagla-/- 
and Daglafl/fl mice (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 4-5 
animals/group (Daglafl/fl and LysM-Dagla-/-), n = 2 animals/group (Dagla-/-), *p < 0.05). (B) Number of Dagla/Iba1 
double-positive cells was significantly reduced in LysM-Dagla-/- mice (Students t-test, values represent mean ± 
SEM: n = 17-20 analyzed slides/group of 3 animals/group, ***p < 0.001). (C) Shown are representative 
microphotographs of Iba1 and Dagla labeled brain slices of 2-3 month old LysM-Dagla-/- mice and Daglafl/fl 
controls. Arrows mark an Iba-positive and Dagla-negative microglia cell (scale: 100 µm). (D) Similar 2-AG levels 
were measured in the cortex, hippocampus or striatum of LysM-Dagla-/- mice and Daglafl/fl controls. (E) However, 
anandamide (AEA) levels were significantly reduced in cortex of LysM-Dagla-/- mice compared to controls. (F) In 
addition, arachidonic acid (AA) content was not altered in LysM-Dagla-/- mice. For direct comparison values of 
constitutive Dagla-/- mice are also presented. Statistical analysis: two-way ANOVA, Bonferroni’s post-hoc test, 
values represent mean ± SEM: n = 4-5 animals/group, *p < 0.05, ***p < 0.001, ****p < 0.0001. 
 
In contrast to the constitutive as well as neuronal deletion of Dagla, microglia-specific 
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female LysM-Dagla-/- mice were similar to age- and gender-matched Daglafl/fl controls (F(1,17) 
=  0.0009384, p = ns; Fig. 27). 
 
 
Figure 27: Body weights were similar for both LysM-Dagla-/- mice and Daglafl/fl controls. Body weight of 
adult (2-3 month old) male and female LysM-Dagla-/- mice did not differ from Daglafl/fl control mice. However, 
female mice have a generally reduced body weight compared to age-matched males regardless of genotype. 
Statistical analysis: two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 5-6 
animals/group, ****p < 0.0001. 
 
In summary, it can be stated that the specific deletion of Dagla in microglia and 
macrophages did not influence 2-AG levels in the brain, but caused a significant reduction in 
cortical anandamide levels. Following the molecular analysis, LysM-Dagla-/- mice were 
analyzed in different anxiety- and depression-related behavioral tests. 
3.3.2 Analysis of anxiety-related behavior  
To investigate locomotor activity and anxiety-related behavior, male LysM-Dagla-/- mice were 
analyzed in the open-field test (Fig. 28A,B). Data are presented as distance travelled (Fig. 
28A) and time spent in the center (Fig. 28B) over time in 10-min bouts. Distance travelled 
(F(1,51) = 0.8485, p = ns; Fig. 28A) and time spent in the center (F(1,50) = 0.1322, p = ns; Fig. 
28B) were similar for both genotypes. LysM-Dagla-/- mice displayed normal locomotor activity 
and similar anxiety-related behavior when compared to Daglafl/fl controls. In addition, a 
decreased distance travelled over time (between the 10-min bouts) was observed in both 
genotypes (time effect: F(2,51) = 21.03, p < 0.0001; Fig. 28A), indicative of a habituation to the 
novel environment. 
Anxiety-like behavior was further analyzed in the zero-maze test (Fig. 28C,D). Time 
spent in the open area (F(1,44) = -1.007x10-13, p = ns; Fig. 28B) and distance travelled in the 
open area (F(1,44) = 0.3474, p = ns; Fig. 28B) revealed no genotype effects. 
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Figure 28: LysM-Dagla-/- mice displayed normal locomotor activity and no anxiety-like behavior. (A,B) 
Exploratory and anxiety-related behavior of male LysM-Dagla-/- was analyzed in the open-field test. (A,B) 
Distance travelled (A) and the time spent exploring the center (B) were similar for both genotypes (two-way 
ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 10 animals/group, ***p < 0.001). (C-D) 
Anxiety-like behavior was further analyzed in the zero-maze test. (C) Time spent in the open and dark area was 
similar for LysM-Dagla-/- mice and Daglafl/fl controls. (D) Distance travelled did not differ between genotypes (two-
way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 10-14 animals/group).   
 
In conclusion, LysM-Dagla-/- mice showed no kind of anxiety-like behavior in the open-
field and zero-maze test. 
3.3.3 Fear conditioning paradigm 
As already shown in previous studies and the present study, mice lacking Dagla either 
ubiquitously (Ternes 2013, Jenniches et al. 2015) or specifically in neuronal tissue (Chapter 
3.2.3) displayed a distinct deficit in fear extinction and increased fear responses in a cue-
dependent conditioning paradigm. However, 2-AG produced by other cell types might also 
influence the extinction of conditioned fear. Accordingly, LysM-Dagla-/- mice were analyzed in 
the same cued fear conditioning paradigm as Syn-Dagla-/- mice (Chapter 3.2.3). 
A distinct decline in the freezing response over time (from extinction trial E1 to E6) was 
observed in LysM-Dagla-/- and Daglafl/fl mice (time effect: F(3,76) = 2.828, p < 0.05; Fig. 29A). 
Both genotypes displayed similar freezing times (genotype effect: F(1,76) = 2.451, p = ns; Fig. 
29A). Thus, LysM-Dagla-/- mice and Daglafl/fl controls exhibited between-session fear 
extinction.  
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Next, within-session fear extinction was determined. For all extinction trials, LysM-
Dagla-/- mice displayed similar extinction patterns as Daglafl/fl control animals (time x genotype 
interaction: E1: F(2,57) = 0.5966, p = ns; E2: F(2,57) = 0.2068, p = ns; E3: F(2,57) = 0.01195, p = 
ns; E6: F(2,60) = 0.09858, p = ns; Fig. 29B-E). The observed freezing times on extinction days 
E1, E2 and E3 did not differ between the genotypes (E1: F(1,57) = 0.02575, p = ns; E2: F(1,57) = 
2.267, p = ns; E3: F(1,57) = 1.055, p = ns; Fig. 29B-D). However, on extinction day E6 freezing 
levels of LysM-Dagla-/- were significantly increased compared to controls (genotype effect: 
F(1,60) = 4.357, p < 0.05; Fig. 29E).  
 
Figure 29: LysM-Dagla-/- mice displayed normal fear extinction, but mildly increased fear response. (A-E) 
LysM-Dagla-/- and Daglafl/fl controls were conditioned with a tone-foot shock pairing in the conditioned chamber. All 
animals were exposed to a 180 s tone in a neutral environment 1, 2, 3 and 6 days after the conditioning 
procedure. (A-E) Similar between- and within-session extinction was observed for LysM-Dagla-/- mice and Daglafl/fl 
controls. (E) However, LysM-Dagla-/- mice showed an increased freezing response on extinction day E6. 
Statistical analysis: two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 10-11 
animals/group, *p < 0.05. 
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The results show that Dagla in microglia does not modulate the extinction of 
conditioned fear, but influences the intensity of the fear response.  
3.3.4 Analysis of depression-related behavior  
Depression-like behavior of LysM-Dagla-/- mice (mixed-gender cohort) was analyzed in the 
forced swim, sucrose preference and social preference tests. Initially, locomotor activity and 
circadian rhythm of LysM-Dagla-/- mice were analyzed by home cage activity measurements. 
Overall activity and circadian rhythm of LysM-Dagla-/- animals were similar to Daglafl/fl 
controls (genotype effect: F(1,17) = 0.4481 , p = ns; time x genotype interaction: F(49,833) = 
0.7016, p = ns; Fig. 30A).  
Next, despair behavior was evaluated in the forced swim test. Immobility time of LysM-
Dagla-/- mice did not differ from controls (t = 0.1110, p = ns; Fig. 30B). However, sucrose 
preference was significantly reduced in LysM-Dagla-/- animals compared to Daglafl/fl mice (U 
= 28.00, p < 0.05; Fig. 30C), indicative of a depressive-like phenotype. 
Furthermore, social preference was determined in an independent mixed-gender 
cohort of animals. Reduced social preference is a further indicator of a depressive-like 
phenotype. Daglafl/fl and LysM-Dagla-/- mice displayed a similar ratio of the time spent with 
the partner mouse compared to the empty cage (t = 0.0, p = ns; Fig. 30D). The time spent 
with the gender-matched partner mouse was significantly higher compared to the empty 
cage in both genotypes (F(1,20) = 28.35, p < 0.0001; Fig. 30E). Thus, LysM-Dagla-/- animals 
displayed a normal sociability. 
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Figure 30: LysM-Dagla-/- mice showed no depressive-like behavior in the forced swim and social 
preference test, but displayed a reduced sucrose preference. (A) Locomotor activity and circadian rhythm 
was analyzed by home cage activity measurements. Circadian rhythm and overall activity of LysM-Dagla-/- mice 
was similar to Daglafl/fl controls (two-way ANOVA repeated measurements, Bonferroni’s post-hoc test, values 
represent mean ± SEM: n = 10 animals/group). (B) LysM-Dagla-/- mice showed no depression-like behavior in the 
forced swim test. The immobility time did not differ between genotypes (Students t-test, values represent mean ± 
SEM: n = 10 animals/group, p = ns). (C) However, LysM-Dagla-/- showed a reduced preference for sucrose 
compared to control animals (Mann-Whitney U test, values represent mean ± SEM: n = 10-12 animals/group, p < 
0.05). (D) LysM-Dagla-/- animals displayed a normal sociability. The ratio of time spent with a partner mouse to 
time spent with an empty cage was similar for both genotypes (Student´s t-test, values represent mean ± SEM: n 
= 10-12 animals/group, p = ns). (E) Preference for the partner mouse was significantly higher in LysM-Dagla-/- and 
Daglafl/fl animals (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 10-12 
animals/group, **p < 0.01, ***p< 0.001). 
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The specific deletion of Dagla in microglia did not cause a depressive-like behavior in 
the forced swim and social preference test. However, LysM-Dagla-/- showed a significantly 
reduced sucrose preference. 
3.4 Chronic	social	defeat	stress	
Several chronic stress models have been established and are widely used to investigate 
stress-induced depressive-like behavior and molecular adaptations in rodents. Chronic social 
defeat stress (CSDS) is one of the most commonly applied stress models. Previous studies 
showed that the lack of CB1 receptors increase the sensitivity to chronic stress in rodents 
(Martin et al. 2002; Urgüen et al. 2004; Valverde & Torrens 2012). To determine whether the 
constitutive and neuronal-specific deletion of Dagla also leads to an altered stress response, 
both mouse lines were exposed to chronic social defeat stress. Furthermore, housing 
conditions prior to the stress paradigm were compared. Intruder mice were either group-
housed or single-caged in the two weeks prior to the first social defeat. 
3.4.1 Chronic	social	defeat	stress:	group-housed	intruder	
The chronic social defeat paradigm (CSDS) with group-housed intruders was conducted 
twice with independent cohorts of animals and 10 animals per group. Dagla-/- mice and 
Daglafl/fl mice were exposed to social defeat for 10 days. Subsequently, feces were collected 
for corticosterone analysis and animals were subjected to different behavioral tests. All 
behavioral experiments were conducted with intervals of at least two days to prevent any 
interactions between the tests. Three days after the last behavioral test, brains were 
collected for molecular analysis and adrenal weights were determined. The exact timeline is 
depicted in figure 31. 
 
Figure 31: Timeline for the chronic social defeat stress paradigm and following behavioral tests (modified 
from Krishnan & Nestler 2008).  
 
Approximately 30 % of the Dagla-/- animals (3 out of 10 mice in each of the two 
paradigms) died in the first three days of chronic stress exposure. In contrast, only one out of 
overall 20 tested Daglafl/fl mice died. The underlying cause of death was uncertain. However, 
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due to the absence of severe wounds, injuries from fighting can be excluded. In addition, 
mice never died during the stress exposure (interaction time), but rather died subsequently to 
the social defeat. This considerable loss of animals led to a final group-size of 14 stressed  
Dagla-/- mice and 19 stressed Daglafl/fl animals for molecular and behavioral analysis.  
Body weight of Dagla-/- mice and Daglafl/fl controls was not affected by chronic stress 
(Fig. 32A). The change in body weight was similar in both genotypes (F(1,65) = 0.06318, p = 
ns; Fig. 32A) regardless of the stress paradigm (F(1,65) = 0.1951, p = ns; Fig. 32A). 
Furthermore, the adrenal glands were examined. The adrenal glands secrete a variety of 
hormones and steroids, including the stress hormone cortisol, and therefore represent an 
important part of the HPA axis. Adrenal weights of Dagla-/- mice were significantly increased 
after CSDS compared to unstressed knockout mice (t = 2.644, p < 0.05; Fig. 32B). 
Significant effects of stress (F(1,65) = 8.493, p < 0.01) and genotype (F(1,65) = 10.82, p < 0.01) 
were detected (Fig. 32B), implying a higher reactivity of Dagla-/- mice to chronic stress. In 
addition, two-way ANOVA of fecal corticosterone levels revealed a significant stress (F(1,63) = 
20.85, p < 0.0001; Fig. 32C), but no genotype effect (F(1,63) = 0.02338, p = ns; Fig. 32C). 
Thus, CSDS increased the release of corticosterone in both Dagla-/- and Daglafl/fl animals. 
 
Figure 32: CSDS increased fecal corticosterone levels and adrenal weights, but did not affect the body 
weight. (A) Body weights were not affected by chronic stress. Change in body weight was similar in both 
genotypes and groups (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 14-20 
animals/group, p = ns). (B) However, adrenal weights of Dagla-/- mice were significantly increased compared to 
unstressed animals and stressed Daglafl/fl mice (two-way ANOVA, Bonferroni’s post-hoc test, values represent 
mean ± SEM: n = 12-19 animals/group, *p < 0.05, **p < 0.01). (C) In addition, CSDS led to a similar increase of 
fecal corticosterone levels in Dagla-/- and Daglafl/fl controls (two-way ANOVA, Bonferroni’s post-hoc test, values 
represent mean ± SEM: n = 14-20 animals/group, *p < 0.05, ***p < 0.001). 
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Subsequently to the chronic stress paradigm, anxiety- and depression-related 
behaviors of stressed and control Dagla-/- and Daglafl/fl mice were analyzed.  
First, anxiety-related behavior was assessed with the open-field and zero-maze tests. 
Representative results of the first group-housed CSDS experiment are shown (Fig. 33). 
Since the Open-field ActiMot system (TSE Systems) was not available during the 
performance of the behavior tests of the second CSDS experiment, the animal tracking 
software EthoVision® XT (Noldus) was utilized. Due to analysis with different software 
systems the data of both CSDS paradigms could not be pooled. Two-way ANOVA of 
distance travelled revealed a significant stress (F(1,30) = 30.80, p < 0.0001; Fig. 33A), but no 
genotype effect (F(1,30) = 2.407, p = ns; Fig. 33A). Chronic stress significantly reduced 
locomotor activity in Dagla-/- mice and Daglafl/fl controls. In addition, time spent in the center 
of the open-field box was equally reduced in stressed Dagla-/- and Daglafl/fl mice (stress 
effect: F(1,30) = 5.343, p < 0.05; genotype effect: F(1,30) = 0.1260, p = ns; Fig. 33B), indicating 
increased anxiety. To exclude that altered locomotor activity caused the reduced time in the 
center of the open-field box, the ratio of time in the center to total time moved was analyzed. 
Two-way ANOVA revealed neither a main effect of stress nor an genotype effect (stress 
effect: F(1,30) = 2.474, p = ns; genotype effect: F(1,30) = 0.1355, p = ns; Fig. 33C).  
Anxiety-related behavior was further analyzed in the zero-maze test. Two-way ANOVA 
of the time spent in the open area revealed a significant effect for genotype (F(1,30) = 5.043, p 
< 0.05; Fig. 33D) and genotype x stress interaction (F(1,30) = 4.190, p < 0.05; Fig. 33D). 
Chronic stress decreased the time spent in the open area in Dagla-/-, but not in Daglafl/fl 
animals (interaction effect). In addition, unstressed Dagla-/- spent more time in the open area 
compared to Daglafl/fl controls (t = 3.173, p < 0.01; Fig. 33D). This altered behavior in the 
zero-maze test was also detected in previous studies (Jenniches et al. 2015; Fig. 16).  
Distance travelled in the open area (F(1,30) = 0.3816, p = ns; Fig. 33E) and overall 
distance travelled (F(1,64) = 0.08651, p = ns; Fig. 33E) of stressed mice was comparable to 
unstressed controls. However, Dagla-/- mice displayed an increased locomotor activity in this 
test. Significant genotype effects for distance travelled in the open area (F(1,30) = 7.741, p < 
0.01; Fig. 33E) and overall distance moved (F(1,64) = 7.924, p < 0.01; Fig. 33F) were 
observed.  
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Figure 33: CSDS decreased locomotor activity and led to a mildly increased anxiety-like behavior. (A,B,C) 
Exploratory and anxiety-related behavior of stressed and unstressed Dagla-/- and Daglafl/fl mice was analyzed in 
the open-field test. (A) Distance travelled was significantly decreased in stressed Dagla-/- and Daglafl/fl mice. (B) In 
addition, time spent exploring the center was markedly reduced in stressed animals. (C) Ratio of time spent in the 
center to total distance travelled revealed no stress effect, but showed a similar tendency to decreased time spent 
in the center. (D-F) Anxiety-like behavior was further analyzed in the zero-maze test. (D) Time spent in the open 
area was not significantly changed by CSDS in Daglafl/fl mice. However, unstressed Dagla-/- spent more time in 
the open area. An interaction between genotype and stress was detected (F(1,30) = 4.190, p < 0.05), indicating a 
higher sensitivity of Dagla-/- to chronic stress compared to Daglafl/fl controls. (E) Distance travelled in the open 
area of stressed mice was comparable to unstressed animals. However, distance travelled in the open area was 
significantly increased in Dagla-/- mice compared to controls. This effect was significant in the unstressed, but not 
in the stressed group. (F) In addition, overall distance travelled was not affected by the stress paradigm. However, 
Dagla-/- mice displayed increased overall distance travelled compared to Daglafl/fl controls. This trend was 
significant in the unstressed, but not in the stressed group of animals. Statistical analysis: two-way ANOVA, 
Bonferroni’s post-hoc test, values represent mean ± SEM: n = 6-10 animals/group, *p < 0.05, **p < 0.01; ****p < 
0.0001.   
 
CSDS decreased the locomotor activity and caused a mild anxiety-like phenotype in 
the open-field test in Dagla-/- and Daglafl/fl animals. In contrast, the zero-maze test revealed 
no stress-related changes in locomotion, but an increased anxiety-like behavior in Dagla-/- 
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mice. A significant interaction between genotype and stress was detected, indicating a higher 
stress-sensitivity of Dagla-/- mice. 
Next, general activity and circadian rhythm were analyzed by home cage activity 
measurements. Both mouse lines displayed normal time-dependent changes in locomotor 
activity (circadian rhythm) after chronic stress. No significant stress effects were detected for 
Dagla-/- mice (stress effect: F(1,26) = 0.1257, p = ns; Fig. 34A) and Daglafl/fl animals (stress 
effect: F(1,28) = 0.8572, p = ns; Fig. 34B). For the Dagla-/- group, a significant stress x time 
interaction was observed (F(67, 1742) = 1.437, p < 0.05; Fig. 34A), indicative of an altered 
activity distribution after CSDS. Dagla-/- mice displayed a slightly shifted day/night cycle after 
chronic stress. 
Furthermore, Dagla-/- mice had an increased activity in the dark and a decreased 
activity in the light phase compared to Daglafl/fl controls. Significant genotype effects for mean 
activity during the dark (F(1,56) = 4.332, p < 0.05; Fig. 34C) and the light phase (F(1,26) = 4.119, 
p < 0.05; Fig. 34D) were observed. However, no stress effects were detected (dark: F(1,56) = 
0.1850, p = ns; Fig. 34C; light: F(1,56) = 1.942, p = ns; Fig. 34D). 
 
Results	 	82	
 
Figure 34: CSDS altered the home cage activity of Dagla-/-, but not Daglafl/fl mice. (A,B) Locomotor activity 
and circadian rhythm was analyzed by home cage activity measurements. (A) Circadian rhythm and overall 
activity of stressed Dagla-/- mice was similar to unstressed controls. However, a significant interaction between 
stress and time of day was detected (two-way ANOVA repeated measurements, Bonferroni’s post-hoc test, 
values represent mean ± SEM: n = 14-15 animals/group, *p < 0.05). (B) CSDS did not alter the home cage 
activity of Daglafl/fl mice (two-way ANOVA repeated measurements, Bonferroni’s post-hoc test, values represent 
mean ± SEM: n = 14-15 animals/group). (C) Dagla-/- had a generally increased activity during the dark phase and 
(D) light phase compared to Daglafl/fl controls regardless of the stress paradigm (two-way ANOVA, Bonferroni’s 
post-hoc test, values represent mean ± SEM: n = 14-15 animals/group, *p < 0.05).  
 
Finally depression-related behavior was analyzed in the social avoidance, forced swim 
and social preference tests. Social avoidance was determined by analyzing the time spent 
interacting with a foreign CD1 mouse. This test was conducted with one cohort of animals. 
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Chronic stress significantly reduced the time spent with the CD1 mouse in Dagla-/- and 
Daglafl/fl mice (F(1,31) = 20.31, p < 0.0001; Fig. 35A), indicative of social avoidance behavior. 
Consequently, CSDS induced social avoidance in defeated mice. In addition, Dagla-/- animals 
spent less time interacting with the CD1 mice regardless of the stress paradigm (genotype 
effect: F(1,31) = 8.382, p < 0.01; Fig. 35A). This result support the notion that untreated 
(unstressed) Dagla-/- mice displayed an anxiety-like phenotype. Furthermore, two-way 
ANOVA of distance travelled revealed a significant stress effect (F(1,32) = 8.917, p < 0.01; Fig. 
35B), but no genotype effect (F(1,32) = 0.5620, p = ns; Fig. 35B). Chronic stress reduced the 
locomotor activity in both genotypes. To exclude that the generally decreased distance 
travelled influenced the outcome of the social avoidance test, the ratio of time spent 
interacting with the CD1 mouse to distance travelled was determined (Fig. 35C). This 
analysis also revealed a significant genotype effect (F(1,32) = 4.381, p < 0.05; Fig. 35C). 
However, the stress effect missed significance (F(1,32) = 3.305, p = 0.0784/ ns; Fig. 35C). 
Thus, the detected social avoidance behavior is not solely arising from the decreased 
locomotor activity. 
Next, anhedonia was analyzed in the sucrose preference test. Sucrose preference of 
stressed mice was comparable to unstressed controls. No significant stress effect was 
detected, using two-way ANOVA (F(1,64) = 0.01105, p = ns; Fig. 35C). However, in line with 
the results shown in chapter 3.1.5, Dagla-/- mice had a reduced sucrose preference 
compared to Daglafl/fl controls regardless of the treatment (genotype effect: F(1,64) = 10.66, p < 
0.001; Fig. 35D).  
Finally, depressive-like behavior was determined in the forced swim test. Immobility 
time was alike for stressed and unstressed animals (stress effect: F(1,66) = 0.7841, p = ns; Fig. 
35E). However, Dagla-/- animals spent significantly more time immobile regardless of the 
stress paradigm. Two-way ANOVA revealed a significant genotype effect (F(1,66) = 30.08, p = 
ns; Fig. 35E), but no stress x genotype interaction (F(1,66) = 0.02214, p = ns; Fig. 35E). On the 
one hand these results show that Dagla-/- mice displayed a depressive-like behavior in this 
test, and on the other hand that CSDS did not induce depression-related phenotypes. 
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Figure 35: CSDS induced social avoidance, but no depressive-like phenotype. (A) CSDS induced social 
avoidance behavior in Dagla-/- mice and Daglafl/fl controls. In addition, Dagla-/- mice spent generally less time 
interacting with the CD1 mouse, indicating an increased anxiety-like behavior. (B) Overall distance travelled was 
similarly reduced in both genotypes after chronic stress. (C) Ratio of time spent interacting with the CD1 mouse to 
distance travelled was not altered after chronic stress. However, the trend was similar to 33A. Again a significant 
genotype effect was detected showing an overall decreased time of interaction in Dagla-/- mice compared to 
Daglafl/fl controls. Statistical analysis of the social avoidance test: two-way ANOVA, Bonferroni’s post-hoc test, 
values represent mean ± SEM: n = 8-10 animals/group, *p < 0.05, **p < 0.01. (D) Anhedonia was assessed by 
sucrose preference. Sucrose preference of stressed Dagla-/- and Daglafl/fl animals was similar to unstressed mice. 
However, sucrose preference of unstressed Dagla-/- mice was significantly decreased compared to Daglafl/fl 
controls (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 14-20 animals/group, *p 
< 0.05). (E) Immobility times of stressed Dagla-/- and Daglafl/fl mice were comparable to unstressed animals. 
However, immobility time of Dagla-/- animals was significantly increased compared to Daglafl/fl controls regardless 
of the stress paradigm (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 14-20 
animals/group, ***p < 0.001).  
 
Analysis of stressed Dagla-/- and Daglafl/fl mice revealed that CSDS caused 
considerable behavioral alterations, especially increased anxiety and social avoidance. In 
addition, fecal corticosterone levels and adrenal weights were markedly increased after 
chronic stress. To determine the underlying molecular mechanisms, gene expression was 
analyzed.  
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Expression of genes related to the ECS and the HPA axis, were analyzed in amygdala, 
hippocampus and paraventricular nucleus of the hypothalamus (PVN). All of these brain 
regions are involved in emotional processing and stress response.  
Quantification of amygdalar mRNA levels revealed no stress-dependent regulation of 
Dagla in Daglafl/fl animals (t = 1.746, p = 0.1113; Fig. 36A). Furthermore, gene expression of 
Daglb (F(1,18) = 3.236, p = ns; Fig. 36B) and CB1 (F(1,17) = 0.01174, p = ns; Fig. 36C) in the 
amygdala of stressed Dagla-/- and Daglafl/fl mice was comparable to unstressed animals.  
Preceding analysis of glucocorticoids showed a stress-induced increase of fecal 
corticosterone levels in Dagla-/- and Daglafl/fl mice, indicative of a dysregulated HPA axis. 
Therefore, gene expression of the glucocorticoid receptor (GR) was determined. The GR is 
an important regulator of the HPA axis, mediating the negative feedback mechanism of 
corticosterone. In addition, GR is often dysregulated in depression. GR expression was not 
affected by the stress paradigm (F(1,17) = 0.001051, p = ns; Fig. 36D), but was significantly 
reduced in the amygdala of Dagla-/- animals compared to Daglafl/fl controls (F(1,17) = 13.79, p < 
0.01; Fig. 36D).  
 
Figure 36: Gene expression analysis of the amygdala. (A-D) Shown are mRNA levels normalized to GAPDH. 
(A) Real-time RT-PCR results showed no significant stress-dependent regulation of Dagla in Daglafl/fl animals. 
However, results showed a trend towards downregulation of Dagla (Students t-test, values represent mean ± 
SEM: n = 4-6 animals/group, p = 0.1113/ ns). (B) Daglb mRNA levels did not differ between stressed and 
unstressed animals. (C) Similar CB1 receptor gene expression levels were detected in the amygdala of stressed 
and unstressed Dagla-/- and Daglafl/fl mice. (D) However, glucocorticoid receptor mRNA was significantly reduced 
in Dagla-/- mice compared to controls regardless of the stress paradigm. In addition, CSDS did not influence GR 
expression. Statistical analysis: two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 
4-6 animals/group, *p < 0.05. 
Next, hippocampal gene expression was determined. Real-time RT-PCR results 
showed no stress-dependent changes of Dagla expression in the hippocampus of Daglafl/fl 
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mice (t = 0.3722, p = ns; Fig. 37A). The stress paradigm did also not affect CB1 receptor 
mRNA levels in none of the genotypes (stress effect: F(1,18) = 1.959, p = ns; genotype effect: 
F(1,18) = 0.09311, p = ns Fig. 37B). To further analyze the HPA axis, GR gene expression was 
determined. Two-way ANOVA of hippocampal GR mRNA revealed no stress effect (F(1,16) = 
0.1546, p = ns; Fig. 37C). However, GR expression was significantly reduced in Dagla-/- mice 
compared to Daglafl/fl animals (F(1,16) = 4.813, p < 0.05; Fig. 37C). This result is in line with the 
reduced GR mRNA levels in the amygdala of Dagla-/- mice (Fig. 36D). Furthermore, gene 
expression of the brain-derived neurotrophic factor (BDNF) was analyzed. BDNF is a 
member of the nerve growth factor family, and is widely expressed in the adult mammalian 
brain. It plays a critical role in the regulation of survival, differentiation, and maintenance of 
different neuronal populations and has neuroprotective functions (for review see Park & Poo 
2013). In addition, BDNF signaling is important for the development of molecular and 
behavioral manifestations of chronic social defeat stress (Berton et al. 2006). However, 
BDNF gene expression was not differentially regulated by the stress paradigm. Two-way 
ANOVA revealed no stress and no genotype effects (stress effect: F(1,17) = 0.8742, p = ns; 
genotype effect: F(1,17) = 0.1990, p = ns Fig. 37D).  
 
 
Figure 37: Gene expression analysis of the hippocampus. (A-E) Shown are mRNA levels normalized to 
GAPDH. (A) Real-time RT-PCR results showed no significant regulation of Dagla in Daglafl/fl animals after CSDS 
(Students t-test, values represent mean ± SEM: n = 5 animals/group, p = ns). (B) CB1 receptor gene expression of 
stressed Dagla-/- and Daglafl/fl mice did not differ from unstressed animals. (C) Glucocorticoid receptor mRNA was 
significantly reduced in Dagla-/- mice compared to Daglafl/fl controls regardless of the stress paradigm. In addition, 
CSDS did not influence GR expression. (D) mRNA levels of BDNF were similar for all four groups. (B-D) 
Statistical analysis: two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 5-6 
animals/group, *p < 0.05. 
Finally, gene expression analysis of whole mRNA of the PVN of stressed and 
unstressed Dagla-/- and Daglafl/fl mice were conducted. The PVN of the hypothalamus 
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controls a large part of stress responses and is an important regulator of the HPA axis. Thus, 
several genes related to the HPA axis were analyzed in detail. GR mRNA levels were 
significantly reduced in the PVN of Dagla-/- mice compared to Daglafl/fl animals (F(1,14) = 5.029, 
p < 0.05; Fig. 38A). However, no main effect for stress was detected (F(1,14) = 4.029, p = 
0.0626; Fig. 38A). 
To further characterize the HPA axis activity, gene expression of the corticotropin-
releasing hormone (CRH) and the corticotropin-releasing hormone receptor 1 (CRHR1) were 
determined. CRH is synthesized and released by the PVN of the hypothalamus and 
represents the first activator of the HPA axis. By binding to CRHR1, which is mainly 
expressed in the anterior pituitary, PVN, amygdala and hippocampus, CRH induces the 
production of adrenocorticotropic hormone (ACTH). Gene expression analysis of CRH 
revealed no significant stress (F(1,13) = 0.006632, p = ns; Fig. 38B) and genotype effects 
(F(1,13) = 0.3961, p = ns; Fig. 38B). However, variances between animals were rather high 
and further experiments are necessary to draw a final conclusion. Additionally, mRNA levels 
of CRHR1 were similar in Dagla-/- and Daglafl/fl animals (F(1,13) = 0.2248, p = ns; Fig. 38C) and 
CRHR1 was not differentially expressed after chronic stress (F(1,13) = 1.812, p = ns; Fig. 38C). 
 
 
Figure 38: Gene expression analysis of the PVN. (A-D) Shown are mRNA levels normalized to GAPDH. (A) 
Glucocorticoid receptor mRNA was significantly reduced in Dagla-/- mice compared to Daglafl/fl controls. In 
addition, a clear tendency towards stress-dependent decrease of GR expression was detected in both genotypes. 
(B) mRNA levels of CRH were similar in both genotypes and not affected by the stress paradigm. (C) CRHR1 
gene expression levels of stressed mice were similar to unstressed animals. Statistical analysis: two-way ANOVA, 
Bonferroni’s post-hoc test, values represent mean ± SEM: n = 3-5 animals/group, *p < 0.05.  
 
Molecular and behavioral analysis of chronically stressed Dagla-/- and Daglafl/fl animals 
revealed increased anxiety-like behaviors, social avoidance and increased fecal 
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corticosterone levels in both genotypes. Nevertheless, CSDS did not result in depressive-like 
behaviors. In addition, GR gene expression was significantly decreased in different brain 
areas of control and stressed Dagla-/- mice. Other genes typically regulated by chronic stress, 
such as BDNF, were not affected.  
To increase the sensitivity to chronic stress, animals were single-caged for two weeks 
before the CSDS paradigm. Results of this experiment are described in the following part of 
the result section. 
 
3.4.2 Chronic	social	defeat	stress:	single-housed	intruder	
The chronic social defeat paradigm with single-housed intruder mice was conducted once 
with Daglafl/fl, Syn-Dagla-/- and constitutive Dagla-/- animals (9-10 animals per group). The 
stress paradigm, all behavioral tests and tissue collection were performed as described in 
chapter 3.4.1 (see Fig. 31). C57BL/6 intruder mice were single-caged for two weeks before 
the first social defeat. As in the group-housed CSDS paradigm (Chapter 3.4.1), several 
stressed animals died during the first days of stress. Three Dagla-/- mice, one Syn-Dagla-/- 
and one Daglafl/fl animal did not survive the 10 days of CSDS. Yet again, none of the 
deceased animals had severe wounds. Thus, cause of death is uncertain. This considerable 
loss of animals led to final group sizes of 6 to 10 animals per group.  
First, body weights were determined. Chronically stressed mice lost approximately 2 % 
of their body weight, whereas unstressed mice gained an average of 1-2 %. Two-way 
ANOVA of changes in body weight revealed a significant stress effect (F(1,41) = 7.231, p < 
0.05; Fig. 39A), but no genotype effect (F(2,41) = 0.09111, p = ns; Fig. 39A). Furthermore, 
adrenal weights were analyzed. Adrenal weights of stressed animals were comparable to 
unstressed mice (F(1,40) = 0.001852, p = ns; Fig. 39B). However, a significant genotype effect 
was observed (F(2,40) = 6.455, p < 0.01; Fig. 39B). Adrenal weights of unstressed Dagla-/- 
mice were significantly higher compared to Daglafl/fl (t = 3.473, p < 0.01) and Syn-Dagla-/- 
animals (t = 3.965, p < 0.001), indicative of an imbalanced HPA axis and increased stress 
hormone release. Analysis of fecal corticosterone levels revealed an increased 
corticosterone content in Dagla-/- animals, but not in Syn-Dagla-/- and Daglafl/fl mice after 
CSDS. A significant stress effect (F(1,33) = 5.584, p < 0.05; Fig. 39C) and stress x genotype 
interaction (F(2,33) = 3.566, p < 0.05; Fig. 39C) was detected. Fecal corticosterone levels of 
stressed Dagla-/- mice were increased compared to both unstressed Dagla-/- mice (t = 3.355, 
p < 0.01) and stressed Syn-Dagla-/- (t = 2.685, p < 0.05) animals. These results indicate an 
elevated stress-sensitivity of Dagla-/- mice. 
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Figure 39: CSDS decreased body weight and increased fecal corticosterone levels in Dagla-/- mice. (A) 
Body weight was significantly decreased after CSDS regardless of the genotype, leading to a significant stress 
effect (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 6-10 animals/group, *p < 
0.05). (B) Adrenal weight was not affected by the stress paradigm. However, adrenal weights of unstressed 
Dagla-/- mice were significantly increased compared to unstressed Daglafl/fl and Syn-Dagla-/- mice (two-way 
ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 6-10 animals/group, **p < 0.01, ***p < 
0.001). (C) In addition, CSDS led to increased of fecal corticosterone levels in Dagla-/-, but not in Daglafl/fl and 
Syn-Dagla-/- mice (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 5-7 
animals/group, **p < 0.01). 
 
Subsequent to the chronic stress, animals were analyzed in different anxiety- and 
depression-related behavioral tests. First, locomotor activity and anxiety-like behaviors were 
analyzed in the open-field test. In this run, instead of Open-field ActiMot system (TSE 
Systems), the animal tracking software EthoVision® XT (Noldus) was utilized. Therefore, the 
direct comparison to previously performed open-field tests is not feasible. 
Distance travelled and time spent in the center of stressed animals was comparable to 
unstressed controls. No stress effects for distance travelled (F(1,41) = 0.01160, p = ns; Fig. 
40A) and time spent in the center (F(1,41) = 1.439, p = ns; Fig. 40B) were detected, using two-
way ANOVA. Locomotor activities and anxiety-related behaviors were not affected by the 
chronic stress paradigm. Though, Syn-Dagla-/- mice spent generally less time exploring the 
center of the open-field box (genotype effect: F(2,41) = 3.463, p < 0.05; Fig. 40B), indicative of 
an anxiety-like phenotype. 
Anxiety-like behavior was further analyzed in the zero-maze test. Two-way ANOVA 
revealed no stress effects for the time in the open area (F(1,41) = 2.502, p = ns; Fig. 40C), 
distance travelled in the open area (F(1,41) = 0.7489, p = ns; Fig. 40C) and overall distance 
travelled (F(1,41) = 1.116, p = ns; Fig. 40C). However, unstressed Dagla-/- mice spent more 
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time in the open area compared to unstressed Daglafl/fl (t = 3.012, p < 0.05; Fig. 40C) and 
unstressed Syn-Dagla-/- (t = 2.866, p < 0.05; Fig. 40C) mice. This indicates a decreased 
anxiety-like phenotype of mice constitutively lacking Dagla. In addition, CSDS significantly 
reduced the time spent in the open area of Dagla-/- animals compared to unstressed Dagla-/- 
mice (t = 2.54, p < 0.05; Fig. 40C), indicating a stress-induced anxiety-like behavior. Overall 
distance travelled was not changed in stressed Dagla-/- mice compared to unstressed Dagla-/- 
animals (t = 0.8716, p = ns; Fig. 40E). In contrast, all three measures were unaffected in 
Daglafl/fl and Syn-Dagla-/- mice.  
 
 
Figure 40: CSDS did not alter locomotor activity, but induced anxiety-like behavior in Dagla-/- mice. (A,B) 
Exploratory and anxiety-related behaviors of stressed and unstressed Dagla-/-, Syn-Dagla-/- and Daglafl/fl mice 
were analyzed in the open-field test. (A) Distance travelled of stressed animals was similar to unstressed controls 
regardless of the genotype. (B) In addition, time spent exploring the center was not altered in stressed animals. 
However, Syn-Dagla-/- spent generally less time exploring the center of the open-field. (C-E) Anxiety-like behavior 
was further analyzed in the zero-maze test. (C) Time spent in the open area was not significantly changed by 
CSDS in Daglafl/fl and Syn-Dagla-/- mice. However, unstressed Dagla-/- spent more time in the open area and 
CSDS significantly reduced the time spent in the open area in stressed Dagla-/- mice. (D) Distance travelled in the 
open area was not altered in stressed Dagla-/-, Syn-Dagla-/- and Daglafl/fl mice compared to unstressed animals. 
control stress
0
20
40
60
80
di
st
an
ce
 tr
av
el
le
d 
(m
)
Open-field: distance travelled 
control stress
0
20
40
60
80
tim
e 
sp
en
t i
n 
ce
nt
er
 (s
)
Open-field: time in center  
* genotype
  effect
control stress
0
50
100
150
200
250
tim
e 
sp
en
t i
n 
op
en
 a
rm
s 
(s
)
Zero-maze: time in open area
*
*
control stress
0
2
4
6
8
10
di
st
an
ce
 tr
av
el
le
d 
(m
)
Zero-maze: distance in open area
control stress
0
5
10
15
20
di
st
an
ce
 tr
av
el
le
d 
(m
)
Zero-maze: distance  
C) D) 
E) 
Daglafl/fl
Syn-Dagla
Dagla-/-
Results	 	91	
(E) In addition, overall distance travelled was similar for stressed and unstressed mice. Statistical analysis: two-
way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 6-10 animals/group, *p < 0.05.  
 
Moreover, locomotor activity and circadian rhythm were analyzed via home cage 
activity measurements. For Daglafl/fl animals, similar time-dependent alterations in home cage 
activity were observed in stressed and unstressed animals. Neither a stress effect (F(1,8) = 
4.069, p = ns) nor a stress x time interaction (F(88,704) = 1.289, p = ns; Fig. 41A) was 
distinguished. Thus, CSDS did not alter the overall home cage activity and the circadian 
rhythm of these mice. In contrast, chronic stress significantly increased the activity of Dagla-/- 
(stress effect: F(1,5) = 15.28, p < 0.05; Fig. 41B) and Syn-Dagla-/- mice (stress effect: F(1,5) = 
5.943, p < 0.05; Fig. 41C) compared to unstressed animals of the same genotype. A 
significant stress x time interaction was detected for Dagla-/- mice (F(88,440) = 3.149, p < 
0.0001; Fig. 41B), but not for Syn-Dagla-/- (F(88,704) = 3.149, p = ns;  Fig. 41C). Thus, CSDS 
not only increased the locomotor activity, but also altered the distribution of motor activity in 
Dagla-/- mice.  
Two-way ANOVA of mean activity during dark and light phase revealed significant 
stress effects (dark: F(1,21) = 16.16, p < 0.001; Fig. 41D; light: F(1,21) = 19.93, p < 0.001 Fig. 
41E), but no genotype effects (dark: F(2,21) = 0.08755, p = ns; Fig. 41D; light: F(2,21) = 2.511, p 
= ns; Fig. 41E). Thus, chronic stress increased the overall activity both during the active and 
inactive phase of the animals. This effect was significant for Dagla-/- mice in the dark phase (t 
= 4.148, p < 0.01; Fig. 41D) and for Daglafl/fl (t = 3.122, p < 0.05: Fig. 41E) and Syn-Dagla-/- 
mice (t = 2.808, p < 0.05: Fig. 41E) in the light phase compared to unstressed animals of the 
same genotype. 
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Figure 41: Chronic stress significantly increased overall activity in the home cage, but did not affect the 
circadian rhythm. (A-E) Locomotor activity and circadian rhythm were analyzed by home cage activity 
measurements. (A) Circadian rhythm and overall activity of stressed Daglafl/fl mice was similar to unstressed 
controls. (B,C) Chronic stress significantly increased the activity of Dagla-/- and Syn-Dagla-/- mice compared to 
unstressed animals of the same genotype (A-C: Statistical analysis: two-way ANOVA repeated measurements, 
Bonferroni’s post-hoc test, values represent mean ± SEM: n = 4-5 animals/group, *p < 0.05). (D,E) Mean activities 
during dark and light phase were significantly increased after stress in Syn-Dagla-/- and Dagla-/- mice. Statistical 
analysis: two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± SEM: n = 4-5 animals/group, *p < 
0.05, **p < 0.01, ***p < 0.001). 
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Depression-related behavior was analyzed in the social avoidance, sucrose preference 
and forced swim tests. At first, animals were subjected to the social avoidance test, in which 
the interaction time with a foreign CD1 mouse is negatively correlated to social avoidance 
behavior. CSDS decreased the interaction time with the CD1 mice in all tested genotypes 
(stress effect: F(1,41) = 8.221, p < 0.001; genotype effect:  F(2,41) = 1.396, p = ns; Fig. 42A), 
indicative of social avoidance and increased anxiety. In addition, the distance travelled of 
Dagla-/-, Syn-Dagla-/- and Daglafl/fl mice was not altered after chronic stress (stress effect: 
F(1,41) = 0.4619, p = ns; Fig. 42B).  
Furthermore, a sucrose preference test was conducted to analyze anhedonic-behavior. 
Two-way ANOVA revealed no stress effect (F(1,41) = 0.6038, p = ns; Fig. 42C). CSDS did not 
decrease the preference for sucrose solution in neither of the Dagla knockout mouse lines 
(Dagla-/-, Syn-Dagla-/-) nor in Daglafl/fl controls.  
Depression-related behavior was further determined in the forced swim test. Immobility 
times of stressed Syn-Dagla-/- and Dagla-/- mice were comparable to unstressed animals. In 
contrast, Daglafl/fl mice showed an increased immobility time after CSDS, but the stress effect 
barely missed significance (F(1,39) = 3.368, p = 0.0741; Fig. 42D). However, a direct 
comparison of unstressed and stressed Daglafl/fl animals revealed a significantly increased 
immobility time in stressed animals (t = 2.649, p < 0.05; Fig. 42E). Thus, CSDS caused a 
depressive-like behavior of Daglafl/fl mice. As previously described (Chapter 3.1.5, 3.2.4), 
Dagla-/- and Syn-Dagla-/- mice displayed an increased immobility time compared to Daglafl/fl 
controls. This baseline depressive-like phenotype impedes the detection of stress-dependent 
effects in both Dagla knockout mouse lines. 
 
 
Figure 42: CSDS induced social avoidance and caused a depressive-like phenotype in Daglafl/fl mice. (A) 
CSDS induced social avoidance behavior in Dagla-/- mice, Syn-Dagla-/- mice and Daglafl/fl controls. (B) Overall 
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distance travelled was not altered after chronic stress in either genotype. (C) Anhedonia was assessed by 
sucrose preference. Sucrose preference of stressed Dagla-/-, Syn-Dagla-/- and Daglafl/fl animals was comparable 
to unstressed animals. However, sucrose preference of unstressed Dagla-/- mice was slightly decreased (not 
significantly) compared to Daglafl/fl controls. (E) Immobility times of stressed and unstressed animals did not differ 
significantly (stress-effect: p = 0.0741) (two-way ANOVA, Bonferroni’s post-hoc test, values represent mean ± 
SEM: n = 6-10 animals/group, *p < 0.05, **p < 0.01). (E) Immobility time of Daglafl/fl mice was significantly 
increased after chronic stress compared to unstressed Daglafl/fl controls (Student´s t-test, values represent mean 
± SEM: n = 8-10 animals/group, *p < 0.05). 
 
Behavioral analysis of chronically stressed mice revealed an increased social 
avoidance behavior and increased activity in the home cage in all genotypes. Furthermore, 
chronic stress induced a depressive-like phenotype in Daglafl/fl mice. To determine which 
pathways may be responsible for these behavioral changes, expression levels of several 
genes related to the ECS and the stress response system were ascertained. Gene 
expression was analyzed in brain areas related to mood, emotion and stress processing. 
Gene expression analysis of amygdalar Dagla mRNA revealed significant main effects 
for stress (F(1,9) = 20.54, p < 0.01; Fig. 43A) and genotype (F(1,9) = 26.92, p < 0.001; Fig. 43A).  
Dagla expression was significantly downregulated in Syn-Dagla-/- and Daglafl/fl mice after 
chronic stress. In addition, Dagla mRNA levels were significantly reduced in the amygdala of 
Syn-Dagla-/- mice. Furthermore, Magl mRNA levels, coding for the main degrading enzyme of 
2-AG, were mildly decreased in the amygdala of Dagla-/-, Syn-Dagla-/- and Daglafl/fl mice after 
chronic stress (F(1,16) = 4.709, p < 0.05; Fig. 43B). Gene expression of the anandamide 
synthesizing enzyme NAPE-PLD was not affected by the stress paradigm in either genotype 
(stress effect: F(1,16) = 4.709, p = ns; Fig. 43C). In contrast, Faah mRNA levels, coding for the 
main degrading enzyme of anandamide, were significantly decreased in the amygdala of 
stressed Dagla-/-, Syn-Dagla-/- and Daglafl/fl mice (stress effect: F(1,16) = 5.892, p < 0.05; 
genotype effect: F(2,16) =, p = ns; Fig. 43D). Gene expression analysis revealed a significant 
downregulation of several genes related to the ECS in the amygdala of chronically stressed 
mice. 
Next, genes related to the HPA axis were analyzed. Two-way ANOVA revealed a 
significant stress-dependent reduction of GR mRNA levels in the amygdala of Dagla-/-, Syn-
Dagla-/- and Daglafl/fl mice (stress effect: F(1,16) = 23.01, p < 0.001; Fig. 43E). This result 
supports that CSDS caused a disruption of the HPA axis. In addition, a significant genotype 
effect was detected (F(2,16) = 4.175, p < 0.05; Fig. 43E), indicative of generally reduced GR 
expression in the amygdala of mice lacking Dagla. Two-way ANOVA of the CRHR1 gene 
expression, a receptor mediating HPA axis signaling, also revealed a significant stress (F(1,16) 
= 5.596, p < 0.05; Fig. 43F) and genotype effect (F(2,16) = 3.691 p < 0.05; Fig. 43F). Chronic 
stress significantly reduced CRHR1 mRNA levels in the amygdala, an effect being most 
pronounced in Dagla-/- mice.  
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Figure 43: Gene expression analysis of the amygdala. (A-G) Shown are mRNA levels normalized to GAPDH. 
(A) Real-time RT-PCR results showed a significant downregulation of Dagla in Syn-Dagla-/- and Daglafl/fl animals 
after CSDS. In addition, Dagla mRNA levels were markedly reduced in Syn-Dagla-/- mice compared to Daglafl/fl 
controls. (B) Magl expression was significantly reduced after CSDS in all genotypes. (C) CSDS did not affect 
Nape-Pld expression. (D) However, Faah mRNA levels were significantly reduced in stressed animals. (E) 
Glucocorticoid receptor mRNA levels were significantly reduced in Dagla-/- mice compared to Daglafl/fl controls 
regardless of the stress paradigm. In addition, CSDS caused a significant downregulation of GR expression. (F) 
CRHR1 gene expression was reduced in the amygdala of stressed animals. This effect was most pronounced in 
Dagla-/- mice (genotype effect: p < 0.05). Statistical analysis: two-way ANOVA, Bonferroni’s post-hoc test, values 
represent mean ± SEM: n = 3-5 animals/group, *p < 0.05, **p < 0.01. 
 
Next, hippocampal gene expression was determined. Gene expression analysis 
revealed similar mRNA levels of Dagla in stressed Syn-Dagla-/- and Daglafl/fl mice compared 
to unstressed animals of the same genotype (F(1,10) = 0.001116, p = ns; Fig. 44A). However, 
a significant genotype effect was detected (F(1,10) = 5.440, p < 0.05; Fig. 44A), indicative of a 
distinct reduction of Dagla mRNA levels in the hippocampus of Syn-Dagla-/- mice. CB1 
expression was not differentially regulated by CSDS in none of the genotypes (stress effect: 
F(1,17) = 0.07383, p = ns; genotype effect: F(2,17) = 0.2438, p = ns Fig. 44B). Moreover, chronic 
stress caused a substantial downregulation of GR mRNA (F(1,16) = 6.4000 p < 0.05; Fig. 44C). 
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This effect was most pronounced in Syn-Dagla-/- mice (t = 2.964, p < 0.05; Fig. 44C). 
Furthermore, gene expression of BDNF was determined. Chronic stress did not alter 
hippocampal mRNA levels of BDNF in Dagla-/-, Syn-Dagla-/- and Daglafl/fl animals (stress 
effect: F(1,15) = 0.01983, p = ns; genotype effect: F(2,15) = 0.4472, p = ns; Fig. 44D).  
 
 
Figure 44: Gene expression analysis of the hippocampus. (A-E) Shown are mRNA levels normalized to 
GAPDH. (A) Real-time RT-PCR results showed similar Dagla mRNA levels in stressed and unstressed animals. 
However, Dagla mRNA levels were significantly reduced in Syn-Dagla-/- mice compared to Daglafl/fl controls (n = 
4-5). (B) CB1 receptor gene expression was not altered in the hippocampus of Dagla-/-, Syn-Dagla-/- or in Daglafl/fl 
mice after chronic stress. (C) However, CSDS caused a significant downregulation of glucocorticoid receptor (GR) 
expression (stress effect: p < 0.05). This effect was significant for Syn-Dagla-/- mice. (D) mRNA levels of BDNF 
were similar for all groups. Statistical analysis: two-way ANOVA, Bonferroni’s post-hoc test, values represent 
mean ± SEM: n = 3-5 animals/group, *p < 0.05. 
 
To confirm possible alterations of the HPA axis, gene expression in the PVN was 
analyzed. Two-way ANOVA of GR mRNA levels revealed neither a stress (F(1,17) = 0.1793, p 
= ns) nor a genotype effect (F(2,17) = 0.7793, p = ns Fig. 45A). However, stress-dependent 
decrease (not significant) of GR expression in the PVN of Daglafl/fl animals was detected (t = 
2.204, p = ns; Fig. 45A). Expression of CRH, the first activator of the HPA axis synthesized in 
the PVN, was not regulated by the stress paradigm in either genotype (stress effect: F(1,16) = 
0.3605, p = ns; genotype effect: F(2,16) = 2.520, p = ns; Fig. 45B). However, real-time RT-PCR 
results of CRH gene expression displayed high variances, which complicate a conclusive 
statistical evaluation. Gene expression analysis of CRHR1, a CRH receptor, revealed similar 
mRNA levels in the PVN of Dagla-/-, Syn-Dagla-/- and Daglafl/fl mice regardless of the stress 
paradigm (stress effect: F(1,17) = 1.844, p = ns; genotype effect: F(2,17) = 1.368, p = ns; Fig. 
45C).  
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Figure 45: Gene expression analysis of the PVN. (A-C) Shown are mRNA levels normalized to GAPDH. (A) 
Glucocorticoid receptor mRNA levels were similar in all groups regardless of genotype and treatment. However, a 
clear tendency towards stress-dependent decrease of GR expression was detected in Daglafl/fl mice. (B) Analysis 
of CRH mRNA levels revealed no stress- and genotype-dependent regulation. (C) CSDS did not alter CRHR1 
gene expression in Dagla-/-, Syn-Dagla-/- and Daglafl/fl animals. Statistical analysis: two-way ANOVA, Bonferroni’s 
post-hoc test, values represent mean ± SEM: n = 3-5 animals/group. 
 
In summary it can be stated that the CSDS paradigm caused not only behavioral, but 
also gene expression changes in single-caged intruder mice. GR was downregulated in 
several brain areas of stressed Daglafl/fl mice, indicative of a stress-dependent dysregulation 
of the HPA axis. In addition, GR expression was reduced in Dagla-/- and Syn-Dagla-/- mice 
compared to Daglafl/fl controls. Interestingly, CSDS caused a downregulation of several 
genes related to the ECS in the amygdala of Dagla-/-, Syn-Dagla-/- and Daglafl/fl animals. To 
determine the effects of these gene expression changes on 2-AG and anandamide levels, 
endogenous cannabinoids were measured (Fig. 46). 
Endocannabinoid measurements revealed that 2-AG levels in the amygdala and PFC 
of Daglafl/fl mice increased after chronic stress, whereas 2-AG contents of Syn-Dagla-/- and 
Dagla-/- mice remained constant. Two-way ANOVA of 2-AG levels in the amygdala and PFC 
revealed no main effects for stress (amygdala: F(1,15) = 1.601, p = ns; PFC: F(1,15) = 0.6248, p 
= ns; Fig. 46A,B), but for genotype (amygdala: F(2,15) = 43.54, p < 0.0001; PFC: F(2,15) = 11.93, 
p < 0.001; Fig. 46A,B). 2-AG levels in the amygdala (t = 5.537, p < 0.001; Fig. 46A) and PFC 
(t = 2.820, p < 0.05; Fig. 46B) of Dagla-/- mice were significantly reduced compared to 
Daglafl/fl controls, but not influenced by the stress paradigm. Bonferroni’s post-hoc analysis 
revealed significantly increased 2-AG levels in the amygdala of stressed Daglafl/fl mice (t = 
2.870, p < 0.05; Fig. 46A). Same tendency was also seen in the PFC (Fig. 46B). In contrast, 
chronic stress did not affect 2-AG contents in the amygdala and PFC of Syn-Dagla-/- mice. 
Furthermore, similar hippocampal 2-AG levels were detected in stressed mice and 
control stress
0.0
0.5
1.0
1.5
fo
ld
 c
ha
ng
e 
(r
el
. t
o 
G
A
PD
H
) Glucocorticoid receptor
control stress
0.0
0.5
1.0
1.5
2.0
fo
ld
 c
ha
ng
e 
(r
el
. t
o 
G
A
PD
H
) CRHR1
control stress
0.0
0.5
1.0
1.5
2.0
2.5
CRH
fo
ld
 c
ha
ng
e 
(r
el
. t
o 
G
A
PD
H
)
A) B) 
C) 
Daglafl/fl
Syn-Dagla-/-
Dagla-/-
Results	 	98	
unstressed animals of the same genotype (F(1,15) = 0.3367, p = ns). Nevertheless, a 
significant genotype effect was observed (F(2,15) = 36.98, p < 0.0001; Fig. 46C) due to the 
tremendously reduced 2-AG levels in Dagla-/- animals. In line with previous results (Chapter 
3.2.1), baseline 2-AG levels were similar for Syn-Dagla-/- and Daglafl/fl mice in all analyzed 
brain areas (Fig. 46A,B,C). 
Next, the amount of the other main endogenous cannabinoid anandamide (Fig. 46D-F) 
was determined. Two-way ANOVA of anandamide levels in the amygdala and hippocampus 
revealed no main effects for stress (amygdala: F(1,15) = 5.620, p = ns; hippocampus: F(1,15) = 
0.8430, p = ns; Fig. 46D,F), but for genotype (amygdala: F(2,15) = 18.60, p < 0.0001; 
hippocampus: F(2,15) = 8.688, p < 0.01; Fig. 46D,F). Anandamide contents were significantly 
decreased in both brain areas of Dagla-/- mice compared to Daglafl/fl controls (amygdala: t = 
3.351, p < 0.05; hippocampus: t = 3.578, p < 0.01; Fig. 46D,F). However, no stress-
dependent changes in anandamide levels of Dagla-/- and Daglafl/fl mice were observed. In 
contrast, a clear tendency to increased anandamide levels after CSDS was detected in the 
amygdala of Syn-Dagla-/- mice (t = 2654, p = ns; Fig. 46D), whereas hippocampal 
anandamide remained constant (t = 0.6325, p = ns; Fig. 46F). For the PFC, a significant 
stress (F(1,15) = 6.792, p < 0.05; Fig. 46E) and genotype effect (F(2,15) = 24.44, p < 0.0001; Fig. 
46E) was detected. Anandamide contents in the PFC of Syn-Dagla-/- mice significantly 
increased in response to chronic stress (t = 3.299, p < 0.05; Fig. 46E). In addition, 
anandamide levels of Dagla-/- mice were significantly reduced compared to Daglafl/fl controls 
(t = 4.794, p < 0.001; Fig. 46E). 
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Figure 46: CSDS altered 2-AG or anandamide levels in the amygdala and PFC of Daglafl/fl and Syn-Dagla-/- 
mice. (A-F) Shown are the amounts of 2-AG and anandamide (AEA) relative to the amount of total protein per 
sample. (A) 2-AG levels were significantly increased in the amygdala of stressed Daglafl/fl mice compared to 
unstressed mice. (B) 2-AG content was increased in the prefrontal cortex (PFC) of Daglafl/fl after CSDS. However, 
this trend did not reach significance. (C) In addition, chronic stress did not affect 2-AG levels in the hippocampus 
of Dagla-/-, Syn-Dagla-/- or Daglafl/fl mice. (D) A trend to increased anandamide levels in the amygdala of stressed 
Syn-Dagla-/- mice compared to unstressed Syn-Dagla-/- mice was detected. (E) Chronic stress significantly 
increased anandamide levels in the PFC of Syn-Dagla-/- mice compared to unstressed Syn-Dagla-/- animals. (F) 
Anandamide levels in the hippocampus of stressed mice were similar to unstressed animals of the same 
genotype. Statistical analysis for eCB measurement: two-way ANOVA, Bonferroni’s post-hoc test, values 
represent mean ± SEM: n = 3-4 animals/group, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.  
 
Lastly, arachidonic acid contents were determined. A significant main effect for stress 
was observed in the PFC (F(1,15) = 5.367, p < 0.05; Fig. 47B). CSDS increased arachidonic 
acid levels in the PFC of Syn-Dagla-/- and Daglafl/fl animals. In contrast, amygdalar and 
hippocampal quantities of arachidonic acid of stressed Dagla-/-, Syn-Dagla-/- and Daglafl/fl 
mice were comparable to unstressed controls (amygdala: F(1,15) = 3.309, p = ns; Fig. 47A; 
hippocampus: F(1,15) = 1.185, p = ns; Fig. 47C).  
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In addition, two-way ANOVA revealed significant genotype effects in all brain areas 
(amygdala: F(2,15) = 69.60, p < 0.0001; PFC: F(2,15) = 40.84, p < 0.0001; hippocampus: F(2,15) = 
39.65, p < 0.0001; Fig. 47A-C). Arachidonic acid values were significantly reduced in the 
amygdala (t = 7.294, p < 0.0001; Fig. 47A), PFC (t = 5.243, p < 0.001; Fig. 47B) and 
hippocampus (t = 7.317, p < 0.0001; Fig. 47C) of Dagla-/- mice compared to Daglafl/fl animals 
regardless of the stress paradigm. 
 
 
Figure 47: Chronic stress caused increased arachidonic acid levels in the PFC of Syn-Dagla-/- and Daglafl/fl 
mice. (A-C) Shown are the amounts of arachidonic acid (AA) relative to the amount of total protein per sample. 
(A) Amygdalar arachidonic acid levels did not differ between stressed and unstressed animals of the same 
genotype. (B) In contrast, CSDS significantly increased arachidonic acid contents in the prefrontal cortex (PFC) of 
Syn-Dagla-/- and Daglafl/fl mice. (C) Hippocampal levels of arachidonic acid were not affected by chronic stress in 
either genotype. (A-C) In addition, arachidonic acid content was significantly decreased in Dagla-/- mice compared 
to Daglafl/fl animals in all brain areas. Statistical analysis for eCB measurement: two-way ANOVA, Bonferroni’s 
post-hoc test, values represent mean ± SEM: n = 3-4 animals/group, ***p < 0.001, ****p < 0.0001. 
 
These results illustrate that CSDS caused substantial changes in the endocannabinoid 
composition in the amygdala and PFC of Syn-Dagla-/- and Daglafl/fl mice. 
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3.5 Identification of potential novel interaction partners of 
DAGLα 
Up to now very little is known about the regulation of DAGLα and its potential interaction 
partners. Thus, this thesis focused on the detailed characterization of DAGLα using knockout 
mouse models and different in vitro approaches. The last part of the result section outlines 
the cloning, expression and purification of the double-tagged DAGLα and subsequent 
identification of co-purified proteins, which potentially interact with the protein of interest. 
3.5.1 Cloning of the DAGLα expression vector  
To purify DAGLα via tandem affinity purification, an expression vector for the overexpression 
of the double-tagged protein was generated using a site-directed two-TAP cloning Kit from 
IBA Lifescience. First, Dagla cDNA was cloned into the entry vector pENTRY-IBA51. 
Therefore, Dagla cDNA was amplified using a forward and a reverse primer containing LguI 
StarCombinase1™ recognition sites (GCTCTTC) for efficient integration into the entry vector, 
leading to a 3135 bp DNA fragment. Importantly, the coding sequence was amplified without 
the stop codon to ensure a continuous transcription leading to a c-terminal double-tagged 
DAGLα protein. In addition, the stop codon was replaced by glycine, one of the linker amino 
acids between the protein of interest and the c-terminal protein tag in the final expression 
vector pESG-IBA168.  
Integration of Dagla cDNA into the vector was verified by restriction digest using the 
endonucleases XbaI and HindIII. Correct integration revealed two DNA fragments of 3175 bp 
and 1860 bp. The 5035 bp DNA fragment corresponds to the linearized or uncut vector (Fig. 
48C). Orientation and sequence was verified for accuracy by sequence analysis (GATC 
Biotech AG). 
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Figure 48: Cloning of the entry vector pENTRY-IBA51-Dagla. (A) Detailed sequence of the pENTRY-IBA51 
cloning site. Gene of interest is inserted in the GOI marked region flanked by the amino acids methionine (M) and 
glycine (G). XbaI and HindIII restriction sites were used for restriction digest. In addition, ENTRY-Primer-for2 and 
ENTRY-primer-rev were used for sequence analysis. (B) Vector map of pENTRY-IBA51. Marked are the 
kanamycin resistance gene (KanR) and the cloning site, including the restriction sites of XbaI and HindIII. (C) 
Verification of Dagla cDNA integration into pENTRY-IBA51 via double restriction digest with XhoI and HindIII, 
resulting in two DNA fragments of 3175 bp and 1860 bp. GOI: gene of interest = Dagla, POI: protein of interest = 
DAGLα, KanR: kanamycin resistance gene (A/B: adopted from IBA Lifescience). 
 
After verification of the first cloning step, Dagla cDNA was subcloned into the final 
expression vector pESG-IBA168. Subcloning was performed in a simultaneous restriction 
and ligation reaction using Esp3I endonuclease (restriction site: CGTCTC, see Fig. 49A) 
and T4-DNA ligase. The final vector pESG-IBA168 contained a C-terminal Strep-Flag-tag, 
a neomycin resistance cassette for selection in mammalian cells and the CMV 
(cytomegalovirus) promoter for high-level protein expression in mammalian cells (Fig. 
49A,B). A short linker of 5 amino acids, enabling a better accessibility of both tags, 
separated the double Strep-tag II and the Flag-tag. The integration of Dagla was once 
more verified by restriction digest with XbaI and HindIII. Correctly inserted cDNA revealed 
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a 5497 bp and a 3294 bp DNA fragment. The final vector had total size of 8791 bp (Fig. 
49C). 
 
 
Figure 49: Cloning of the final expression vector pESG-IBA168-Dagla. (A) Detailed sequence of the 
expression cassette of pESG-IBA168 showing the c-terminal Strep-Flag-tag. Gene of interest, Dagla, is inserted 
in the GOI marked region. C-terminal Strep-Flag-tag and the five linker amino acids are marked by yellow arrows. 
DNA bases and corresponding amino acids forming the two tags are encircled in black. (B) Vector map of pESG-
IBA168. Ampicillin resistance gene (AmpR), neomycine resistance gene (NeoR), cytomegalovirus (CMV) 
promoter, origin of replication (ColEL ori) and the expression cassette are marked by yellow arrows. (C) 
Verification of Dagla cDNA integration into the vector pESG-IBA168 via double restriction digest with XbaI and 
HindIII resulting in two DNA fragments of 5497 bp and 3294 bp. (A/B: adopted from IBA Lifescience). 
 
The final expression vector pESG-IBA168-Dagla was used to overexpress the C-
terminal tagged DAGLα in a mouse neuroblastoma cell line (Neuro-2a) for subsequent 
tandem purification or in vitro assays using click-chemistry. A neuronal cell line allows a 
detailed investigation of the function and regulation of DAGLα in neuronal tissue. This is of 
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special interest, because previous studies showed that DAGLα is the main producing 
enzyme of 2-AG in the brain (Gao et al. 2010). In addition, Neuro-2a cells are widely and 
extensively used to study neuronal signaling pathways, axonal growth and differentiation.  
3.5.2 Tandem affinity purification of DAGLα 
Double-tagged DAGLα was purified from Neuro-2a cells. Therefore, Neuro-2a cells were 
transfected with the pESG-IBA168-Dagla expression vector using Lipofectamine®2000 
transfection reagent (Life Technologies), providing a high transfection efficiency and high 
transgene expression in numerous mammalian cell types.  
Subsequent to the transfection, positive Neuro-2a cell clones were selected via 
neomycine (G418) resistance. Untransfected Neuro-2a cells with the same passage number 
were used as controls. Transfected and control cells were applied for tandem affinity 
purification (TAP) and treated equally throughout all experiments. Tandem affinity purification 
allows efficient isolation of native protein complexes and thereby the identification of protein-
protein interactions. This method was applied to identify potential interaction partners of 
DAGLα and detect possible regulatory mechanisms. In this study, a C-terminal tandem 
Strep-tag II was combined with a Flag-tag, which led to a quite small TAP-tag (SF-TAP) of 
just 4.6 kDa. Due to its small size, this TAP-tag rarely interferes with protein folding and 
activity. In the first step, transfected Neuro-2a and control cell homogenates were purified 
using a modified streptavidin affinity chromatography system. In a second step, the eluted 
proteins were purified using an anti-Flag agarose. Subsequently, samples of the different 
purification steps were analyzed via SDS-PAGE and western blot to determine the 
purification efficiency.  
Coomassie staining of SDS-PAGE gels revealed a great number of purified proteins in 
the flag purification eluate (first purification step) and the flow-through of the streptavidin-
affinity purification in transfected as well as control Neuro-2a cells (Fig. 50A). However, no 
proteins were detected in the eluate of the streptavidin-affinity purification, the second and 
final purification step (eluate S Fig. 50A). In addition, neither the TAP purification (eluate S) 
from transfected Neuro-2a nor from the control cells revealed a Coomassie stained band in 
the expected size of 116 kDa corresponding to DAGLα (eluate S; Fig. 50A).  
To increase the sensitivity of detection and to specifically identify recombinant DAGLα, 
the same samples were analyzed via western blot using anti-Flag and anti-DAGLα 
antibodies (Fig. 50B,C). Western Blot analysis, utilizing the anti-Flag antibody, showed a 
strong and distinct band with a molecular weight of approximately 110 kDa in the transfected 
Neuro-2a cells, resembling recombinant DAGLα (Fig. 50B). DAGLα was detected in all 
purification steps. These results show that antibody detection had a distinctly higher 
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sensitivity than classical Coomassie staining. The detection of recombinant DAGLα proofed 
a successful transfection and sufficient expression of the bait protein in Neuro-2a cells.  
However, the efficiency of the streptavidin-affinity purification was rather low, leading to 
significant losses of the bait protein (Fig. 50B). In addition, western blot analysis with the anti-
FLAG antibody revealed several other bands in the flag purification eluate of transfected and 
control cells. These protein bands most likely originated from unspecific antibody binding to 
non-target structures (Fig. 50B). Western blot analysis, utilizing the anti-DAGLα antibody, 
only revealed one distinct band at a molecular size of around 110 kDa in the flag purification 
eluate of the transfected cells, corresponding to DAGLα (Fig. 50C). Thus, western blot 
analysis enabled a clear detection of DAGLα after flag purification of transfected Neuro-2a 
cells. However, even after fourfold concentration of the streptavidin-affinity eluate, DAGLα 
quantity was below the detection limit of the anti-DAGLα antibody (Fig. 50C).  
Since the streptavidin-affinity purification was too inefficient, the TAP purification 
protocol was modified to increase the quantity of the bait protein. However, neither changing 
the order of the two purification steps, doubling the amount of Strep-Tactin® agarose 
(column material: 100 to 200 µl), increasing the time of column binding (1 h up to 3 h) nor 
changing the binding temperature (RT or 4°C) revealed markedly higher amounts of 
recombinant DAGLα (data not shown). Most likely the Strep-tag was not fully accessible due 
to steric hindrance and protein folding, based on its location very close to the N-terminus of 
the protein.  
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Figure 50: Tandem affinity purification of recombinant DAGLα. Eluates from different purification steps with 
the bait DAGLα were loaded onto SDS-PAGE followed by Coomassie staining (A) or western blotting using anti-
Flag (B) or anti-DAGLα antibodies (C). Black arrows indicate the band size corresponding to DAGLα. Eluate F: 
Eluate flag purification; Flow-thr S: Flow-through streptavidin-affinity purification; Eluate S: Eluate streptavidin-
affinity purification; c. Eluate S: 4x concentrated eluate streptavidin-affinity purification; N-2a: Neuro-2a cells. 
 
In a next step, the TAP- and flag-purified proteins were analyzed by MALDI-TOF/TOF 
mass spectrometry to identify potential interaction partner of DAGLα. Due to the high 
sensitivity and specificity of this method even low amounts of recombinant DAGLα and co-
purified proteins can be detected and identified. In fact, lower amounts of the overexpressed 
protein minimize the chance of random protein-protein interactions. 
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3.5.3 Analysis of bound proteins via MALDI-TOF 
Concentrated samples of TAP-purified proteins from transfected and control Neuro-2a cells 
(c. Eluate S, Fig. 50B) were analyzed by MALDI-TOF/TOF-MS to identify potential interaction 
partners of DAGLα. Even though MALDI-TOF/TOF-MS is a very sensitive technique with low 
detection limits, DAGLα could not be detected in none of the two samples (data not shown). 
Antibody detection of recombinant DAGLα in the same samples elucidates the high 
sensitivity of certain antibodies compared to MALDI-TOF/TOF-MS (Fig. 50B).  
As mentioned in chapter 3.5.2, the streptavidin-affinity purification led to significant 
losses of the bait protein (Fig. 50B). The Strep-tag was most likely not fully accessible and 
therefore could not unrestrictedly bind to the column resin. To strongly increase the yield of 
the bait protein, recombinant DAGLα was only purified using the flag affinity purification (Fig. 
50B,C). MALDI-TOF/TOF-MS analysis of flag-purified proteins from transfected and control 
Neuro-2a cells (for representative western blot see Fig. 50B,C: Eluate F) enabled a certain 
identification of the bait protein DAGLα in the sample of transfected cells. Three unique 
peptides were identified leading to sequence coverage of around 4 % between the detected 
peptides and DAGLα (Fig. 51). This result allowed the reliable identification of DAGLα. In 
addition, DAGLα was solely detected in the sample of transfected cells, indicating a very 
specific purification of the recombinant protein. 
 
 
Figure 51: Sequence coverage of DAGLα. Three different peptides (marked in green) belonging to DAGLα 
were identified via MALDI-TOF/TOF-MS in the sample of transfected Neuro-2a cells, leading to sequence 
coverage of 3.93 % (Figure kindly provided by Dr. Marc Sylvester). 
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Overall approximately 1400 additional proteins were clearly identified, using MALDI-
TOF/TOF-MS. Most of these proteins were present in both transfected and control samples 
and are therefore most likely to have no specific interactions with DAGLα. However, 142 of 
the 1400 identified proteins were exclusively present in the purification of transfected Neuro-
2a cells. These proteins are mainly involved in RNA processing, energy and lipid metabolism 
and vesicular trafficking (Fig. 52, see Appendix A.1 for the protein list).  
 
 
Figure 52: Potential interaction partners of DAGLα classified into groups according to their function and 
possible involvement in different signaling cascades. Numbers of assigned proteins are enclosed in brackets. 
 
Interaction partners of the protein of interest are usually co-purified in similar quantities. In 
the following, 3 out of the 142 identified proteins, which fulfill these criteria and might be of 
special interest, are described in more detail and summarized in table 9.  
Table 9 shows the direct comparison of MALDI-TOF/TOF-MS results from control 
Neuro-2a cells, sample A, and DAGLα overexpressing (transfected) Neuro-2a cells, sample 
B. The 3 selected proteins are of special interest due to their possible contribution to 
signaling pathways, in which DAGLα is or may be involved. These include NCAM, dynamin-1 
and Mitogen-activated protein kinase 8 (MAPK8). All proteins were exclusively detected and 
identified in sample B (transfected Neuro-2a cells) by the identification of two peptides for 
each protein leading to sequence coverage of approximately 2 to 6 %. The amount of 
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peptides indicated protein quantities with a similarity to DAGLα (Tab. 9). The protein 
quantities were estimated based on the amount of peptides and peptide spectrum matches 
(PSM) resulting from the mass spectrometry analysis (Tab. 9). Peptides (Tab. 9) quote the 
amount of different identified peptides of one protein and therefore determine the sequence 
coverage. In this case, more protein leads to more identified peptides. The PSM represents 
the amount of MS spectra assigned to one peptide of a protein, used as an indicator for the 
protein quantity. A further measured value is the area, referring the added area of the 
chromatographic peaks belonging to the 3 strongest peptides of one protein, allowing a 
rough estimation of the protein amount within one sample.  
Proteins were identified based on matches to their sequences resulting from comparing 
of observed peptide MS/MS spectra to theoretical spectra. For MAPK8, also known as c-Jun 
N-terminal kinase 1 (JNK1), 3 proteins were identified (Tab. 9). Thus, the identified peptides 
matched with more than one protein sequence related to MAPK8. In this case, 3 out of the 4 
different isoforms coded by the Jnk1 gene were identified. Importance of the described 
proteins and their potential relation to DAGLα will be discussed in the last section of the 
discussion. 
 
Table 9: MALDI-TOF/TOF mass spectrometry analysis of recombinant DAGLα and co-purified proteins  
Accession Description ΣCoverage Σ# Proteins A: Area B: Area 
Coverage 
A 
Coverage 
B 
# 
Peptides 
A 
# PSM 
A 
# 
Peptides 
B 
# PSM 
B 
 ALBUMIN-
BOVIN 
82,54 62 5,674E9 8.019E8 82,54 72,49 65 1734 51 764 
Q6WQJ1 Sn1-specific 
DAGLa  
3,93 1 0 1,138E6 0,00 3,93 0,00 0,00 3 4 
P13595 Neural cell 
adhesion 
molecule 1  
3,32 1 1,774E6 1,238E6 0,00 3,32 0,00 0,00 2 2 
P39053 Dynamin-1  1,96 1 0 4,471E5 0,00 1,96 0,00 0,00 2 2 
Q91Y86 Mitogen-
activated 
protein 
kinase 8 
5,73 3 1,911E6 9,947E4 0,00 5,73 0,00 0,00 2 2 
 
 
High amounts of other unspecific purified proteins like albumin, most likely artifacts from cell 
culture or sample preparation, were detected in both samples (Tab. 9). These contaminants 
exacerbate the identification of low occurring proteins, because large peptide peaks of these 
proteins can overlap or completely overwhelm small chromatographic peaks.  
 
In conclusion, DAGLα was successfully overexpressed and purified from Neuro-2a 
cells followed by identification via MALDI-TOF/TOF-MS. In addition, first results show the 
identification of potential interaction partners of DAGLα. 
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3.5.4 In vitro assays using click-chemistry 
 
To analyze possible regulatory mechanisms and potential protein-protein interactions of 
DAGLα in detail, a new easy to perform in vitro assay for the analysis of DAGLα activity was 
tested. This in vitro assay is based on the so-called click-chemistry, in which a labeled 
biomolecule is detected via copper-catalyzed azide-alkyne cycloaddition. In this study, one 
fatty acid of a diacylglycerol (DAG) was labeled with a c-c triple bound (alkyne). These 
alkynes are not appearing naturally in fatty acids. Nevertheless, they do not affect the natural 
metabolism (Thiele et al. 2012).  The labeled DAGs were used as DAGLα substrates in 
different in vitro activity assays. 
Two different labeled DAGs were utilized as substrates for DAGLα, on the one hand 1-
click-palmitoyl-2-arachidonoyl-sn-glycerol (Fig. 10; Fig. 53) and on the other hand 1-click-
palmitoyl-2-linoyl-sn-glycerol (Fig. 10). DAGLs generally metabolize DAGs into 
monoacylglycerols (MAGs) and free fatty acids. Previous studies showed that DAGLα 
equally metabolizes DAGs with either linoleic or arachidonic acid on the sn2 position. In 
contrast, the ß isoform prefers linoleic to arachidonic acid (Bisogno et al. 2010). Furthermore, 
DAGLα also accepts DAGs with different fatty acids in position 1, such as oleic (Bisogno et 
al. 2010) or stearic acid (Pedicord et al. 2011; Johnston et al. 2012). However, until now 
mainly radiolabeled substrates (Bisogno et al. 2010; Johnston et al. 2012) were used to 
determine DAGLα activity in vitro.  
Figure 53 exemplarily depicts the metabolism of 1-click-palmitoyl-2-arachidonoyl-sn-
glycerol (in the following referred as substrate S) by DAGLα and subsequent labeling of the 
resulting product. Metabolism of the second substrate 1-click-palmitoyl-2-linoyl-sn-glycerol (in 
the following referred as substrate S2) proceeds exactly similar. 
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Figure 53: Metabolism of labeled DAGs by DAGLα. DAGLα activity is exemplarily shown for the metabolism of 
1-click-palmitoyl-2-arachidonoyl-sn-glycerol. DAGLα converts the DAG into a labeled free fatty acid (click-palmitic 
acid) and an unlabeled monoacylglycerol, in this case 2-arachidonoyl-sn-glycerol (2-AG). In a next step, the 
labeled fatty acid reacts with the fluorogenic dye 3-azido-7-hydroxycoumarin. The resulting molecule can be 
detected by fluorescence imaging. 
 
Both substrates were tested in different in vitro assays, utilizing cultured cells or cell 
lysates of bone marrow-derived macrophages (BMM) from WT and constitutive Dagla-/- mice 
(Fig. 54A,B,D). Assays with WT and Dagla-/- cells were performed to analyze the substrate 
specificity. Isolation of primary BMM is simple, quick and always yields in high amount of 
cells. In addition, the activity of flag- or TAP-purified DAGLα (from transfected Neuro-2a 
cells) was analyzed (Fig. 54C). The metabolic activity of DAGLα was determined by 
quantification of the band intensity of free click-palmitic acid relative to the applied substrate 
(S or S2).  
Analysis of the in vitro assays with substrate S (1-click-palmitoyl-2-arachidonoyl-sn-
glycerol) revealed similar band intensities of click-palmitic acid after 30 min and 3 h 
incubation for Dagla-/- and WT cell lysates (genotype effect: F(1,4) = 0.05412, p = ns, Fig. 
54A,E), indicating that enzymes other than DAGLα metabolized substrate S. However, the 
produced palmitic acid clearly showed a functional metabolism of substrate S (Fig. 54A). 
Addition of 10 µM orlistat, a lipase inhibitor often used to inhibit DAGLs (also known as 
tetrahydrolipstatin (THL)), almost completely blocked the metabolism of substrate S in WT 
and Dagla-/- cell lysates. Relative band intensities of palmitic acid were strongly reduced for 
in vitro assays containing orlistat (lane 1-4; Fig. 54B) compared to untreated assays (lane 7-
11; Fig. 54B). Thus, the enzymes metabolizing substrate S belong to the family of lipases, 
which could be inhibited by orlistat. One of these lipases might be the second DAGL isoform, 
DAGLß, which is still functional in Dagla-/- mice. However, other lipases can convert DAGs 
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into free fatty acids and MAGs and might therefore be responsible for the detected metabolic 
activity in Dagla-/- cell lysates (Fig. 54A). 
Next, the activity of flag- and TAP-purified DAGLα enzymes (see Chapter 3.5.2; Fig. 
50B) was analyzed. Purified proteins were incubated for up to 3 h with substrate S. 
Fluorescence imaging of isolated lipids revealed no band size corresponding to free click-
palmitic acid in samples of flag- and TAP-purified DAGLα (Fig. 54C). Thus, no metabolic 
activities of the purified enzymes were detectable (Fig. 54C). This might be due to the 
vigorous purification steps or the missing of yet unknown co-factors.  
To test the substrate specificity of the second substrate 1-click-palmitoyl-2-linoyl-sn-
glycerol (S2) different in vitro assays were performed, using Dagla-/- and WT cells and cell 
lysates (Fig. 54D). First, the substrate S2 was added to the culture medium of Dagla-/- and 
WT cells for 24 h. No differences in the formation of free click-palmitic were detected in 
Dagla-/- cells compared to WT controls (Fig. 54D, lane 1-4). In addition, various further bands 
were detected in both samples (Fig. 54). These signals correspond to different lipid 
molecules, such as MAGs (marked by a grey arrow) and phospholipids, containing the 
labeled click-palmitic acid (Fig. 54D, lane 1-4). These results suggest that the alkyne label 
did not generally interfere with the metabolism of the substrates and allowed a tracing of the 
lipid metabolism. However, no definite conclusion about the lipid metabolism of Dagla-/- cells 
compared to WT cells can be drawn.  
Finally, substrate S2 was used for in vitro assays with Dagla-/- and WT BMM cell 
lysates (lane 5-15; Fig. 54D). Formation of click-palmitic acid was observed for Dagla-/- and 
WT cell lysates (Fig. 54D). However, two-way ANOVA of the relative band intensities of click-
palmitic acid revealed no genotype effect (F(1,6) = 0.004366, p = ns; Fig. 54F), but a 
significant time effect (F(2,6) = 7.744, p < 0.05; Fig. 54F). Thus, the formation of free palmitic 
acid increased over time, but the metabolic activity was not dependent on DAGLα.  
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Figure 54: In vitro assays to determine DAGLα activity using click-chemistry. (A-D) Shown are 
representative pictures of DAGLα in vitro assays separated on TLC plates. Black arrows indicate the band size of 
free click-palmitic acid. Grey arrows indicate the band size of the monoacylglycerols (A-C,E) In vitro assays with 
substrate S (1-click-palmitoyl-2-arachidonoyl-sn-glycerol) (A) Lane 1-3: Dagla-/- BMM lysates incubated for 0 min, 
30 min and 3 h; lane 4: click-palmitic-acid; lane 5: click-palmitoyl-sn-glycerol; lane 6: substrate S; lane 7-9: WT 
BMM lysates incubated for 0 min, 30 min and 3 h. (B) lane 1-2: WT BMM lysates incubated for 30 min and 3h with 
10 µM Orlistat; lane 3-4: Dagla-/- BMM lysates incubated for 30 min and 3 h with 10 µM Orlistat; lane 5-7: 
standards, lane 8-9: WT BMM lysates incubated for 30 min and 3 h; lane 10-11: Dagla-/- BMM lysates incubated 
for 30 min and 3 h. (C) Lane 1-3: Flag-purified DAGLα incubated for 0 min, 30 min, and 3h; lane 4-6: standards; 
lane 7-9: flag-purified DAGLα incubated for 0 min, 30 min, and 3h. (D) In vitro assays with substrate S2 (1-click-
palmitoyl-2-linoyl-sn-glycerol): lane 1-2: Dagla-/- BMM cells overnight incubated, lane 3-4: WT BMM overnight 
incubated; lane 5-8: Dagla-/- BMM lysates incubated for 0 min, 10 min, 30 min and 3 h; lane 9-10: standards; lane 
11: substrate S2; lane 12-15: WT BMM lysates incubated for 0 min, 10 min, 30 min and 3 h. (E,F) Intensities of 
individual bands of free click-palmitic acid were quantified using ImageJ densitometry software, and expressed 
relative to the substrate signal. (E) Formation of free palmitic acid did not differ between Dagla-/- and WT cells. (F) 
Metabolism of substrate S2 was similar in both genotypes (two-way ANOVA, Bonferroni’s post-hoc test, values 
represent mean ± SEM: n = 2). 
 
In conclusion, both substrates were metabolized in Dagla-/- and WT BMM cell lysates 
and could easily be detected by click-chemistry and subsequent fluorescence imaging. Click-
chemistry is a promising approach to analyze enzyme activity in vitro. However, the applied 
substrates were not specific for DAGLα. DAGLß or other lipases might have metabolized the 
labeled DAGs. Further studies are required to confirm whether other labeled DAGs are more 
specific for DAGLα or not.   
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 Discussion 
One aim of this thesis was to determine the impact of DAGLα, the main synthesizing 
enzyme of 2-AG in the CNS, on the development and manifestation of mood disorders, such 
as anxiety and depression. Therefore, constitutive as well as neuronal- and microglia-specific 
Dagla knockout mice were comprehensively analyzed in a variety of behavioral paradigms 
related to anxiety and depressive disorders. To further characterize the different knockout 
mouse lines, molecular analysis, including endocannabinoid measurements and gene 
expression analysis, were performed. Mice lacking Dagla displayed substantial modifications 
of the composition of endogenous cannabinoids and severe behavioral changes. 
A second aim was to analyze the sensitivity of Dagla-/- and Syn-Dagla-/- mice to chronic 
stress. The widely applied model of chronic social defeat stress was used to challenge 
knockout and control mice. Subsequently, behavioral and molecular stress responses were 
determined. 
Lastly, this thesis aimed to establish a method disclosing interaction partners of 
DAGLα. Tandem affinity purification and subsequent MALDI-TOF/TOF mass spectrometry 
analysis revealed several candidate proteins, presenting an advantageous approach to 
discover potential interaction partners of DAGLα. Furthermore, novel in vitro DAGLα activity 
assays using the non-radioactive click-chemistry method were performed. Results of this part 
will be discussed in the finishing section of the discussion. 
4.1 Behavioral and molecular characterization of mice 
lacking Dagla 
The present study demonstrates that mice with a constitutive deletion of Dagla showed a 
phenotype of increased emotional and stress-related behaviors. This was characterized by a 
reduced exploration of the central area of the open-field, a maternal neglect behavior, a fear 
extinction deficit, increased behavioral despair and increased anxiety-related behaviors in the 
light/dark box test. Some of these behavioral changes resemble those observed in animals 
lacking the main neuronal cannabinoid receptor CB1. Together, these findings strongly 
support the notion that a disruption of endocannabinoid signaling adversely affects the 
emotional state of animals and results in enhanced anxiety-, stress- and fear-responses.  
Dagla-/- animals showed an extensive reduction (80-90%) in hippocampal, cortical, 
amygdalar and striatal 2-AG levels, confirming that DAGLα is the main 2-AG synthesizing 
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enzyme in the brain. This finding is also supported by previous studies showing that 2-AG in 
the CNS is predominantly produced by DAGLα, while DAGLß is the main synthesizing 
enzyme of 2-AG in peripheral tissues (Gao et al. 2010). Gao and colleagues found that 
constitutive deletion of Daglb caused a 50 % reduction of 2-AG in the brain and 90 % 
reduction in the liver (Gao et al. 2010). Consequently, DAGLß cannot compensate the loss of 
function of DAGLa. Nevertheless, DAGLß is expressed in neurons and non-neuronal cells in 
the CNS and is certainly responsible for the remaining 10-20 % 2-AG content. 
Expression analysis of other ECS-related genes revealed no changes. In addition, CB1 
signaling was not changed in Dagla-/- mice. THC treatment induced similar behavioral 
changes in the tetrad test in Dagla-/- and WT mice, indicative of an unaltered CB1 signaling. 
Consequently, the behavioral and molecular changes detected in Dagla-/- mice can be 
directly linked to the lack of Dagla and not to modified CB1 signaling. 
Interestingly, the levels of anandamide were also significantly decreased in the 
hippocampus, amygdala and cortex, but not in the striatum, of Dagla-/- mice. This finding is in 
agreement with previous studies that have indicated a correlation of 2-AG and anandamide 
production in the brain (Gao et al. 2010). It seems that the activity of DAGLα and thus the 
level of 2-AG influenced anandamide levels in a brain region-specific manner. Although the 
underlying mechanism is unknown, it is noteworthy that the administration of the MAGL 
inhibitor JZL184 to Dagla-/- mice increased not only 2-AG levels, but also normalized the level 
of anandamide (Fig. 18). It is unlikely that MAGL contributes directly to the degradation of 
anandamide, because MAGL deficient mice have normal anandamide levels and acute 
JZL184 treatment does not affect anandamide concentrations in WT mice (Schlosburg et al. 
2010; Nomura et al. 2011). It is more likely that the vastly reduced production of 2-AG in 
Dagla-/- mice leads to a decrease in anandamide synthesis, or an increase in anandamide 
degradation through an indirect mechanism. 
Furthermore, 2-AG levels in the brain of neuronal- and microglia-specific Dagla 
knockout mice were not altered, most likely indicating that neither neurons nor microglia are 
the main 2-AG producing cells in the adult brain. In addition, anandamide levels were 
significantly reduced in the cortex, but not the hippocampus and striatum of LysM-Dagla-/- 
mice. These findings together with the reduced anandamide levels in Dagla-/- mouse brain 
suggest that the lack of Dagla in microglia influences the production of anandamide either 
released by microglia itself or other cell-types in a brain region-dependent manner. However, 
it should be considered that using the LysM-Cre line only led to a 30-40 % deletion of Dagla. 
Hence, other microglia-specific mouse lines with higher deletion efficiencies need to be 
analyzed to confirm this result. The present study is the first to analyze 2-AG production in 
different cell types in vivo, using conditional Dagla knockout mouse lines. In addition, the 
findings show for the first time that the main amount of 2-AG in the brain is not only released 
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by neurons. It is very unlikely that compensatory mechanisms, such as an upregulation of 
neuronal DAGLß or increased 2-AG production by other cell-types, are solely responsible for 
the entirely unchanged 2-AG content. Nevertheless, to further verify these results, 2-AG 
levels of cultured Syn-Dagla-/- neurons and LysM-Dagla-/- microglia should be determined.  
 
In line with previous studies (Gao et al. 2010), a significantly reduced body weight was 
observed in Dagla-/- mice. This effect seems to be due to decreased food intake and shifts in 
energy metabolism. Treatment with a DAGLα inhibitor significantly decreased the intake of 
high-fat diet in mice (Bisogno et al. 2013). In addition, a recent study showed that Dagla-/- 
mice and CB1-/- mice had similar lean phenotypes and reduced body fat when raised on 
chow or high fat diet. Body fat was decreased up to 50 % in comparison to wild type 
littermates (Powell et al. 2015). Pair-fed studies showed that hypophagia was the reason for 
this lean phenotype (Powell et al. 2015), as also reported for CB1-/- animals (Cota et al. 
2003). In addition, high fat diet-fed Dagla-/- mice had significantly lower insulin and total 
cholesterol levels after glucose challenge (Powell et al. 2015). These reductions in body 
weight and body fat were not detected in Daglb-/- animals (Powell et al. 2015), which have a 
markedly higher 2-AG level in the brain than mice lacking Dagla (Gao et al. 2010). Thus, the 
lean phenotype is most likely due to 2-AG-CB1 signaling in the CNS rather than in peripheral 
tissues. This hypothesis is consistent with the finding that mice with a neuronal-specific 
deletion of Dagla also displayed a reduced body weight. Even though the effect occurred to a 
lower extent, the present study implies that neuronal DAGLα at least partially contributes to 
the lean phenotype. Microglia-specific knockout of Dagla did not affect the body weight. 
However, as mentioned above, the LysM-Cre mouse line only displayed a deletion-efficiency 
of 30-40 % in microglia and 80 % in bone marrow-derived macrophages (Jehle et al. 2016). 
Previous studies indicated that hormones and dietary signals control microglia activity during 
obesity (Gao et al. 2014) and that microglia might play an important role in the physiological 
control of metabolism (for review see Argente-Arizón et al. 2015). To determine to which 
extent microglia and neurons contribute to the metabolic changes seen in HFD-fed Dagla-/- 
mice, conditional knockout mouse lines are still to be analyzed in HFD pair-feeding studies. 
 
Behavioral studies performed with CB1-/- mice indicated that a disrupted CB1 signaling 
promotes anxiety-related behaviors in various paradigms, such as the light-dark box or the 
plus maze test (Martin et al. 2002; Haller et al. 2004; Urigüen et al. 2004). Thus, a disrupted 
CB1 signaling seemed to promote anxious behavior. The opposite was reported when 
endocannabinoid levels were increased. Inhibition of the 2-AG degrading enzyme MAGL 
(Busquets-Garcia et al. 2011; Sciolino et al. 2011) or the pharmacologic blockade of the 
anandamide-degrading enzyme FAAH, led to reduced anxiety-related behavior. This effect 
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was antagonized by the CB1 antagonist rimonabant, demonstrating an involvement of the 
CB1 receptor (Moreira et al. 2008). Consistently, a mild anxiety- or stress-related phenotype 
in Dagla-/- mice in the open-field and light-dark box tests was observed in the present study. 
The mice spent less time exploring the center of the open-field box, which is correlated with 
anxiety-like behavior. However, the phenotype is rather mild and only significant for some 
time points. A similar mild anxiety-related phenotype was detected in the light/dark box test. 
In this test, the main measure for anxiety is the activity and time spent in the two areas of the 
light/dark box, based on the innate aversion of rodents to brightly illuminated areas. The 
number of transitions between the light and dark area and number of rearings were markedly 
reduced in mice lacking Dagla, indicating that reduced levels of 2-AG caused a decreased 
exploratory behavior. Furthermore, a reduced number of transitions, without decreased 
spontaneous locomotion, are related to an increased anxiety (Bourin & Hascoet 2003). 
Previous studies showed that the deletion of CB1 caused a comparable, but more 
pronounced phenotype with decreased time spent in the light area and reduced number of 
transitions (Martin et al. 2002). It was suggested that the CB1 anxiety phenotype largely 
depends on the basal anxiety level of the animals in the test situation (Haller et al. 2002, 
2004). Locomotion (distance travelled) was not affected in neither of the two test paradigms. 
However, there was no genotype effect in the open arm time of the zero-maze, but an 
increased distance travelled. Dagla-/- mice thus also showed a behavioral change in the more 
aversive zero-maze test, but these changes cannot be readily related to anxiety.  
Furthermore, it is possible that the increased anxiety- or stress-related behavior in 
Dagla-/- mice also contributed to the altered maternal behavior in the pup retrieval test.  
Dagla-/- mice needed much more time to retrieve a pup back into the nest, but the nursing 
behavior was unaffected and the body weight of Dagla-/- pups did not differ from WT controls. 
It thus appears that Dagla-/- dams have no general deficit in maternal behavior, but rather 
behaved different from WT dams because of the stressful test situation. This hypothesis is 
supported by the unchanged behavior of Dagla-/- mice in the social preference test, which 
indicates that the altered maternal behavior is not due to a generally impaired social interest 
of the knockout animals. This hypothesis is also in line with previous studies showing that 
treatment with rimonabant or deletion of the CB1 resulted in slower pup retrieval (Schechter 
et al. 2012, 2013), whereas nursing behavior was not affected. Schechter et al. (2013) have 
also suggested that the increased stress sensitivity of CB1-/- mice (Martin et al. 2002; Haller 
et al. 2004) contributed to the deficit in maternal care. Nevertheless, it cannot be ruled out 
that vice versa a dysfunctional maternal behavior contributed to the anxiety, fear and stress-
related behavioral phenotypes. 
The anxiety- and stress-related behavioral phenotypes of Dagla-/- mice are entirely 
consistent with the observed reduction in endocannabinoid levels in the amygdala and 
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hippocampus, two brain regions essential for normal fear and anxiety behaviors. To 
determine more precisely how endocannabinoid signaling modulates the neuronal circuits 
associated with affective behaviors, cell type-specific Dagla knockout mice were analyzed in 
the same behavioral paradigms. Neuronal- and microglia-specific deletion of Dagla did not 
affect anxiety-like behavior in the open-field, zero-maze or light/dark box test. Together with 
the finding that both mouse lines had unaltered 2-AG levels, the mild anxiety-like phenotype 
of Dagla-/- is most likely dependent on the tremendous reduction of 2-AG. However, it cannot 
be ruled out that the reduced anandamide levels also contribute to the observed phenotype. 
 
Previous studies revealed a distinct fear extinction deficit in Dagla-/- mice and an increased 
freezing response, indicative of an altered stress-response (Ternes 2013; Jenniches et al. 
2015). To determine the impact of DAGLα expressed in neurons and microglia, both 
conditional mouse lines were subjected to a fear conditioning paradigm. A distinct deficit in 
fear extinction and increased freezing responses were detected in Syn-Dagla-/- similar to that 
seen in Dagla-/- animals. While Daglafl/fl controls displayed progressive fear extinction from 
day E1 to E3, the freezing response of Syn-Dagla-/- increased over time. The mild 
unexpected increase of freezing time observed in Daglafl/fl mice on day E6 is most likely due 
to fear-inducing disturbances, such as disruptive noise during the behavioral test or previous 
cage changes. In addition, LysM-Dagla-/- showed a mildly increased freezing responses on 
day E6, but no deficits in the extinction of fear.  
The levels of 2-AG and anandamide increased after the first extinction training in the 
basolateral amygdala, a brain region critically involved in the acquisition and expression of 
conditioned fear (Marsicano et al. 2002; Myers & Davis 2007). Genetic ablation of CB1 
receptors or pharmacological blockage, systemically or within the amygdala, prevents the 
extinction of conditioned fear responses. Fear extinction involves safety learning, which 
refers to the formation of a new association between the conditioned stimulus with the non-
appearance of the punishment. The second process involves a non-associative component 
of extinction, namely the habituation to the conditioned stimulus (Kamprath & Wotjak 2004). 
CB1-/- mice showed distinct deficits in both processes. In particular, CB1-/- mice showed 
delayed between-session extinction, also termed long-term extinction, and inability in 
achieving within-session extinction (short-term extinction) (Marsicano et al. 2002; Ruehle et 
al. 2012; Kamprath et al. 2006). It is not entirely clear if and how both of these processes are 
modulated by the ECS. Studies focusing on repeated homotypic stress showed that 2-AG 
levels in cortical brain regions were elevated after a repeated stress exposure, whereas 
glutamate release declined gradually (Rademacher et al. 2008; Patel & Hillard 2008). This 
mechanism of stress adaptation is supposedly mediated through an increased synthesis of 
2-AG (Patel & Hillard 2008). Therefore, the impaired fear extinction seen in Dagla-/- and Syn-
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Dagla-/- mice could be due to a deficit in habituation, which was also shown in CB1-/- mice 
(Kamprath et al. 2006). This stress-induced increase of 2-AG, which mediates stress 
adaptation, is very likely reliant on the activity of neuronal DAGLα. This hypothesis is 
consistent with the finding that Syn-Dagla-/- mice have a distinct fear extinction deficit similar 
to that seen in Dagla-/- animals, although total brain 2-AG levels are not reduced in these 
animals. In addition, chronic social defeat stress caused significantly increased 2-AG levels 
in the amygdala of Daglafl/fl, but not Syn-Dagla-/- mice. Accordingly, neuronal deletion of 
Dagla negatively affected the habituation to stress. 
In addition, contrary to Dagla-/- mice, Syn-Dagla-/- mice almost completely lacked 
between-session fear extinction, representing a strong deficit in safety learning. Thus, 
neuronal 2-AG at least partially mediates this learning paradigm in auditory fear conditioning. 
The different behaviors observed in Dagla-/- and Syn-Dagla-/- mice might be due to 
compensatory mechanisms in consequence to the continually reduced 2-AG levels in the 
amygdala and other brain regions critically involved in fear extinction. On the other hand, 
reduced anandamide levels in the amygdala and hippocampus of Dagla-/- mice might alter 
fear conditioning and subsequent fear extinction. Treatment with the FAAH inhibitor URB597, 
thus increased anandamide levels, enhanced extinction in several paradigms (reviewed in 
Gunduz-Cinar et al. 2013). However, the consequence of short- or long-term reductions of 
anandamide levels is still uncertain. Furthermore, microglia-specific deletion of Dagla, 
causing decreased cortical anandamide levels, did not produce general deficits in fear 
extinction, but mildly increased the fear response. Since control animals displayed only 
limited fear extinction in this particular test, it needs to be repeated to allow a firm conclusion. 
In addition, LysM-Cre only generated a 30-40 % knockout, and more potent microglia-
specific Dagla knockout mouse lines are needed to confirm these results. Together with CB1 
knockout and pharmacological studies, using either systemic or brain-region-specific 
blockade of endocannabinoid signaling, the present findings show that the ECS is crucial for 
efficient extinction learning. 
 
The deletion of Dagla also induced depression-like behaviors. Thus, Dagla-/- mice displayed 
an enhanced behavioral despair in the forced swim test, anhedonia in the sucrose 
preference test, and reduced hippocampal neurogenesis (Jenniches et al. 2015), but a 
normal sleep/wake cycle. It is not clear if these behavioral phenotypes can be entirely 
attributed to the reduced levels of 2-AG, or if the reduced anandamide levels also had a 
contribution. However, neither JZL184 nor URB597 treatment, which both increased 
anandamide concentrations, affected the immobility time in the forced swim test. In addition, 
deletion of neuronal Dagla also caused behavioral despair and anhedonia similar to that 
seen in Dagla-/- mice. Therefore, not the generally decreased brain 2-AG levels, but rather 
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the lack of neuronal 2-AG caused the observed phenotype. It is most likely that neuronal and 
synaptic plasticity and/or cell-cell communication are limited due to the loss of 2-AG 
produced by DAGLα in neurons, contributing to the observed behavioral changes. Reduced 
neuroplasticity is directly connected with depression and other stress-related mood disorders 
(for review see Pittenger & Duman 2008). In addition, the lack of CB1 receptors impaired 
neuronal plasticity (for review see Valverde et al. 2012). More importantly, synaptic plasticity 
is at least partially mediated by 2-AG, produced by DAGLα (Chevaleyre et al. 2003; 
Hashimotodani et al 2008; Gao et al. 2010). 
Another hallmark of animal models of depression is a reduced adult neurogenesis. 
Nevertheless, neuronal proliferation and survival was not affected by the deletion of neuronal 
Dagla, indicating that 2-AG produced by non-neuronal cells caused the significant reduction 
of neuronal proliferation and survival observed in Dagla-/- mice (Gao et al. 2010; Jenniches et 
al. 2015). Previous studies showed that microglia and astrocytes are critically involved in 
adult neurogenesis (Morrens et al. 2012). Thus, future studies should analyze the neuronal 
proliferation and survival in LysM-Dagla-/- mice and further in astrocyte-specific knockout 
animals.  
ECS signaling, in particular the activity of the CB1 receptor, is known to modulate 
depression-related behavior in rodents and depression in humans. Thus, CB1-/- mice are 
more sensitive in developing a depressive-like phenotype after chronic stress (Martin et al. 
2002, Schechter et al. 2013) and the CB1 receptor antagonist rimonabant increased 
depressive symptoms in humans. Increase of 2-AG via the blockade of MAGL also produced 
antidepressant- and anxiolytic effects, and enhanced adult hippocampal neurogenesis 
(Zhong et al. 2014; Zhang et al. 2014). Furthermore, chronic treatment with antidepressants 
led to a significant increase in 2-AG levels in various brain areas, indicating that 2-AG could 
be important for the antidepressant effect of these drugs (Smaga et al. 2014). Previous 
studies showed a significant reduction in serum 2-AG levels of female patients with major 
depressive disorders (Hill et al. 2008a; Hill et al. 2009). In contrast, a recent study indicated 
that mice lacking MAGL display an anxiety and depressive-like phenotype similar to that 
observed in mice with reduced 2-AG levels (Imperatore et al. 2015). The authors claim that 
desensitization of CB1 receptors caused an excitatory/inhibitory imbalance, which leads to 
an excitatory drive in the PFC and an inhibitory drive in the amygdala and hippocampus. 
Together with the present study these results indicate that alterations in the eCB composition 
and CB1 signaling severely affect the emotional state. 
The analysis of CB1-/- mice showed that the CB1 receptor is essential for normal brain 
development. It is thus difficult to tell whether the behavioral phenotypes are direct effects of 
the disrupted 2-AG biosynthesis, or rather an indirect consequence of developmental effects. 
Discussion	 121	
This uncertainty, which concerns all studies with genetic mouse models, may be addressed 
with the help of an inducible Cre recombinase (Lewandowski 2001; Feil et al. 2009). 
 
In conclusion, the results of this study indicate an important role of 2-AG, in particular 
produced by neurons, in the modulation of emotion and stress-responses. In addition, the 
activity of microglial Dagla also partially contributes to the processing of fear responses and 
anhedonic-like behavior. These findings are consistent with the idea that a disrupted 
endocannabinoid signaling contributes to the development of affective disorders, which is 
supported by clinical data.  
4.2 Chronic social defeat stress  
A further aim of this study was to analyze the sensitivity of constitutive and neuronal-specific 
Dagla knockout animals to chronic stress. Chronic stress models, such as chronic social 
defeat stress, are known to induce behavioral and molecular changes resembling signs and 
symptoms of humans with affective disorders (for review see Hammels et al. 2015). Thus, 
this model mimics cardinal features of a multitude of psychiatric disorders including 
depression, anxiety and post-traumatic stress disorders.  
The ECS plays an important role in stress adaptation. The genetic or pharmacological 
blockade of CB1 receptors was shown to cause an anxiety- and depressive-like phenotype 
and increased the sensitivity to chronic stress (Haller et al. 2002; Martin et al. 2002; Beyer et 
al. 2010). In this study, an increased stress sensitivity was also observed in mice 
constitutively lacking Dagla. The mortality rate of Dagla-/- mice exposed to chronic social 
defeat stress exceeded 30 %, whereas only 2 out of 30 tested Daglafl/fl controls and 1 out of 
10 Syn-Dagla-/- mice died in consequence to the stress exposure. None of the deceased 
animals had severe wounding, thus physiological changes, such as cardiovascular 
affections, were most likely the leading cause of death. In line with this, social defeat was 
shown do induce a higher degree of cardiac arrhythmias compared to other chronic stress 
models (Sgoifo et al. 1999; Sgoifo et al. 2005). Furthermore, the individual susceptibility to 
chronic stress varies greatly among individuals (for review see Krishnan 2014). As a 
consequence, the most susceptible mice, which died during the stress paradigm, could not 
be included in the subsequent behavioral and molecular analysis. 
The deletion of Dagla, thus the lack of 2-AG, tremendously increased the sensitivity to 
chronic stress. Chronic social defeat stress caused a robust long-lasting increase of 2-AG 
levels in the amygdala of Daglafl/fl and slightly increased quantities in the PFC. Both brain 
parts belong to the limbic circuit, which is critically involved in the formation and regulation of 
emotional processes and stress-related behaviors. In contrast, 2-AG levels of Dagla-/- mice 
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were not affected, indicating that stress-induced increase of 2-AG is dependent on DAGLα 
and not the second DAGL isoform DAGLß. Likewise, 2-AG levels of Syn-Dagla-/- were not 
altered after CSDS, showing that the stress-dependent increase of 2-AG is dependent on the 
activity of neuronal DAGLα.  
Habituation to homotypic stress is at least partially mediated by an increase of 
amygdalar 2-AG (Patel & Hillard 2008; Hill et al. 2010b). Accordingly, Dagla-/- mice might 
have a distinct deficit in stress adaptation and habituation, which possibly contributed to the 
high mortality rate. In contrast to 2-AG, anandamide levels were shown to decrease in the 
amygdala, PFC, hypothalamus and hippocampus following chronic homotypic and 
unpredictable stress (Hill et al. 2010b; Hill et al. 2008b). However, CSDS did not affect 
anandamide levels in wild type animals (Daglafl/fl). These discrepancies are most likely due to 
the use of different stressors and the time point of eCB measurements. In this study, 
endocannabinoid levels were determined 12 days after the last day of CSDS and not 
immediately following the last stress exposure. Thus, it cannot be excluded that anandamide 
quantities normalized during this time delay. Interestingly, chronic stress lastingly increased 
anandamide levels in the PFC of Syn-Dagla-/- mice. The same tendency was seen in the 
amygdala. This effect presumably represents a compensatory mechanism. Due to the lack of 
a stress-dependent increase in 2-AG levels, the second most common eCB, anandamide, 
increased to mediate stress adaptation (see also below).  
Furthermore, CSDS caused a mild downregulation of several genes related to the 
ECS. Reduced levels of Magl, Faah and Dagla expression were observed in the amygdala of 
chronically stressed mice. Accordingly, increased 2-AG levels in the amygdala of Daglafl/fl 
mice were most likely caused by the increased activity of the DAGLα protein, irrespective of 
gene expression, and a decreased metabolism via MAGL. Furthermore, mRNA levels of 
Nape-Pld and CB1 were not affected. In contrast, previous studies showed that chronic 
stress caused significant changes in CB1 gene expression and binding site density in a brain 
region-specific manner. Chronic unpredictable stress increased gene expression (Hillard et 
al. 2006) and binding site densities of CB1 in the PFC (Hill et all. 2008b), while both 
parameters were decreased in the hippocampus and hypothalamus (Hill et all. 2008b). 
Furthermore, FAAH gene expression was upregulated after chronic stress (Patel 2005; Hill & 
McEwan 2010c), most likely responsible for the reduced anandamide levels described in 
previous studies (Hill et al. 2010b). The different types of stressors might explain the 
differences observed in ECS gene expression. Social defeat belongs rather to the homotypic 
than to the unpredictable stress models. In line with this, CSDS caused significantly 
increased brain 2-AG levels - an effect being more consistent following repeated homotypic 
stress exposures compared to unpredictable stressors. Increased 2-AG levels following 
chronic homotypic stress have been described in the amygdala, hippocampus, PFC and 
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hypothalamus (Dubreucq et al. 2012; Rademacher et al. 2008; Patel & Hillard 2008). 
 
Responses to acute and chronic stress are predominantly manifested in an activation of the 
HPA axis, leading to increased stress hormone levels. Glucocorticoid hormones, in rodents 
mainly corticosterone, are the body´s stress hormones and generally increased after 
exposure to acute or chronic stress. In contrast to plasma corticosterone levels, which show 
great fluctuation in response to stress, fecal corticosterone levels enable the analysis of long-
term effects (cumulative levels of secreted corticosterone). Chronic social defeat stress 
induced a significant increase of fecal corticosterone levels in group-housed intruder mice 
regardless of the genotype. However, this effect was not observed in single-housed mice. In 
this group, baseline corticosterone levels of unstressed mice were already as high as the 
corticosterone levels of stressed group-housed animals. Even though housing itself was 
shown not to influence fecal corticosterone levels (Toth et al. 2015), it leads to a sensitization 
of the HPA axis. Previous studies showed that single-caged mice had higher plasma 
corticosterone levels after acute stress (Ros-Simó & Valverde 2012). During the ten days of 
CSDS control animals were housed with unknown C57BL/6 mice, separated by a perforated 
Plexiglas wall and handled daily for body weight measurements. Thus, the single-housed 
intruder mice were most likely more sensitive to these stressful testing conditions, leading to 
higher baseline corticosterone levels in unstressed animals. Nevertheless, a significant 
increase of fecal corticosterone was detected in stressed single-caged Dagla-/- mice, but not 
in Daglafl/fl or Syn-Dagla-/- mice. Thus, the stress-dependent release of corticosterone was 
most pronounced in mice constitutively lacking Dagla, indicative of higher stress sensitivity 
and altered HPA axis regulation. In line with these findings, previous studies showed that the 
lack of CB1 receptors increased the release of corticosterone in response to stress (Urigüen 
et al. 2002, Zoppi et al. 2011). Furthermore, CB1 receptor antagonism prevented HPA axis 
habituation (Hill et al. 2010b) and CB1 receptors within the PVN mediated glucocorticoid 
feedback inhibition (Evanson et al. 2007). In addition, 2-AG and anandamide have been 
shown to be involved in HPA axis regulation. A multitude of studies indicated that 2-AG 
signaling contributed to the termination and adaptation of the HPA axis, while a stress-
dependent decrease in anandamide levels appeared to contribute to the manifestation of the 
stress response, including an activation of the HPA axis (for review see Morena et al. 2016). 
Moreover, 2-AG synthesis in the PFC after acute stress was controlled by a corticosterone-
mediated activation of GR (Hill et al. 2011). Hill and colleagues showed that this effect was 
CB1-dependent, since the blockade of CB1 receptors in the PFC prolonged corticosterone 
secretion. Thus, 2-AG-CB1 signaling in the PFC critically contributed to the feedback 
inhibition of the HPA axis (Hill et al. 2011). This is in line with the present findings showing 
that mice constitutively lacking Dagla displayed higher corticosterone levels after exposure to 
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CSDS compared to Daglafl/fl and Syn-Dagla-/- mice, indicative of a disrupted HPA axis 
feedback inhibition in Dagla-/- mice. In addition, these finding supports the hypothesis that 
increased anandamide levels in the PFC of Syn-Dagla-/- took on the role of 2-AG in reaction 
to chronic stress. More precisely, anandamide seemed to mediate the termination of the HPA 
axis response to stress, leading to lower corticosterone levels in Syn-Dagla-/- mice compared 
to Dagla-/- animals. Since both eCBs act through the same receptors, share common 
functions, and have somehow interconnected biosyntheses, a cell-specific compensatory 
role of anandamide in case of 2-AG deficiency is reasonable. However, this compensatory 
role seemed to be restricted to a reaction to chronic stress, since under baseline conditions 
neuronal deletion of Dagla caused similar behavioral alterations as observed in Dagla-/- mice. 
In addition, a comparable compensatory effect of anandamide was missing in Dagla-/- mice, 
substantiated by significantly reduced anandamide levels in several brain areas, possibly 
caused by a disruption in the anandamide biosynthesis. 
Corticosterone is produced and released from the adrenal glands, representing the end 
effectors of the HPA axis. As a result of long-term corticosterone production, for instance due 
to chronic stress, adrenal weights can increase. Indeed, CSDS caused significantly 
increased adrenal weights in Dagla-/- mice, but not Daglafl/fl mice. However, this effect was 
not seen in the single-caged intruder animals. In this case, the unstressed Dagla-/- animals 
had higher adrenal weights compared to unstressed control mice. Discrepancies between 
increased corticosterone levels and adrenal weights might be due to the time period of 
approximately two weeks between both measurements. However, the results further support 
that mice constitutively lacking Dagla inhibited strong alterations in HPA axis activity, leading 
to an increased corticosterone release in response to chronic stress.  
Conclusively, the present study offers additional support for the overarching hypothesis 
that endocannabinoid signaling is fundamental to the intrinsic regulation of the HPA axis. In 
addition, this study shows for the first time that neuronal DAGLα-dependent 2-AG release in 
the amygdala and PFC contributed to the regulation of HPA axis responses to stress (Fig. 
55). Furthermore, in case of neuronal deletion of Dagla, presumably anandamide took over 
this task and compensated the lack of neuronal 2-AG. 
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Figure 55: Source of 2-AG under baseline conditions and in response to chronic stress. (A) In the healthy 
brain neurons produce only a minor part of 2-AG. Since astrocytes and microglia produce more 2-AG compared 
to neurons in vitro, glia cells might be responsible for the main 2-AG content in the unstressed brain. (B) However, 
in response to chronic stress neurons in the amygdala and PFC release high amounts of 2-AG mediating stress 
habituation. Abbreviations: 2-AG: 2- arachidonoylglycerol, CB1: cannabinoid receptor 1, DAGL: diacylglycerol 
lipase, NT: neurotransmitter. 
 
The role of glucocorticoids in the brain is not only dependent on the hormonal levels, but also 
on the expression profiles of the glucocorticoid (GR) and mineralocorticoid receptors (MR) 
(Hermann 1993). Due to the low binding affinity of glucocorticoids to GR in comparison to 
MR, the second adrenal steroid receptor, GR is only activated during periods of high 
circulating glucocorticoid levels, as experienced during stress. As a result of this binding 
profile, GR mediates the majority of glucocorticoid negative feedback mechanisms (for 
review see Myers et al. 2012). The constitutive deletion of Dagla caused significantly 
reduced GR gene expression in the amygdala, hippocampus and PVN, brain parts critically 
involved in the regulation of the HPA axis. In line with this, previous studies showed that the 
constitutive deletion of CB1 caused a significant downregulation of GR in the hippocampus, 
but not the PVN (Cota et al. 2007). However, gene expression of the corticotropin-releasing 
hormone (CRH) and its main receptor CRHR1 were unchanged following chronic stress. In 
contrast, Cota et al. (2007) found a significant upregulation of CRH in the PVN of CB1-/- mice. 
Since gene expression analysis of CRH mRNA levels displayed high variances, further 
studies are required to confirm these results. 
In conclusion, the lack of Dagla at least partially altered HPA axis activity and gene 
expression, leading to a reduced GR expression and most likely a reduced GR-mediated 
feedback inhibition. In contrast, neuronal-specific deletion of Dagla did not affect the 
expression of GR in the brain. With respect to previous studies, reduced GR mRNA levels 
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were possibly caused by the persistently decreased 2-AG levels in the brain of Dagla-/- mice 
and the lack of 2-AG-CB1 signaling.  
Glucocorticoids were shown to rapidly modulate glutamatergic (Karst et al. 2005; Karst 
et al. 2010) and GABAergic (Verkuyl et al. 2005) transmission in stress-sensitive brain 
regions through alterations of neurotransmitter release. Recent studies supported the 
hypothesis that glucocorticoids modulated the release of glutamate and GABA as a result of 
enhanced endocannabinoid signaling (for review see Hillard 2014). In line with this, previous 
studies showed that corticosterone increased 2-AG production in the PFC via activating GR 
(Hill et al. 2011). This would mean that corticosterone increases 2-AG release and in turn 2-
AG inhibits the release of corticosterone. In line with this, mice constitutively lacking Dagla, 
thus 2-AG, had higher corticosterone levels. However, the direct link between DAGLα, thus 
2-AG, and GR gene expression remains elusive and further experiments are needed to 
clarify the possible role of the endocannabinoid system in the modulation of brain GR 
function. Taken together, these results show that the connection between the ECS and the 
HPA axis is multifaceted and an appropriate interplay between both signaling systems is 
necessary to maintain homeostasis. 
A severe threat to the body´s homoeostasis is chronic stress. It is known to cause an 
overactivity of the HPA axis and significant reductions of GR gene expression. More than  
50 % of depressed patients show hyperactivity of the HPA axis and impaired GR-mediated 
negative feedback (Anacker et al. 2011). Indeed, CSDS significantly decreased GR mRNA 
levels in the amygdala and at least partially in the hippocampus of Daglafl/fl, Dagla-/- and Syn-
Dagla-/- mice. However, this effect was only observed in single-caged intruder mice, again 
indicative of an increased stress-sensitivity due to housing conditions prior to the stress 
exposure. Stress-dependent changes in GR gene expression were independent of 2-AG and 
not directly related to increased corticosterone levels. Thus, 2-AG seems to influence GR 
expression under baseline conditions, but not in response to chronic stress.  
 
A further housing effect was detected in the stress-dependent regulation of the body weight. 
CSDS significantly decreased the body weight of single-caged, but not group-housed 
intruder mice regardless of the genotype. However, since the single-caged CSDS was 
performed only with one cohort of animals, individual susceptibility of the mice might have 
contributed to the observed differences. The effects of stress on the body weight were shown 
to vary greatly depending on the type and duration of the stressor. In rodents, chronic 
stressors usually decreased chow intake and body weight (Dallmann 2001), while intake of 
palatable food was specifically increased (Dallmann et al. 2003). Krishnan and colleagues 
described reduced body weights in susceptible, but not unsusceptible mice after CSDS 
(Krishnan et al. 2007). In humans, individual differences in food intake responses to acute 
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stress were also noted. Approximately 40 % increased and 40 % decreased their caloric 
intake, while 20 % did not change their eating behaviors at all. Similar differences have been 
observed in response to chronic stress (for review see Yau & Potenza 2013). In addition, 
depression, which can often be triggered by chronic exposure to stressful events, was 
frequently associated with a reduced appetite (Nestler et al. 2002). Taken together, these 
findings suggest that stress promotes irregularities in eating patterns. Several studies 
indicated that these effects are substantially mediated by glucocorticoids, which act on the 
hypothalamus to modulate food intake (for review see Dallmann et al. 2004). However, the 
activity of DAGLα, thus the amount of 2-AG, did not contribute to stress-dependent changes 
in body weight. This differs clearly from basal conditions, in which both neuronal and 
constitutive deletion of Dagla significantly reduced the body weight of adult mice.  
 
Besides the molecular alterations, chronic stress is known to modulate behavior, leading to 
increased anxiety and depressive-like phenotypes. In the following, behavioral alterations 
due to chronic stress are discussed in detail. CSDS produced a robust social avoidance 
phenotype in all animals. Housing conditions prior to the stress exposure and the deletion of 
Dagla did not affect the stress-induced avoidance behavior. However, even unstressed 
Dagla-/- mice inhibited an increased anxiety phenotype in this behavioral test, reflected by a 
decreased interaction time with the foreign CD1 mouse. Since mice constitutively lacking 
Dagla inhibited a distinct social preference for a conspecific, the increased avoidance was 
most likely due to increased anxiety towards an older male animal of a different strain. This is 
in line with the anxiety-like phenotype of Dagla-/- observed in other behavioral tests, such as 
the open-field or the light/dark box test.  
Stress-dependent social avoidance towards animals of the same species/strain, like 
the former aggressor animal, was also described in previous studies (Berton et al. 2006; 
Dadomo et al. 2011). However, social avoidance was not detected using conspecific 
C57BL/6 mice (Desbonnet et al. 2012; data not shown). In conclusion, social avoidance 
against a former aggressor animal is a reliable measure of the successful performance of the 
stress paradigm and has been used to distinguish between susceptible and resilient animals 
(Krishnan et al. 2007). Krishnan and colleagues correlated the susceptibility to increased 
nucleus accumbens (NAc) BNDF protein levels, not accompanied by BDNF mRNA changes, 
and upregulated firing-rates in ventral-tegmental area (VTA) dopamine neurons (Krishnan et 
al. 2007). The nucleus accumbens has a major role in the cognitive processing of aversion, 
motivation, and reward and gets major inputs from the PFC, the amygdala and the 
hippocampus. The VTA is the origin of dopaminergic neurons of the mesocorticolimbic 
system and is mainly involved in the reward circuitry. In the present study no differences in 
the manifestation of social avoidance between the stressed animals could be detected, thus 
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all animals were susceptible. Furthermore, BDNF gene expression in different brain areas 
remained constant. However, protein levels might be altered and are still to be analyzed. 
Increased dopamine release in animals susceptible to social defeat was also shown to 
disturb other neurotransmitter systems, such as GABAergic and glutamatergic signaling (for 
review see Hammels et al. 2015), which might contribute to the stress susceptibility. 
Endocannabinoids critically contribute to the control of neurotransmitter release, thus altered 
neurotransmitter release and composition due to the lack of Dagla most likely contributed to 
the increased stress-sensitivity of Dagla-/- mice. 
Besides the induction of social avoidance, chronic stress is known to increase anxiety 
in rodents. Accordingly, anxiety-like behavior was assessed in the open-field and zero-maze 
test. CSDS mildly increased anxiety in the open-field test, but did not elicit anxiety-like 
phenotypes of Daglafl/fl or Syn-Dagla-/- mice in the zero-maze test. However, Dagla-/- mice 
showed significantly increased anxiety-like behavior in the zero-maze test after exposure to 
chronic stress, representing a further evidence for the augmented stress sensitivity of mice 
lacking Dagla. In contrast, CB1-/- mice did not show higher anxiety-like behavior in the zero-
maze test after CSDS (Dubreucq et al. 2012). These divergent observations can most likely 
be ascribed to different social defeat protocols, because other chronic stress models, such 
as chronic mild stress, significantly increased the anxiety-like behavior of CB1-/- mice 
compared to wild type controls (Martin et al. 2002). Increased corticosterone levels of Dagla-/- 
mice might have contributed to the enhanced stress sensitivity, emerging in increased 
anxiety. In line with this, previous studies showed that corticosterone administration caused 
significantly increased anxiety-like behavior in rodents (Demuyser et al. 2015). 
 
Chronic stress is a main risk factor for the development of depression. In laboratory animals 
depressive-like behavior is assessed by measuring signs of anhedonia, behavioral despair, 
decreased general activity, and altered circadian rhythm. Anhedonia is the inability to 
experience pleasure from activities usually considered enjoyable, and represents one of the 
core symptoms of major depression in humans. CSDS did not induce anhedonic behavior, 
manifested in reduced sucrose preference. However, the generally decreased sucrose 
preference observed in Syn-Dagla-/- and Dagla-/- mice impede the detection of a stress-
dependent anhedonic phenotype in these animals. Contradictory studies have been 
published concerning anhedonia after CSDS. Croft and colleagues (Croft et al. 2005) and 
von Frijtag and colleagues (von Frijtag et al. 2002) found no difference in sucrose preference 
after 5 days of CSDS, while other studies reported anhedonia after 10 days of CSDS 
(Covington et al. 2009; Yu et al. 2011). In contrast, Dubreucq and colleagues detected 
increased sucrose preference in wild type and CB1-/- mice after 7 days of CSDS (Dubreucq 
et al. 2012). Different social defeat protocols and handling procedures might explain the 
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different stress-dependent alterations in preference for sweet solutions.  
Furthermore, behavioral despair was analyzed in the forced swim test. A mild 
depressive-like phenotype was observed in single-caged, but not group-housed Daglafl/fl 
mice. These results indicate that caging influenced the reactivity to CSDS. Again, the strong 
baseline depressive-like phenotype of Syn-Dagla-/- and Dagla-/- mice exacerbated the 
detection of potential stress effects in these animals. However, several studies reported no 
significant effects of social defeat exposure on the forced swim test (Kinsey et al. 2007; 
Krishnan et al. 2007).  Thus, it is difficult to draw a final conclusion regarding the effect of 
social defeat on depressive-like behaviors.  
A further core symptom of depression in humans is fatigue or loss in energy (DSM-V, 
American Psychiatric Association 2013), in rodents mirrored by reduced activity in the home 
cage. However, CSDS caused increased locomotor activity especially during the dark phase, 
an effect being most pronounced in Dagla-/- and Syn-Dagla-/- mice. In contrast, Bartolomucci 
and colleagues detected reduced home cage motor activity of defeated mice, using 
radiotelemetry recordings (Bartolomucci et al. 2003). However, these authors (Bartolomucci 
et al. 2003) applied a longer social defeat protocol (15 days) and used a different method for 
the activity measurements. Other studies also showed increased home cage activity and 
altered day/night pattern in chronically stressed mice, marked by a similar increased activity 
during the active phase (dark phase) of the animals as observed in the present study (for 
review see Strekalova et al. 2011). These authors (Strekalova et al. 2011) suggest that the 
long lasting increase in locomotion may be due to elevated sympathetic activation and are 
directly related to the increased stress response of those animals. Thus, the obtained results 
gives further evidence for the importance of 2-AG in stress response and reactivity.  
 
Finally, it can be stated that a disrupted ECS signaling increase the sensitivity to chronic 
social defeat stress. In particular, brain 2-AG levels critically modulate the susceptibility to 
stress. This is the first study showing that augmented 2-AG levels in the amygdala and PFC 
after chronic homotypic stress are released by neurons. In case of a neuron-specific deletion 
of Dagla, anandamide contributes to this stress adaptation and compensates the lack of 2-
AG. Furthermore, the housing of the animals prior to the stress exposure might influence the 
reactivity to chronic stress. Considering all the stress-dependent behavioral alterations 
observed in the present study, CSDS represents a valid model for anxiety- and stress-related 
rather than depressive-like disorders. 
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4.3 In vitro approaches to characterize DAGLα and 
identify potential interaction partners 
Besides the behavioral and molecular characterization of mice lacking Dagla, this thesis 
aimed to establish a method to identify novel interaction partners of DAGLα and to analyze 
the activity of DAGLα in vitro. Both approaches are of high importance, because up to now 
very little is known about the regulation of DAGLα and its direct interaction with other 
proteins. A few studies described possible regulatory mechanisms based on posttranslational 
modifications or protein bindings. Proteomic studies indicated that both DAGL isoforms, 
DAGLα and DAGLß, can be palmitoylated (Kang et al. 2008; Martin & Cravatt 2009), but the 
exact mechanisms still remain unclear. Besides palmitoylation, phosphorylation is an 
important posttranslational modification used to control the activation of a variety of different 
proteins. Phosphorylation plays critical roles in many cellular processes including cell cycle, 
apoptosis and signal transduction pathways. DAGL purified from brain microsomes was 
shown to be positively regulated with direct phosphorylation by protein kinase A 
(Rosenberger et al. 2007). In line with this, protein kinase A (PKA) and C (PKC) were able to 
increase 2-AG production in neuronal culture, most likely through DAGL-dependent 
mechanisms (Vellani et al. 2008). In 2013, Shonesy and colleagues uncovered that the 
calcium/calmodulin dependent protein kinase II α (CaMKIIα) interacts with the C-terminal 
domain of DAGLα, phosphorylates two serine residues and thereby inhibits DAGLα activity 
(Shonesy et al. 2013). These results suggest that DAGLα interacts with different protein 
kinases, which regulates the lipase activity via phosphorylation. Moreover, interaction of 
DAGLα with CC-Homer proteins (Homer-1, Homer-2) was shown to be required for the 
membrane localization of this lipase, but most likely not for its activity (Jung et al. 2007). 
Thus far, CC-Homer proteins, PKC and CamKIIα are the only clearly identified interaction 
partners and regulators of DAGLα. Other proteins that may modulate the subcellular 
targeting or enzyme activity are poorly understood. Besides protein-protein interactions and 
posttranslational modifications, co-factors like metal ions or small organic molecules are 
important regulators of enzyme activity. Previous studies showed that the activity of DAGLα 
seemed to be dependent on glutathione and Ca2+, even though the exact mechanisms are 
unknown (Bisogno et al. 2003).  
To discover further potential regulators of DAGLα, this thesis aimed to establish a 
method for the identification of protein-protein interactions of DAGLα. Therefore, C-terminal 
tagged DAGLα was successfully overexpressed and purified from the mouse neuroblastoma 
cell line Neuro-2a. Subsequent analysis of co-purified proteins via MALDI-TOF/TOF mass 
spectrometry revealed several potential interaction partners of DAGLα. Two of the identified 
proteins are of special interest, namely NCAM and dynamin-1, because of their impact on 
neuronal growth and function. NCAM is involved in a variety of contact-mediated interactions 
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among neurons, astrocytes and oligodendrocytes. Furthermore, NCAM influences axonal 
growth during development and synapse formation in the adult brain (for review see Weledji 
& Assob 2014). DAGLα is also critically involved in these processes. Previous studies 
showed that activity of DAGLα enhanced axonal growth in the developing brain (Williams et 
al. 2003; Oudin et al. 2011) and that the deletion of DAGLα caused a reduced adult 
neurogenesis (Gao et al. 2010; Jenniches et al. 2015). In addition, fibroblast growth factor 
(FGF) in coordination with NCAM was shown to increase 2-AG levels via DAGL activation in 
cerebellar neurons to promote axonal growth (Williams et al. 2003). Thus, a direct interaction 
between DAGLα and NCAM as shown in this study is feasible and further analysis of this 
protein-protein interaction is promising. 
The second interesting candidate protein is dynamin-1. This neuron-specific GTP-
binding protein was shown to be involved in synaptic vesicle endocytosis and especially 
needed during strong neuronal activity (Ferguson et al. 2007). In addition, previous studies 
showed that dynamin-1 mediated the internalization of CB1 receptors (McDonald et al. 2006) 
and a knockdown of dynamin-2, the ubiquitously expressed isoform, reduced the uptake of 
anandamide in neuronal cells in vitro (McFarland et al. 2008). Up to now, connections 
between 2-AG and dynamins are not reported. However, this study showed that constitutive 
deletion of Dagla also led to significantly decreased anandamide levels. Thus, biosynthetic 
pathways of both endocannabinoids are somehow linked and uptake of 2-AG might also be 
dependent on dynamin activity. Consequently, dynamins might play an important role in 
regulating the ECS by controlling the uptake of eCBs. 
Finally, mitogen-activated protein kinase 8 (MAPK8) was co-purified with DAGLα. 
MAPK8, also known as c-Jun N-terminal kinase 1 (JNK1), belongs to the superfamily of 
MAP-kinases, mediating a variety of cellular processes. The JNK family consists of ten 
isoforms coded by three different genes, Jnk1, Jnk2 and Jnk3, all found in the mammalian 
brain (Gupta et al. 1996). JNK proteins are generally activated by cytokines and 
environmental stress and control the expression of genes essential for many cellular 
responses, including cell growth and apoptosis (Marshall 1995). Activation of cannabinoid 
receptors leads to the activation of MAPK pathways (Howlett et al. 2010). Previous studies 
showed that cannabinoid receptors activated JNK1 through a pathway that includes 
phosphatidylinositide 3-kinase (PI3K) and Ras (Rueda et al. 2000). In line with this, CB1 
receptor antagonists blocked the THC-dependent activation of JNK1 and 2 in cortical 
neurons (Downer et al. 2003). In addition, DAGs might promote JNK1 activation via different 
pathways. Previous studies proposed that IL-1β-induced DAG generation might contribute to 
the phosphorylation and activation of JNK1 in vitro (Welsh 1996). Among others, DAGLs 
metabolize DAGs and thereby control their cellular concentration and as a consequence the 
DAG-dependent activation of JNK1.  
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The main function of the protein kinase JNK1 is the regulatory phosphorylation of 
various proteins. Consequently, a feedback inhibition might be a possible link between 
DAGLα and JNK1. JNK1, as a downstream mediator of CB1 signaling, might phosphorylate 
and thereby inhibit DAGLα, as a consequence of enhanced CB1 signaling due to high 2-AG 
levels. Accordingly, this cascade would represent a novel inhibitory feedback mechanism of 
2-AG-CB1 signaling. However, further studies are needed to verify this hypothesis and to 
characterize the protein-protein interaction in detail, for instance via protein complex 
immunoprecipitation. 
 
CamKIIα, PKA, PKC and CC-Homer proteins were already shown to interact with DAGLα. 
However, none of these proteins were detected and identified in the bulk of co-purified 
proteins. This might be due to the usage of different tissues, cell lines and methods of 
measurement. For instance, interaction of DAGLα and CamKIIα was detected in mouse 
striatal extracts using a shotgun proteomics approach, in which DAGLα was 
immunoprecipitated from solubilized adult mouse striatum (Shonesy et al. 2013). In contrast, 
phosphorylation of DAGLα by PKA and PKC was shown using either cultured sensory 
neurons (Vellani et al. 2008) or in vitro assays with DAGLα purified from bovine brain 
microsomes (Rosenberger et al. 2007). In none of the described studies, DAGLα was tag-
purified from Neuro-2a cells as in the present study. In addition, the amount of purified 
DAGLα was quite low, thus some potential interaction partners might had concentrations 
below the effective detection limit of MALDI-TOF/TOF-MS and were therefore not identified.  
In conclusion, DAGLα was successfully overexpressed and purified from Neuro-2a 
cells followed by identification via MALDI-TOF/TOF-MS. In addition, several proteins 
representing potential interaction partners of DAGLα were identified. Further studies are 
needed to confirm possible protein-protein interactions. Nevertheless, the described method 
is a prospective technique for the identification of novel regulatory mechanisms of DAGLα. 
 
Furthermore, to analyze the activity of DAGLα in vitro, a novel enzyme activity assay using 
click chemistry was performed. Click chemistry has become recognized as a flexible tool to 
label biomolecules, such as nucleic acids, proteins and lipids (Thirumurugan et al. 2013). In 
this study, click chemistry was used to detect either free or glycerol bound labeled fatty acids. 
The labeling consists of a terminal alkyne (C-C triple bound), which neither alters the fatty 
acid metabolism nor occurs naturally in biomolecules (Thiele et al. 2012). In addition, alkynes 
do not react with any other molecule present in cells or tissue. Among the various click 
chemistry reactions, the applied azide-alkyne cycloaddition is the most widely employed 
reaction in biological studies (Horisawa 2014). This method allows among others the 
comprehensive non-radioactive tracing and characterization of lipid metabolism (Thiele et al. 
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2012).  
Only a limited number of DAGLα activity assays are currently available. One group of 
assays is using fluorogenic and chromogenic surrogate substrates (Pedicord et al. 2011; 
Johnston et al. 2012; Appiah et al. 2014). Nevertheless, surrogate substrates have limited 
structural similarity to natural ones and might alter the measurable enzyme activity. Up to 
now, three assays have been reported that utilize DAG, the natural substrate of DAGLα, to 
determine the lipase activity. For one, radiometric assays mainly using 1-stearoyl-2-
[14C]arachidonoyl-sn-glycerol as a substrate have been frequently described (Bisogno et al. 
2003, 2013; Jung et al. 2011). However, the synthesis of this substrate is quite expensive 
and requires handling of radioactive material. Moreover, previously described assays were 
performed with either membrane preparations or cell lysates of DAGLα overexpressing COS-
7 (Bisogno et al. 2003, 2013), HEK293T (Johnston et al. 2012) or Neuro-2a cells (Jung et al. 
2011). This is the first study using a click chemistry-based assay and Dagla-/- cell lysates.  
In the present study, two different click-labeled DAGs were applied as substrates for 
the enzyme activity assays. Metabolic activity of wild type and Dagla-/- cells were detected via 
thin-layer chromatography. In fact, a time-dependent product synthesis was noticeable. 
However, none of the tested DAGs showed substrate specificity for DAGLα. Substrate 
conversion was similar in primary wild type and Dagla-/- macrophages. In addition, the 
unspecific lipase inhibitor orlistat entirely blocked DAG conversion. These results imply that 
labeled DAGs were metabolized by lipases, although not exclusively by DAGLα. Detected 
metabolic activity was possibly dependent on, the second DAGL isoform, which is normally 
expressed in Dagla-/- mice. In addition, a recent study showed that DAGLß might be the 
predominant DAGL isoform in macrophages, since treatment with selective DAGLß inhibitors 
significantly reduced 2-AG levels in peritoneal macrophages (Hsu et al. 2012). Remarkably, 
previous studies never determined the substrate specificity of applied DAGs by using Dagla-/- 
or Daglb-/- cell lysates.  
Although the tested DAGs were not appropriate to analyze DAGLα activity in cell 
lysates of bone marrow-derived macrophages, they might be suitable for in vitro assays 
using membrane fractions or cell lysates of DAGLα overexpressing cells. Further studies are 
needed to establish a robust click chemistry based activity assay. Nevertheless, click 
chemistry is a promising tool for the in vitro characterization of lipases such as DAGLα.  
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4.4 Conclusion and Outlook 
Growing evidence supports the notion that the ECS is an integral regulator of emotional 
processes and critically contributes to the regulation of stress responses. Several psychiatric 
disorders are associated with altered release of endogenous cannabinoids, mainly 2-AG and 
anandamide, and altered CB1 receptor expression and viability. The present study gives 
further support for the involvement of disrupted ECS signaling to the development and 
manifestation of anxiety and depressive-like behaviors. The neuronal and constitutive 
deletion of Dagla negatively influenced the emotional state of rodents, leading to an 
enhanced anxiety, depressive-like behavior and impaired extinction of conditioned fear. This 
is the first study showing that 2-AG especially released by neurons importantly contributed to 
the body´s homeostasis and prevented the formation of depressive-related phenotypes. 
Even though the main cerebral 2-AG is most likely not produced by neurons, the stress-
dependent increase of 2-AG in the amygdala and PFC is depended on the activity of 
neuronal DAGLα mediating stress habituation and adaptation. In addition, the deletion of 
Dagla in microglia affected fear responses in mice, but did not result in 2-AG content 
changes. However, the use of LysM-Cre mouse line only led to a 30-40 % knockout of Dagla 
in microglia. Astrocytes and microglia were shown to produce higher amounts of 2-AG 
compared to neurons in vitro. Thus, future studies need to confirm which exact cell-type is 
responsible for the main production of 2-AG in the brain. Therefore, more potent microglia-
specific and astrocyte-specific Dagla knockout mouse lines are inevitable. Additionally, both 
the constitutive and microglia-specific deletion of Dagla caused a markedly decreased 
anandamide level in specific brain regions. Up to now, the connection between the 
biosynthesis of both cannabinoids remains elusive. This aspect should be emphasized in 
future studies, to allow a discriminability of the observed behavioral and molecular alterations 
to one of the eCBs.  
 
Chronic stress is a key risk factor for the development of mood disorders, such as PTSD and 
depression. Therefore, the stress reactivity of mice lacking Dagla to chronic social defeat 
stress was analyzed. The deletion of Dagla increased the sensitivity to chronic stress, 
manifested in increased anxiety and augmented corticosterone release. However, the 
neuron-specific deletion of Dagla did not affect the susceptibility towards chronic stress. Most 
likely the stress-dependent increase of anandamide in the amygdala and PFC compensated 
the lack of neuronal 2-AG and mediated stress habituation. In summary, the current 
discoveries highlight an essential role of 2-AG in the neuroendocrine network that regulates 
the HPA axis and the development of affective behaviors. Thus, alterations of the central 
endogenous cannabinoid tone might be involved in the pathophysiology of stress-related 
diseases. The effects of stress on the ECS are apparently quite multifaceted, brain region-
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specific and dependent on the type and chronicity of stress exposure. The social defeat 
paradigm produced specific behaviors and physiological changes resembling signs and 
symptoms of humans with affective disorders. However, it contains both a physical and a 
social component, which restricts the comparison to human social stress or exclusion. To 
ensure the impact of 2-AG to stress-sensitivity, constitutive and conditional Dagla knockout 
mice need to be examined in further chronic stress models, such as chronic mild stress. 
 
Mood and anxiety disorders represent one of the largest health burdens in Western society, 
yet only little novel therapeutics have emerged in the past two decades. Thus, the specific 
targeting of the ECS or the development of new drugs indirectly increasing eCB levels 
represents a promising tool to develop new antidepressants and anxiolytic agents.  
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A Appendix 
A.1 Protein list 
Proteins detected and identified via MALDI-TOF/TOF-MS. The list only contains the 142 
proteins, which were solely identified in the sample of transfected Neuro-2a cells (sample B). 
 
Accession Description Σ Coverage 
Σ# 
Proteins A: Area B: Area 
Coverage 
A 
Coverage 
B 
# 
Peptides 
A 
# 
PSM 
A 
# 
Peptides 
B 
# 
PSM 
B 
Q8K2C9 Very-long-chain 
(3R)-3-hydroxyacyl-
[acyl-carrier protein] 
dehydratase 3 
OS=Mus musculus 
GN=ptplad1 PE=1 
SV=2 - 
[HACD3_MOUSE] 
11,88 1 2,219E7 1,911E6 0,00 11,88   3 3 
P08752 Guanine nucleotide-
binding protein G(i) 
subunit alpha-2 
OS=Mus musculus 
GN=Gnai2 PE=1 
SV=5 - 
[GNAI2_MOUSE] 
10,14 1 2,019E7 4,365E6 0,00 10,14   3 3 
Q52KR3 Protein prune 
homolog 2 OS=Mus 
musculus 
GN=Prune2 PE=2 
SV=2 - 
[PRUN2_MOUSE] 
1,88 1 1,461E7 2,200E6 0,00 1,88   3 3 
Q9CQ71 Replication protein 
A 14 kDa subunit 
OS=Mus musculus 
GN=Rpa3 PE=2 
SV=1 - 
[RFA3_MOUSE] 
45,45 1 1,244E7 2,081E6 0,00 45,45   5 5 
Q9D2M8 Ubiquitin-
conjugating enzyme 
E2 variant 2 OS=Mus 
musculus 
GN=Ube2v2 PE=2 
SV=4 - 
[UB2V2_MOUSE] 
11,72 2 1,229E7 4,368E6 0,00 11,72   2 2 
P59708 Pre-mRNA branch 
site protein p14 
OS=Mus musculus 
GN=Sf3b14 PE=2 
SV=1 - 
[PM14_MOUSE] 
32,00 1 1,229E7 1,649E6 0,00 32,00   3 4 
P97379 Ras GTPase-
activating protein-
binding protein 2 
OS=Mus musculus 
GN=G3bp2 PE=1 
SV=2 - 
[G3BP2_MOUSE] 
11,83 1 1,209E7 1,300E6 0,00 11,83   3 7 
O35381 Acidic leucine-rich 
nuclear 
phosphoprotein 32 
family member A 
OS=Mus musculus 
GN=Anp32a PE=1 
SV=1 - 
[AN32A_MOUSE] 
10,93 1 1,165E7 4,012E6 0,00 10,93   2 3 
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Accession Description Σ Coverage 
Σ# 
Proteins A: Area B: Area 
Coverage 
A 
Coverage 
B 
# 
Peptides 
A 
# 
PSM 
A 
# 
Peptides 
B 
# 
PSM 
B 
Q80UW8 DNA-directed RNA 
polymerases I, II, and 
III subunit RPABC1 
OS=Mus musculus 
GN=Polr2e PE=2 
SV=1 - 
[RPAB1_MOUSE] 
14,76 1 1,012E7 2,037E6 0,00 14,76   2 2 
Q91V12 Cytosolic acyl 
coenzyme A thioester 
hydrolase OS=Mus 
musculus GN=Acot7 
PE=1 SV=2 - 
[BACH_MOUSE] 
5,77 1 9,677E6 4,981E6 0,00 5,77   2 2 
Q9CZH3 Proteasome 
assembly chaperone 3 
OS=Mus musculus 
GN=Psmg3 PE=1 
SV=1 - 
[PSMG3_MOUSE] 
22,95 1 9,315E6 1,559E6 0,00 22,95   2 2 
P70698 CTP synthase 1 
OS=Mus musculus 
GN=Ctps1 PE=1 
SV=2 - 
[PYRG1_MOUSE] 
11,51 1 9,256E6 2,226E6 0,00 11,51   5 6 
P45878 Peptidyl-prolyl cis-
trans isomerase 
FKBP2 OS=Mus 
musculus GN=Fkbp2 
PE=1 SV=1 - 
[FKBP2_MOUSE] 
39,29 1 9,117E6 7,352E5 0,00 39,29   3 3 
O35658 Complement 
component 1 Q 
subcomponent-
binding protein, 
mitochondrial 
OS=Mus musculus 
GN=C1qbp PE=1 
SV=1 - 
[C1QBP_MOUSE] 
19,42 1 8,779E6 4,054E6 0,00 19,42   4 5 
Q8BGJ9 Splicing factor 
U2AF 26 kDa subunit 
OS=Mus musculus 
GN=U2af1l4 PE=1 
SV=1 - 
[U2AF4_MOUSE] 
10,00 2 8,204E6 4,520E6 0,00 10,00   3 5 
P56959 RNA-binding 
protein FUS OS=Mus 
musculus GN=Fus 
PE=2 SV=1 - 
[FUS_MOUSE] 
7,72 1 7,874E6 1,664E6 0,00 7,72   2 8 
Q923D5 WW domain-
binding protein 11 
OS=Mus musculus 
GN=Wbp11 PE=1 
SV=2 - 
[WBP11_MOUSE] 
4,06 1 7,835E6 7,170E5 0,00 4,06   2 2 
P00405 Cytochrome c 
oxidase subunit 2 
OS=Mus musculus 
GN=Mtco2 PE=1 
SV=1 - 
[COX2_MOUSE] 
11,45 1 6,829E6 1,675E6 0,00 11,45   2 3 
Q61584 Fragile X mental 
retardation syndrome-
related protein 1 
OS=Mus musculus 
GN=Fxr1 PE=1 
SV=2 - 
[FXR1_MOUSE] 
5,91 1 6,555E6 9,556E5 0,00 5,91   3 4 
P06837 Neuromodulin 
OS=Mus musculus 
GN=Gap43 PE=1 
SV=1[NEUM_MOU] 
31,72 1 5,869E6 2,954E6 0,00 31,72   4 5 
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B 
O88653 Ragulator complex 
protein LAMTOR3 
OS=Mus musculus 
GN=Lamtor3 PE=1 
SV=1 - 
[LTOR3_MOUSE] 
27,42 1 5,381E6 1,220E6 0,00 27,42   3 3 
P60898 DNA-directed RNA 
polymerase II subunit 
RPB9 OS=Mus 
musculus GN=Polr2i 
PE=2 SV=1 - 
[RPB9_MOUSE] 
27,20 1 5,366E6 6,288E5 0,00 27,20   2 2 
P42125 Enoyl-CoA delta 
isomerase 1, 
mitochondrial 
OS=Mus musculus 
GN=Eci1 PE=2 
SV=2 - 
[ECI1_MOUSE] 
9,69 1 4,971E6 0,000E0 0,00 9,69   2 2 
P28740 Kinesin-like protein 
KIF2A OS=Mus 
musculus GN=Kif2a 
PE=1 SV=2 - 
[KIF2A_MOUSE] 
6,52 1 4,816E6 2,923E6 0,00 6,52   4 4 
Q8BTW3 Exosome complex 
component MTR3 
OS=Mus musculus 
GN=Exosc6 PE=1 
SV=1 - 
[EXOS6_MOUSE] 
15,38 1 4,801E6 1,873E6 0,00 15,38   3 3 
P51807 Dynein light chain 
Tctex-type 1 
OS=Mus musculus 
GN=Dynlt1 PE=1 
SV=1 - 
[DYLT1_MOUSE] 
23,01 1 4,677E6 1,613E6 0,00 23,01   2 2 
Q9CQC6 Basic leucine zipper 
and W2 domain-
containing protein 1 
OS=Mus musculus 
GN=Bzw1 PE=1 
SV=1 - 
[BZW1_MOUSE] 
11,93 1 4,612E6 0,000E0 0,00 11,93   2 2 
Q9JKY0 Cell differentiation 
protein RCD1 
homolog OS=Mus 
musculus GN=Rqcd1 
PE=1 SV=1 - 
[RCD1_MOUSE] 
10,37 1 4,610E6 1,392E6 0,00 10,37   2 2 
P26041 Moesin OS=Mus 
musculus GN=Msn 
PE=1 SV=3 - 
[MOES_MOUSE] 
15,08 1 4,568E6 3,874E6 0,00 15,08   7 7 
Q8R349 Cell division cycle 
protein 16 homolog 
OS=Mus musculus 
GN=Cdc16 PE=2 
SV=1 - 
[CDC16_MOUSE] 
3,23 1 4,386E6 1,799E6 0,00 3,23   2 2 
P62897 Cytochrome c, 
somatic OS=Mus 
musculus GN=Cycs 
PE=1 SV=2 - 
[CYC_MOUSE] 
32,38 2 4,147E6 1,216E6 0,00 32,38   4 5 
P97496 SWI/SNF complex 
subunit SMARCC1 
OS=Mus musculus 
GN=Smarcc1 PE=1 
SV=2 - 
[SMRC1_MOUSE] 
10,51 1 3,977E6 2,519E6 0,00 9,51   7 8 
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Q8CGC6 RNA-binding 
protein 28 OS=Mus 
musculus 
GN=Rbm28 PE=1 
SV=4 - 
[RBM28_MOUSE] 
3,33 1 3,646E6 8,301E5 0,00 3,33   2 3 
Q9R190 Metastasis-
associated protein 
MTA2 OS=Mus 
musculus GN=Mta2 
PE=1 SV=1 - 
[MTA2_MOUSE] 
8,08 1 3,424E6 9,315E5 0,00 8,08   4 4 
Q61191 Host cell factor 1 
OS=Mus musculus 
GN=Hcfc1 PE=1 
SV=2 - 
[HCFC1_MOUSE] 
1,61 1 3,364E6 1,871E6 0,00 1,61   2 3 
Q9CQV5 28S ribosomal 
protein S24, 
mitochondrial 
OS=Mus musculus 
GN=Mrps24 PE=2 
SV=1[RT24_MOUS] 
12,57 1 3,260E6 3,092E5 0,00 12,57   2 2 
P83870 PHD finger-like 
domain-containing 
protein 5A OS=Mus 
musculus GN=Phf5a 
PE=1 SV=1 - 
[PHF5A_MOUSE] 
40,00 1 3,204E6 1,446E6 0,00 40,00   4 4 
Q9JIX0 Enhancer of yellow 
2 transcription factor 
homolog OS=Mus 
musculus GN=Eny2 
PE=2 SV=1 - 
[ENY2_MOUSE] 
25,74 1 3,189E6 8,512E5 0,00 25,74   2 3 
Q9WU78 Programmed cell 
death 6-interacting 
protein OS=Mus 
musculus 
GN=Pdcd6ip PE=1 
SV=3 - 
[PDC6I_MOUSE] 
6,90 1 3,143E6 8,741E5 0,00 6,90   4 4 
Q3UEB3 Poly(U)-binding-
splicing factor PUF60 
OS=Mus musculus 
GN=Puf60 PE=2 
SV=2 - 
[PUF60_MOUSE] 
25,89 1 2,932E6 5,525E6 0,00 25,89   8 11 
Q9JHU9 Inositol-3-
phosphate synthase 1 
OS=Mus musculus 
GN=Isyna1 PE=2 
SV=1 - 
[INO1_MOUSE] 
5,21 1 2,894E6 1,654E6 0,00 5,21   2 2 
Q99KG3 RNA-binding 
protein 10 OS=Mus 
musculus 
GN=Rbm10 PE=1 
SV=1 - 
[RBM10_MOUSE] 
2,69 1 2,848E6 1,212E6 0,00 2,69   2 2 
Q3U0V1 Far upstream 
element-binding 
protein 2 OS=Mus 
musculus GN=Khsrp 
PE=1 SV=2 - 
[FUBP2_MOUSE] 
11,10 1 2,731E6 9,296E5 0,00 11,10   5 6 
Q91VD9 NADH-ubiquinone 
oxidoreductase 75 
kDa subunit, 
mitochondrial 
OS=Mus musculus 
GN=Ndufs1 PE=1 
SV=2 - 
[NDUS1_MOUSE] 
9,35 1 2,620E6 1,392E6 0,00 9,35   4 4 
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P47856 Glutamine--
fructose-6-phosphate 
aminotransferase 
[isomerizing] 1 
OS=Mus musculus 
GN=Gfpt1 PE=1 
SV=3 - 
[GFPT1_MOUSE] 
6,74 1 2,539E6 8,801E5 0,00 6,74   3 3 
Q91W50 Cold shock domain-
containing protein E1 
OS=Mus musculus 
GN=Csde1 PE=2 
SV=1 - 
[CSDE1_MOUSE] 
5,89 1 2,413E6 8,716E5 0,00 5,89   3 4 
Q61205 Platelet-activating 
factor acetylhydrolase 
IB subunit gamma 
OS=Mus musculus 
GN=Pafah1b3 PE=1 
SV=1 - 
[PA1B3_MOUSE] 
13,36 1 2,328E6 7,487E5 0,00 13,36   2 2 
O54774 AP-3 complex 
subunit delta-1 
OS=Mus musculus 
GN=Ap3d1 PE=1 
SV=1 - 
[AP3D1_MOUSE] 
3,42 1 2,319E6 1,746E6 0,00 3,42   3 3 
Q6PD26 GPI transamidase 
component PIG-S 
OS=Mus musculus 
GN=Pigs PE=1 SV=3 
- [PIGS_MOUSE] 
12,61 1 2,168E6 9,287E5 0,00 12,61   4 4 
O08992 Syntenin-1 
OS=Mus musculus 
GN=Sdcbp PE=2 
SV=1 - 
[SDCB1_MOUSE] 
12,04 1 2,146E6 4,041E5 0,00 12,04   2 2 
Q60790 Ras GTPase-
activating protein 3 
OS=Mus musculus 
GN=Rasa3 PE=1 
SV=2 - 
[RASA3_MOUSE] 
10,07 1 2,102E6 9,804E5 0,00 10,07   6 6 
P56960 Exosome 
component 10 
OS=Mus musculus 
GN=Exosc10 PE=1 
SV=2 - 
[EXOSX_MOUSE] 
3,83 1 1,996E6 1,219E6 0,00 3,83   2 2 
Q9QXK7 Cleavage and 
polyadenylation 
specificity factor 
subunit 3 OS=Mus 
musculus GN=Cpsf3 
PE=1 SV=2 - 
[CPSF3_MOUSE] 
4,97 1 1,914E6 1,323E6 0,00 4,97   2 2 
Q91Y86 Mitogen-activated 
protein kinase 8 
OS=Mus musculus 
GN=Mapk8 PE=1 
SV=1 - 
[MK08_MOUSE] 
5,73 3 1,911E6 9,947E4 0,00 5,73   2 2 
Q8CCP0 Nuclear export 
mediator factor Nemf 
OS=Mus musculus 
GN=Nemf PE=1 
SV=2 - 
[NEMF_MOUSE] 
3,38 1 1,904E6 7,387E5 0,00 3,38   3 3 
Q61495 Desmoglein-1-
alpha OS=Mus 
musculus GN=Dsg1a 
PE=2 SV=2 - 
[DSG1A_MOUSE] 
2,27 2 1,904E6 6,053E5 0,00 2,27   2 3 
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P52479 Ubiquitin carboxyl-
terminal hydrolase 10 
OS=Mus musculus 
GN=Usp10 PE=1 
SV=3 - 
[UBP10_MOUSE] 
4,29 1 1,746E6 6,238E5 0,00 4,29   3 3 
Q9R0P6 Signal peptidase 
complex catalytic 
subunit SEC11A 
OS=Mus musculus 
GN=Sec11a PE=2 
SV=1 - 
[SC11A_MOUSE] 
15,64 1 1,738E6 6,566E5 0,00 15,64   3 3 
Q8R050 Eukaryotic peptide 
chain release factor 
GTP-binding subunit 
ERF3A OS=Mus 
musculus GN=Gspt1 
PE=1 SV=2 - 
[ERF3A_MOUSE] 
9,28 1 1,721E6 2,235E6 0,00 9,28   4 4 
Q8CJG0 Protein argonaute-2 
OS=Mus musculus 
GN=Eif2c2 PE=1 
SV=3 - 
[AGO2_MOUSE] 
3,95 1 1,645E6 7,501E7 0,00 3,95   2 2 
P23780 Beta-galactosidase 
OS=Mus musculus 
GN=Glb1 PE=2 
SV=1 - 
[BGAL_MOUSE] 
3,55 1 1,590E6 8,945E5 0,00 3,55   2 2 
Q9ESV0 ATP-dependent 
RNA helicase 
DDX24 OS=Mus 
musculus GN=Ddx24 
PE=1 SV=2 - 
[DDX24_MOUSE] 
4,55 1 1,564E6 9,572E5 0,00 4,55   3 3 
Q11011 Puromycin-
sensitive 
aminopeptidase 
OS=Mus musculus 
GN=Npepps PE=1 
SV=2 - 
[PSA_MOUSE] 
6,74 1 1,532E6 5,664E5 0,00 6,74   5 5 
Q9CWG9 Biogenesis of 
lysosome-related 
organelles complex 1 
subunit 2 OS=Mus 
musculus 
GN=Bloc1s2 PE=1 
SV=1 - 
[BL1S2_MOUSE] 
25,17 1 1,478E6 1,613E6 0,00 25,17   2 2 
Q8CI11 Guanine nucleotide-
binding protein-like 3 
OS=Mus musculus 
GN=Gnl3 PE=1 
SV=2 - 
[GNL3_MOUSE] 
9,67 1 1,416E6 7,133E5 0,00 9,67   3 5 
Q8BUN5 Mothers against 
decapentaplegic 
homolog 3 OS=Mus 
musculus GN=Smad3 
PE=1 SV=2 - 
[SMAD3_MOUSE] 
5,65 3 1,304E6 2,817E6 0,00 5,65   2 2 
Q9CQZ5 NADH 
dehydrogenase 
[ubiquinone] 1 alpha 
subcomplex subunit 6 
OS=Mus musculus 
GN=Ndufa6 PE=1 
SV=1 - 
[NDUA6_MOUSE] 
14,50 1 1,241E6 2,918E5 0,00 14,50   2 2 
 
Appendix																																																																															 161	
Accession Description Σ Coverage 
Σ# 
Proteins A: Area B: Area 
Coverage 
A 
Coverage 
B 
# 
Peptides 
A 
# 
PSM 
A 
# 
Peptides 
B 
# 
PSM 
B 
Q9D706 RNA polymerase 
II-associated protein 
3 OS=Mus musculus 
GN=Rpap3 PE=1 
SV=1 - 
[RPAP3_MOUSE] 
9,39 1 1,180E6 7,470E5 0,00 9,39   3 3 
O08740 DNA-directed RNA 
polymerase II subunit 
RPB11 OS=Mus 
musculus GN=Polr2j 
PE=2 SV=1 - 
[RPB11_MOUSE] 
15,38 1 1,161E6 4,434E5 0,00 15,38   2 2 
Q9JMA1 Ubiquitin carboxyl-
terminal hydrolase 14 
OS=Mus musculus 
GN=Usp14 PE=1 
SV=3 - 
[UBP14_MOUSE] 
8,92 1 1,129E6 1,139E6 0,00 8,92   3 3 
O35343 Importin subunit 
alpha-4 OS=Mus 
musculus GN=Kpna4 
PE=2 SV=1 - 
[IMA4_MOUSE] 
5,95 1 1,107E6 1,635E6 0,00 5,95   2 3 
Q99KK7 Dipeptidyl 
peptidase 3 OS=Mus 
musculus GN=Dpp3 
PE=2 SV=2 - 
[DPP3_MOUSE] 
5,56 1 1,045E6 9,731E5 0,00 5,56   2 2 
Q9ES00 Ubiquitin 
conjugation factor E4 
B OS=Mus musculus 
GN=Ube4b PE=1 
SV=3 - 
[UBE4B_MOUSE] 
2,90 1 1,031E6 4,459E5 0,00 2,90   2 2 
Q7TT50 Serine/threonine-
protein kinase MRCK 
beta OS=Mus 
musculus 
GN=Cdc42bpb PE=1 
SV=2 - 
[MRCKB_MOUSE] 
1,81 1 9,817E5 1,763E5 0,00 1,81   2 2 
Q8BIJ6 Isoleucine--tRNA 
ligase, mitochondrial 
OS=Mus musculus 
GN=Iars2 PE=2 
SV=1 - 
[SYIM_MOUSE] 
5,24 1 9,600E5 5,403E5 0,00 5,24   3 3 
Q3TIV5 Zinc finger CCCH 
domain-containing 
protein 15 OS=Mus 
musculus 
GN=Zc3h15 PE=1 
SV=2 - 
[ZC3HF_MOUSE] 
12,21 1 8,853E5 3,980E6 0,00 12,21   3 3 
O88379 Bromodomain 
adjacent to zinc 
finger domain protein 
1A OS=Mus 
musculus GN=Baz1a 
PE=1 SV=3 - 
[BAZ1A_MOUSE] 
1,61 1 7,883E5 2,824E5 0,00 1,61   2 2 
Q01405 Protein transport 
protein Sec23A 
OS=Mus musculus 
GN=Sec23a PE=1 
SV=2 - 
[SC23A_MOUSE] 
11,37 1 7,751E5 2,116E6 0,00 11,37   6 7 
D3YXK2 Scaffold attachment 
factor B1 OS=Mus 
musculus GN=Safb 
PE=1 SV=2 - 
[SAFB1_MOUSE] 
5,66 1 6,170E5 1,105E6 0,00 5,66   3 3 
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P70399 Tumor suppressor 
p53-binding protein 1 
OS=Mus musculus 
GN=Tp53bp1 PE=1 
SV=2 - 
[TP53B_MOUSE] 
3,47 1 5,838E5 7,391E5 0,00 3,47   4 4 
P37913 DNA ligase 1 
OS=Mus musculus 
GN=Lig1 PE=1 
SV=2 - 
[DNLI1_MOUSE] 
5,13 1 2,861E5 4,498E5 0,00 5,13   3 3 
Q6PGG6 Guanine nucleotide-
binding protein-like 
3-like protein 
OS=Mus musculus 
GN=Gnl3l PE=1 
SV=1 - 
[GNL3L_MOUSE] 
6,24 1 2,548E5 2,802E5 0,00 6,24   2 2 
Q70FJ1 A-kinase anchor 
protein 9 OS=Mus 
musculus GN=Akap9 
PE=2 SV=2 - 
[AKAP9_MOUSE] 
0,66 1 0,000E0 7,145E4 0,00 0,66   2 2 
P39053 Dynamin-1 
OS=Mus musculus 
GN=Dnm1 PE=1 
SV=2 - 
[DYN1_MOUSE] 
1,96 1 0,000E0 4,471E5 0,00 1,96   2 2 
Q60902 Epidermal growth 
factor receptor 
substrate 15-like 1 
OS=Mus musculus 
GN=Eps15l1 PE=1 
SV=3 - 
[EP15R_MOUSE] 
2,98 1 0,000E0 4,826E5 0,00 2,98   2 2 
Q8CHG3 GRIP and coiled-
coil domain-
containing protein 2 
OS=Mus musculus 
GN=Gcc2 PE=1 
SV=2 - 
[GCC2_MOUSE] 
1,61 1 0,000E0 4,051E5 0,00 1,61   2 2 
Q9CQQ8 U6 snRNA-
associated Sm-like 
protein LSm7 
OS=Mus musculus 
GN=Lsm7 PE=3 
SV=1 - 
[LSM7_MOUSE] 
25,24 1 0,000E0 6,622E5 0,00 25,24   2 2 
Q8K224 N-acetyltransferase 
10 OS=Mus 
musculus GN=Nat10 
PE=2 SV=1 - 
[NAT10_MOUSE] 
11,72 1 0,000E0 9,199E5 0,00 11,72   9 9 
Q9CSH3 Exosome complex 
exonuclease RRP44 
OS=Mus musculus 
GN=Dis3 PE=2 
SV=4 - 
[RRP44_MOUSE] 
2,92 1 0,000E0 5,435E5 0,00 2,92   2 2 
Q8CH25 SAFB-like 
transcription 
modulator OS=Mus 
musculus GN=Sltm 
PE=1 SV=1 - 
[SLTM_MOUSE] 
5,63 1 0,000E0 9,269E5 0,00 5,63   4 4 
Q8BLY2 Probable threonine-
-tRNA ligase 2, 
cytoplasmic OS=Mus 
musculus GN=Tarsl2 
PE=2 SV=1 - 
[SYTC2_MOUSE] 
2,91 1 0,000E0 3,957E5 0,00 2,91   2 2 
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Q6PFR5 Transformer-2 
protein homolog 
alpha OS=Mus 
musculus GN=Tra2a 
PE=1 SV=1 - 
[TRA2A_MOUSE] 
15,66 1 0,000E0 2,427E6 0,00 15,66   3 3 
Q8C7V3 U3 small nucleolar 
RNA-associated 
protein 15 homolog 
OS=Mus musculus 
GN=Utp15 PE=2 
SV=1 - 
[UTP15_MOUSE] 
3,79 1 0,000E0 3,560E5 0,00 3,79   2 2 
Q99KQ4 Nicotinamide 
phosphoribosyltransf
erase OS=Mus 
musculus GN=Nampt 
PE=1 SV=1 - 
[NAMPT_MOUSE] 
5,09 1 0,000E0 2,495E6 0,00 5,09   2 2 
Q6P542 ATP-binding 
cassette sub-family F 
member 1 OS=Mus 
musculus GN=Abcf1 
PE=1 SV=1 - 
[ABCF1_MOUSE] 
7,29 1 0,000E0 7,370E5 0,00 7,29   4 4 
Q9EST5 Acidic leucine-rich 
nuclear 
phosphoprotein 32 
family member B 
OS=Mus musculus 
GN=Anp32b PE=1 
SV=1 - 
[AN32B_MOUSE] 
11,40 1 0,000E0 5,485E6 0,00 11,40   2 2 
Q99LI7 Cleavage 
stimulation factor 
subunit 3 OS=Mus 
musculus GN=Cstf3 
PE=1 SV=1 - 
[CSTF3_MOUSE] 
3,91 1 0,000E0 9,368E5 0,00 3,91   2 2 
Q8CI75 DIS3-like 
exonuclease 2 
OS=Mus musculus 
GN=Dis3l2 PE=1 
SV=1 - 
[DI3L2_MOUSE] 
3,68 1 0,000E0 0,000E0 0,00 3,68   2 2 
Q5U458 DnaJ homolog 
subfamily C member 
11 OS=Mus musc 
GN=Dnajc11 PE=2 
SV=2 – 
[DJC11_MOUSE] 
4,83 1 0,000E0 5,401E5 0,00 4,83   2 2 
Q91WJ8 Far upstream 
element-binding 
protein 1 OS=Mus 
musculus GN=Fubp1 
PE=1 SV=1 – 
[FUBP1_MOUSE] 
3,99 1 0,000E0 1,258E6 0,00 3,99   2 2 
P07310 Creatine kinase M-
type OS=Mus 
musculus GN=Ckm 
PE=1 SV=1 – 
[KCRM_MOUSE] 
11,81 1 0,000E0 4,678E6 0,00 11,81   4 4 
Q9QWT9 Kinesin-like protein 
KIFC1 OS=Mus 
musculus GN=Kifc1 
PE=1 SV=2 – 
[KIFC1_MOUSE] 
7,72 1 0,000E0 1,250E6 0,00 7,72   3 4 
Q99KE1 NAD-dependent 
malic enzyme, 
mitochondrial 
OS=Mus musculus 
GN=Me2 PE=2 
SV=1 – 
[MAOM_MOUSE] 
4,24 1 0,000E0 9,576E5 0,00 4,24   2 2 
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Q91YP2 Neurolysin, 
mitochondrial 
OS=Mus musculus 
GN=Nln PE=2 SV=1 
- [NEUL_MOUSE] 
4,12 1 0,000E0 8,037E5 0,00 4,12   2 2 
Q9R0B9 Procollagen-
lysine,2-oxoglutarate 
5-dioxygenase 2 
OS=Mus musculus 
GN=Plod2 PE=2 
SV=2 - 
[PLOD2_MOUSE] 
4,48 1 0,000E0 3,010E5 0,00 4,48   3 3 
Q99LL5 Periodic tryptophan 
protein 1 homolog 
OS=Mus musculus 
GN=Pwp1 PE=1 
SV=1 - 
[PWP1_MOUSE] 
17,96 1 0,000E0 4,030E6 0,00 17,96   5 5 
Q9D1H8 39S ribosomal 
protein L53, 
mitochondrial 
OS=Mus musculus 
GN=Mrpl53 PE=2 
SV=1[RM53_MOU] 
25,42 1 0,000E0 1,415E6 0,00 25,42   2 2 
Q6NZC7 SEC23-interacting 
protein OS=Mus 
musculus GN = 
Sec23ip PE=1 SV=2 
- [S23IP_MOUSE] 
3,21 1 0,000E0 1,276E6 0,00 3,21   3 4 
Q60520 Paired amphipathic 
helix protein Sin3a 
OS=Mus musculus 
GN=Sin3a PE=1 
SV=3 - 
[SIN3A_MOUSE] 
4,71 1 0,000E0 6,654E5 0,00 4,71   5 5 
Q9CZW5 Mitochondrial 
import receptor 
subunit TOM70 
OS=Mus musculus 
GN=Tomm70a PE=1 
SV=2 - 
[TOM70_MOUSE] 
5,73 1 0,000E0 1,816E6 0,00 5,73   2 2 
Q8CE96 tRNA (adenine(58)-
N(1))-
methyltransferase 
non-catalytic subunit 
TRM6 OS=Mus 
musculus GN=Trmt6 
PE=1 SV=1 - 
[TRM6_MOUSE] 
3,82 1 0,000E0 9,263E5 0,00 3,82   2 2 
Q6PAM1 Alpha-taxilin 
OS=Mus musculus 
GN=Txlna PE=2 
SV=1 - 
[TXLNA_MOUSE] 
5,05 1 0,000E0 1,020E6 0,00 5,05   2 2 
Q9D1C1 Ubiquitin-
conjugating enzyme 
E2 C OS=Mus 
musculus GN=Ube2c 
PE=2 SV=1 - 
[UBE2C_MOUSE] 
18,44 1 0,000E0 1,651E6 0,00 18,44   2 2 
Q9JKC8 AP-3 complex 
subunit mu-1 
OS=Mus musculus 
GN=Ap3m1 PE=1 
SV=1 - 
[AP3M1_MOUSE] 
6,70 1 0,000E0 2,043E6  6,70   2 2 
Q91XV3 Brain acid soluble 
protein 1 OS=Mus 
musculus GN=Basp1 
PE=1 SV=3 - 
[BASP1_MOUSE] 
30,09 1 0,000E0 3,936E6  30,09   2 2 
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P67871 Casein kinase II 
subunit beta OS=Mus 
musculus 
GN=Csnk2b PE=1 
SV=1 - 
[CSK2B_MOUSE] 
12,56 1 0,000E0 2,860E6  12,56   2 2 
Q9JIQ3 Diablo homolog, 
mitochondrial 
OS=Mus musculus 
GN=Diablo PE=1 
SV=2 - 
[DBLOH_MOUSE] 
12,66 1 0,000E0 3,534E5  12,66   2 2 
Q6WQJ1 Sn1-specific 
diacylglycerol lipase 
alpha OS=Mus 
musculus GN=Dagla 
PE=1 SV=2 - 
[DGLA_MOUSE] 
3,93 1 0,000E0 1,138E6  3,93   3 4 
O70378 ER membrane 
protein complex 
subunit 8 OS=Mus 
musculus GN=Emc8 
PE=1 SV=1 - 
[EMC8_MOUSE] 
12,08 1 0,000E0 6,897E5  12,08   2 2 
O08579 Emerin OS=Mus 
musculus GN=Emd 
PE=1 SV=1 - 
[EMD_MOUSE] 
12,36 1 0,000E0 4,238E5  12,36   2 2 
Q8BFZ9 Erlin-2 OS=Mus 
musculus GN=Erlin2 
PE=1 SV=1 - 
[ERLN2_MOUSE] 
8,53 1 0,000E0 2,383E6  8,53   2 2 
P51859 Hepatoma-derived 
growth factor 
OS=Mus musculus 
GN=Hdgf PE=1 
SV=2 - 
[HDGF_MOUSE] 
27,00 1 0,000E0 3,010E6  27,00   3 3 
Q9CQZ1 Heat shock factor-
binding protein 1 
OS=Mus musculus 
GN=Hsbp1 PE=2 
SV=1 - 
[HSBP1_MOUSE] 
39,47 1 0,000E0 2,545E5  39,47   2 2 
Q8BWW4 La-related protein 4 
OS=Mus musculus 
GN=Larp4 PE=1 
SV=2 - 
[LARP4_MOUSE] 
4,03 1 0,000E0 2,977E5  4,03   2 2 
P53986 Monocarboxylate 
transporter 1 
OS=Mus musculus 
GN=Slc16a1 PE=1 
SV=1 - 
[MOT1_MOUSE] 
6,09 1 0,000E0 2,397E6  6,09   2 2 
Q9DCJ5 NADH 
dehydrogenase 
[ubiquinone] 1 alpha 
subcomplex subunit 8 
OS=Mus musculus 
GN=Ndufa8 PE=1 
SV=3 - 
[NDUA8_MOUSE] 
18,60 1 0,000E0 1,046E6  18,60   2 2 
P52503 NADH 
dehydrogenase 
[ubiquinone] iron-
sulfur protein 6, 
mitochondrial 
OS=Mus musculus 
GN=Ndufs6 PE=1 
SV=2 - 
[NDUS6_MOUSE] 
25,00 1 0,000E0 1,958E5  25,00   2 3 
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Q99N92 39S ribosomal 
protein L27, 
mitochondrial 
OS=Mus musculus 
GN=Mrpl27 PE=2 
SV=1 - 
[RM27_MOUSE] 
17,57 1 0,000E0 5,434E5  17,57   2 2 
Q9CZ83 39S ribosomal 
protein L55, 
mitochondrial 
OS=Mus musculus 
GN=Mrpl55 PE=2 
SV=1 - 
[RM55_MOUSE] 
30,71 1 0,000E0 1,295E6  30,71   4 4 
Q791N7 DNA-directed RNA 
polymerase I subunit 
RPA12 OS=Mus 
musculus GN=Znrd1 
PE=2 SV=1 - 
[RPA12_MOUSE] 
30,89 1 0,000E0 6,175E5  30,89   2 2 
Q60710 SAM domain and 
HD domain-
containing protein 1 
OS=Mus musculus 
GN=Samhd1 PE=1 
SV=2 - 
[SAMH1_MOUSE] 
6,38 1 0,000E0 6,807E5  6,38   2 2 
Q8CAY6 Acetyl-CoA 
acetyltransferase, 
cytosolic OS=Mus 
musculus GN=Acat2 
PE=1 SV=2 - 
[THIC_MOUSE] 
9,07 1 0,000E0 2,793E6  9,07   2 2 
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A.2 Publications 
 
Parts of this work have been published: 
 
 
1.  Jenniches I, Ternes S, Albayram O, Otte DM, Bach K, Bindila L, Michel K, Lutz B, Bilkei-
Gorzo A, Zimmer A. (2016): Anxiety, Stress, and Fear Response in Mice with Reduced 
Endocannabinoid Levels. Biol Psychiatry. 79(10):858-68. 
2. Jenniches I, Zimmer A. (2016): Reply To: The Anxiolytic Actions of 2-Arachidonoylglycerol: 
Converging Evidence from Two Recent Genetic Endocannabinoid Deficiency Models. Biol 
Psychiatry. 79(10):e80-1. 
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I hereby solely declare that I prepared this thesis entitled “Importance of endogenous 
cannabinoids in stress and depression” entirely by myself except otherwise stated. All text 
passages that are literally or correspondingly taken from published or unpublished 
papers/writings are indicated as such. All materials or services provided by other persons are 
equally indicated. 
         
Bonn, April 2016 
 
         
         Imke Jenniches 
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